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Abstract 
Dementia is a common cause of disability in the elderly and, in the absence of a 
successful long-term treatment, it is important to investigate possible lifestyle interventions 
to help reduce an individual’s risk of developing the condition. This thesis investigated the 
relationship between physical activity and dementia risk, finding that not all research 
supports the link. The literature review presented in this thesis (Chapter 2) highlighted 
several possible mediating factors, specifically the type of physical activity performed, the 
cognitive domains being studied and participant characteristics. Women seemed most 
susceptible to the effect of physical activity and some other forms of midlife interventions, 
possible mechanisms for which were discussed in another review (Appendix A). The 
cognitive test battery to be used in later studies was evaluated for its relevance to 
dementia and treatment during a 6-month study of Alzheimer's disease patients and their 
carers (Chapter 3). Memory tasks were found to be especially sensitive to clinical 
outcomes of dementia treatment (Chapter 4). An observational study of Indonesian elderly 
found a positive relationship between physical activity and memory performance on the 
same tests. This effect was strongest in women and in those with no pre-existing cognitive 
impairment (Chapter 5). However, the relationship could be further modified by other 
demographic factors, such as education. Health was independently affected in this model 
by exercise and its association with engaging in physical activity in this cohort was further 
investigated in Chapter 6. A randomised controlled trial (Chapter 7) was conducted to 
assess the effect of a 12-week programme of non-aerobic physical activity in sedentary 
middle-aged adults. Results indicated that resistance training, but not flexibility exercises, 
influenced memory but not executive function. Overall, this thesis suggests that several 
types of physical activity may be effective at slowing cognitive decline in elderly groups 
who are at increased risk of dementia, such as those in middle age and elderly women 
(Chapter 8). These findings should be expanded with the aim to improve healthcare 
advice and influence policy-making.  
 
Keywords: physical activity, cognitive impairment, dementia, aging, memory, resistance 
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General Introduction 
As people age, cognitive abilities change and can range from superior 
performance to impairment that impedes activities of daily living. In pathological cases this 
decline takes the form of a clinical syndrome, or dementia. There are different types of 
dementia – the most common being Alzheimer's disease (AD) (Fratiglioni et al., 1991) – 
and the vast majority of sufferers are over 65 years old. With improving technology and 
healthcare, life expectancy is increasing around the world and the percentage of the UK 
population over the age of 65 years is expected to rise from 16.7% in 2011 to almost 23% 
by 2034 (Office of National Statistics [ONS], 2010). Dementia is therefore expected to 
continue to be a growing problem in the future, with the projected number of cases rising 
from 24.3 million in 2001 to 81.1 million worldwide by 2040 (Ferri et al., 2005). 
There is currently no treatment that reverses the neural damage and symptoms of 
AD or other forms of dementia and many patients die from complications of the disease, 
such as pneumonia or severe malnutrition caused by immobility, infection and swallowing 
disorders. Disease progression lasts on average 7 years before death (Fitzpatrick, Kuller, 
Lopez, Kawas, & Jagust, 2005) but can be much longer, leaving patients in need of 
substantial financial, medical and practical assistance with daily living. According to Wimo, 
Winblad and Jönsson (2010), the financial cost of care for those with dementia worldwide 
totalled around $422 billion in 2009. People with dementia often need help with everyday 
tasks such as shopping, personal hygiene, housekeeping and managing money, and 
many caregivers are relatives of the patient which can bring its own social challenges. A 
focus group made up of carers reported feeling tired, frustrated at a lack of information 
and support, and guilty about the proxy end-of-life decisions they may be forced to make 
(Livingston et al., 2010). AD and other forms of dementia thus have additional impacts on 
patients and their carers beyond those caused directly by cognitive impairment.   
The consequences of AD even in the earliest stages mean that research into the 
prevention of the disease is especially important. Brookmeyer, Johnson, Ziegler-Graham 
and Arrighi (2007) suggest that delaying AD onset in individuals by just 1 year would 
substantially reduce the burden of AD by 2050 by reducing the number of patients 
needing a high level of care, such as residential placement. The aim of this thesis was 
thus to investigate the effectiveness of lifestyle interventions for AD, which can be low cost 
and easily accessible to the majority of the public.  
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Physical activity as a lifestyle intervention for dementia has been explored 
previously and there are a wealth of studies showing strong associations between 
physical activity and cognitive abilities. Our aim, therefore, was not to establish presence 
or absence of a link but rather to identify variables that may influence the relationship to 
determine whether certain groups benefit more from physical activity than others, whether 
the cognitive benefits are domain specific, whether certain types of physical activity are 
more effective than others, and whether certain variables act as mediating or moderating 
factors.  
Part One of this thesis discusses and reviews existing literature in this field. In 
Chapter 1, we describe the key features of AD and discuss the mechanisms by which 
physical activity interventions may reduce an individual’s risk of developing the disease. In 
Chapter 2, we present a literature review that describes and compares studies 
investigating the effects of physical activity on cognitive performance. This review aimed 
to identify some of the possible mediating and moderating factors that will be addressed in 
the later sections of this thesis and identify why controversy exists within this field. The 
review was published as a chapter in the Handbook of Cognitive Aging: Causes, 
Processes and Effects (Clifford, Bandelow & Hogervorst, 2009). As effects of physical 
activity seemed most prominent in women from the literature review, another review (see 
Appendix A) focused on other midlife lifestyle interventions to prevent cognitive decline 
and dementia for women specifically (published as a full paper in Aging Health; Clifford, 
Yesufu Udechuku, Edwards, Bandelow & Hogervorst., 2009).  
 In Part Two, we introduce the cognitive tests that were used in the studies 
presented in this thesis and discuss their relevance to age-related cognitive decline and 
dementia. In Chapter 3 we discuss their relevance to the cognitive deficits seen in AD. In 
Chapter 4 we present the specific methods used and validate our versions of these tests 
in a 6-month treatment study of AD patients and their carers. This study showed high 
sensitivity to AD for most of our tests and showed that they were suitable for use in the 
physical activity studies.  
Part Three (Chapter 5) describes an observational cohort study investigating the 
association between physical activity and cognition in Indonesia. The aims of this study 
were to assess the impact of sex and age on the relationship between everyday physical 
activity and cognition. Physical health measures were included to determine whether they 
act as a causal pathway. Age and sex were both found to mediate the relationship and 
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better physical health explained some, but not all, of the association between participation 
in physical activity and better memory. This study also revealed some cultural factors that 
should be considered in future research investigating physical activity interventions. 
Chapter 6 discusses the associations of health and exercise in more depth.  
 Part Four (Chapter 7) describes a pilot intervention study based in the UK that 
assessed the impact of a 12-week resistance-training programme on cognitive 
performance. This study recruited middle-aged men and women who had no evidence of 
cognitive impairment and built upon the findings of the literature review and previous 
observational study by assessing strength training, causal pathways and different 
cognitive domains measured. Significant associations were seen between resistance 
training and memory, but not executive function, independently of muscle strength 
changes. Effects were strongest in women, similar to findings in Chapters 2 and 5. 
Part Five (Chapter 8) combines the results of the previous chapters and gives 
recommended directions for future research. 
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This chapter is published in part with the Discussion in “Frontiers in Clinical Drug 
Research – Alzheimer Disorders” 
Part One – Literature review 
Chapter 1 – Introduction to dementia 
 
1.1. Description of Dementia and Alzheimer’s disease 
The term ‘dementia’ refers to a group of acquired cognitive symptoms that impact 
on activities of daily living and that are most commonly seen in those over the age of 65 
years. The idea of age-associated cognitive decline has been documented since Greco-
Roman times (Karenberg & Forstl, 2006). However, we now know that there are several 
types of dementia, each with their own aetiologies, symptoms and progression. Some 
forms of dementia can be at least partially reversed or halted by removing the cause, such 
as vitamin deficiencies, endocrine disease, electrolyte imbalance, lead intoxication and 
alcoholism. Other types of dementia are progressive and non-reversible, showing gradual 
decline until death. Such dementias include Lewy Body dementia, Frontotemporal 
dementia, dementia with Parkinson’s disease and Creutzfeld-Jakob disease. Alzheimer's 
disease (AD) accounts for around 50-70% of diagnosed cases of progressive dementia 
(e.g. Hardy, 1997) and often co-occurs with Vascular Dementia (VaD). Dementia can thus 
be considered an umbrella term for a range of disorders of which AD is the most common.   
Many of the difficulties experienced in AD are with memory, both verbal and non-
verbal. AD often becomes apparent due to a progressive decline in remembering new 
information, with more severe cases experiencing difficulties recalling events from many 
years previously (American Psychiatric Association [APA], 1994). For example, individuals 
may fail to recognise familiar people such as family and friends, forget recent events, and 
get lost in familiar surroundings. Not all symptoms of AD are related to memory, however, 
and other cognitive domains are usually also affected. These include reduced executive 
function abilities which manifest as difficulty in planning activities, such as making a meal, 
washing oneself and playing a game, and making judgements such as dressing 
appropriately for the occasion. Attention and language can also be affected, causing 
difficulties with following a conversation, remembering words and using the correct word in 
a sentence. Although these deficits are common in AD, they do vary widely between 
individuals and as such different cases can present with very different symptom profiles. 
14 
The heterogeneity of symptoms means that diagnosis of AD is not straightforward, 
especially since many older individuals experience some decline in memory ability and 
changes in brain activity as part of the normal aging process (Bishop, Lu & Yankner, 
2010). In order to be diagnosed as having AD, a memory deficit should be accompanied 
by impairment in at least one other cognitive domain (e.g. language, object recognition, 
motor functions) that interferes with the ability to carry out daily tasks (Diagnostic and 
Statistical Manual of Mental Disorders 4th Edition; [DSM-IV]; APA, 1994). Memory 
impairments should normally be present for at least 6 months before a diagnosis can be 
made to help rule out potentially reversible syndromes, such as transient ischemic attack, 
brain trauma or hydroencephalus (International Statistical Classification of Disease and 
Related Health Problems 10th Revision [ICD-10]; World Health Organisation [WHO], 
1992). Cognitive symptoms should also occur without impaired awareness or altered 
consciousness (i.e. delirium) but may be accompanied by mood changes, such as apathy 
or irritability (WHO,1992). In addition, the diagnostic procedure may be supported by 
neuroimaging and analysis of biomarkers of the disease (e.g. Dubois et al., 2010; 
McKhann et al., 2011). Those with a memory complaint who do not reach the criteria for 
probable AD (McKhann et al., 2011) may be diagnosed with possible AD or Mild Cognitive 
Impairment (MCI; Petersen et al., 1999), which is characterised by a memory impairment 
that does not affect activities of daily living. Approximately 64% of people who are 
diagnosed with MCI go on to be diagnosed with AD after 2 years (Geslani, Tierney, 
Herrmann & Szalai, 2005). However, some patients with MCI never develop AD, and it 
remains unclear whether MCI represents a transitional stage to AD or whether it is an 
independent disorder that makes an individual vulnerable to further decline. 
An analysis of neuropathology reveals characteristic features of AD that are being 
increasingly considered as potential biomarkers. A loss of brain volume in the medial 
temporal lobe, especially in the hippocampus, temporal poles and temporoparietal 
junction, is seen in over 70% of AD patients (Dubois et al., 2007). These brain areas are 
thought to be responsible for memory and increased atrophy in these areas is associated 
with poor memory performance in AD as well as in healthy individuals (e.g. Golomb et al., 
1994; Lind et al., 2006; de Toledo-Morrell et al., 2000). At a cellular level, AD patients tend 
to show increased levels of intracellular neurofibrillary tangles (NFTs), which consist of 
hyperphosphorylated tau protein, and extracellular protein plaques containing high levels 
of Amyloid-β (Aβ). Tau protein is involved in giving structure to the axon of a neuron and a 
15 
decline in its quality can cause the microtubules of the axon to lose their shape. Aβ is a 
peptide formed from the cleavage of Amyloid Precursor Protein whose own function is 
currently unclear but is thought to be involved in the passage of messages across 
synapses (Priller et al., 2006). Excess insoluble Aβ in the brain causes deposits (plaques) 
on the outside of the neuron, affecting neuronal quality and function. Although NFTs and 
Aβ plaques are seen in healthy aging (Hyman et al., 2012), they are generally seen in 
excessive amounts in those with AD and abnormal levels can be measured in 
cerebrospinal fluid years before onset of symptoms (Dubois et al., 2007). The dominant 
theory suggests that these features cause dementia symptoms (Mohajeri & Leuba, 2009). 
However, it remains controversial whether Aβ plaques cause AD or are simply a feature of 
it, especially since research into treatments that target these features has to date been 
relatively unsuccessful (e.g. bapineuzumab [Johnson & Johnson, 2012], tarenflurbil 
[Myriad Genetics, 2008] and semagacestat [Eli Lily, 2010]).  
 
1.2. Non-modifiable risk factors: Genetics and AD risk 
Despite extensive research using humans as well as mouse, rat and fly models, 
the cause of AD is currently unknown. Several genes have been identified that appear to 
increase an individual’s risk of developing late onset AD (early onset AD has a clear 
familial genetic component but is relatively rare and is not the topic of this thesis). One of 
the better-known genes is called Apolipoprotein E (ApoE), where possession of two 
epsilon-4 alleles increases risk of AD in comparison to possession of just one, which itself 
increases risk of AD compared to possession of no epsilon-4 alleles (Corder et al., 1993; 
Tsai et al., 1994). In contrast, the epsilon-2 allele has been observed to be protective 
against AD (Tsai et al., 1994). ApoE has been linked to lipid transport and the breakdown 
of Aβ (Raber, 2008). The epsilon-4 allele appears to be less effective at this breakdown 
process than other variants (Baum, Chen, Ng & Pang, 2000) resulting in higher levels of 
amyloid plaques. Other genes implicated in AD susceptibility such as CLU, BIN1 and 
PICALM are thought to be involved in mitochondrial energy metabolism and stress 
resistance, lipid metabolism, endocytosis and neuroinflammation (Harold et al., 2009; Hu 
et al., 2011; Liang et al., 2008). However, these genes predict a minority of AD cases 
(Rocchi, Pellegrini, Siciliano, & Murri, 2003) and so it is likely that external factors, 
including environment and chance, play a large part. Lifestyle behaviours may thus 
significantly contribute to an individual’s risk of developing the disorder.  
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1.3. Modifiable protective factors: Lifestyle, physical activity and prevention of dementia 
Physical activity refers to any type of sustained movement, including day-to-day 
activity such as walking as well as structured exercise such as sport and fitness classes. 
Physical activity has long been recommended to promote physical health in the elderly 
because it helps to maintain a healthy weight, lowers cholesterol and blood pressure (BP), 
and reduces risk of disorders such as diabetes, heart disease and cancer (Haskell et al., 
2007). Even a small amount of physical activity can have a huge impact on health; Wen et 
al. (2011) showed that all-cause mortality over 8 years was reduced by 14% in those 
exercising to the equivalent of just 15 minutes per day compared to those who were 
inactive.  However, less than 40% of middle- to older-aged adults meet the recommended 
amount of physical activity (which is 30 minutes, at least 5 times per week; Haskell et al., 
2007). Physical activity can be low cost, there is choice of different activities, and it is 
accessible to most regardless of ability. Encouraging an active lifestyle in the elderly is 
therefore a sensible intervention that is worthy of consideration. Moreover, there is a 
social component to group activities, which may add to their appeal and possibly their 
effectiveness. Psychosocial mediators of the effect of physical activity on cognitive 
function are discussed in more detail elsewhere (Stock, Clifford & Hogervorst, 2012).  
 
1.4. Mechanisms for protective effects of physical activity on brain function 
Physical activity seems to be a sensible intervention for Alzheimer’s disease but an 
equally important question is whether there are any theoretical mechanisms through 
which physical activity may impact on cognitive functioning. There are many plausible 
mechanisms that have been suggested, which are described below and presented in 
Figure 1. 
 
1.4.1. Direct causal effects and the association of physical activity with cognitive reserve 
Physical activity is believed to increase cell proliferation and promote the 
maturation of cells to fully integrated neurons (van Praag, Christie, Sejnowski & Gage, 
1999; Kim et al., 2010; for a review see Schaeffer, Novaes, da Silva, Skaf & Mendes-
Neto, 2009). Van der Borght, Havekes, Bos, Eggen & Van der Zee (2007) found that  
running increased the number of young neurons in the mouse dentate gyrus (see also  
17 
Kim et al., 2010). While previously controversial, it is now generally accepted that 
neurogenesis occurs in two regions within the adult brain, one of which is the subgranular 
zone of the dentate gyrus in the hippocampus (Zhao, Deng & Gage, 2008), an area 
implicated in memory (Diana, Yonelinas & Ranganath, 2007) that is particularly affected in 
AD (Rombouts, Barkhof, Witter & Scheltens, 2000). Reduced neurogenesis is not 
considered to be directly or solely responsible for AD but neurogenesis is known to 
decline in older age (Verret, Trouche, Zerwas & Rampon, 2007) and preventing cells from 
dividing impairs memory performance (Shors et al., 1995), potentially exacerbating the 
effects of dementia pathology. In addition, Acetylcholinesterase Inhibitor (AChEI) 
treatments – the primary treatment for AD that can temporarily help to slow symptom 
progression – increase the number of young cells and neuroblasts (cells that are mature 
but not yet integrated in neural networks), found in vivo and in vitro (DeCarolis & Eisch, 
2010).  
Levels of neurotrophins increase after physical activity, such as Insulin-Like Growth 
Factor-1 (IGF-1; Nakajima, Ohsawa, Ohta, Ohno & Mikami, 2010). Exercise induced IGF-
1 is associated with increased neurogenesis (LLorens-Martín, Torres-Alemán & Trejo, 
2010). This may reflect a downstream process as IGF-1 induces Brain-Derived 
Neurotrophic Factor (BDNF), which helps to promote the survival of neural stem cells (e.g. 
Zhao et al., 2008; Bothwell, 1995). BDNF supports cholinergic neurons and it is secreted 
by pyramidal neurons in the hippocampus (Schaeffer et al., 2009). Physical activity is also 
associated with increased levels of Granulocyte Colony Stimulating Factor (G-CSF) in the 
cingulate and prefrontal cortices in older human adults (Flöel et al., 2010). G-CSF helps to 
inhibit proinflammatory cytokines, such as IL1, TNF and IFN-, which are released by 
microglia as part of an immune response by plaque deposition, potentially worsening 
dementia pathology through a cyclical relationship (Nichol et al., 2008). Inflammatory 
markers within the hippocampus have been observed to decrease following physical 
activity (Lovatel et al., 2013). Direct causal effects of physical activity on cognition are 
therefore plausible and this makes it important to evaluate physical activity as an 
intervention for AD. However, new cells take time to become functional and integrated into 
the dentate gyrus (Zhao, Teng, Summers Jr,, Ming & Gage, 2006), yet memory and 
attention improvements have been demonstrated after an acute bout of physical activity 
(e.g. Hogervorst, Bandelow, Clifford & Stock, unpublished raw data). Neurogenesis is 
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therefore not the only potential causal pathway through which physical activity can 
influence cognitive functioning. 
 
 
 
Figure 1 
Theoretical mechanisms for protective effects of physical activity on cognitive function
1 
 
 
Physical activity that increases the heart rate encourages the flow of blood and 
oxygen around the body including the brain (Querido & Sheel, 2007; Ogoh, 2008; Rhyu et 
al., 2010), preventing loss of tissue through hypoxia to which the hippocampus is thought 
to be particularly sensitive (Di Paola et al., 2008). Brain volume is at least maintained in 
both gray and white matter areas after long-term physical activity (Colcombe et al., 2006) 
and perhaps particularly the right anterior frontal cortex (Flöel et al., 2010) and the 
                                                 
1Figure developed by Prof E Hogervorst 
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hippocampus (Yuede et al, 2009), both of which are involved in memory. Direct 
neurological effects of physical activity are purported to affect cognitive functioning 
through what has come to be known as “cognitive reserve”. Supporters of this theory 
suggest that the brain has the capacity to function relatively normally in the presence of 
disease pathology (Nithianantharajah & Hannah, 2009; Stern, 2002). This is supported by 
the observation that degree of AD pathology at post-mortem is not always indicative of 
decreased cognitive performance (Katzman et al., 1989). Increased cognitive reserve is 
not thought to significantly extend life expectancy but rather maintains cognitive abilities 
for longer during the lifetime of the individual (Marioni, van den Hout, Valenzuela, Brayne 
& Matthews, 2012). Although some accounts of cognitive reserve suggest that it is a 
predefined threshold, others consider cognitive reserve as adaptive and the proposed 
impact of physical activity on cognitive reserve is largely based on neural networks being 
modifiable. While education and childhood IQ (which are associated with early acquired 
cognitive reserve) predicted age at onset of both hypertension and dementia (Hogervorst, 
Clifford, Stock, Xin & Bandelow, 2012), education in most models remains independent of 
other risk and protective factors, suggesting scope for later-life interventions.  
 
1.4.2. Association with cardiovascular risk factors 
Healthy lifestyles may influence cognition through their effects on cardiovascular 
risk factors, which are also risk factors for AD. For example, the Cardiovascular Risk 
Factors, Aging, and Dementia (CAIDE) study followed their 1449 participants from middle-
age, beginning at around the mid 40th decade of their lives (Kivipelto et al., 2005). They 
found that being obese (Body Mass Index [BMI] >30kg/m2), having a high BP and high 
total cholesterol in midlife increased the risk for AD 18 years later by a factor 1.5 to 2, i.e. 
these factors doubled the risk. When the three factors were present together, the risk for 
AD was increased by a factor 6. This was independent of reported fat intake or physical 
activity, age and education. Similarly, in the Honolulu-Asia Aging Study (Launer et al., 
2000), increased BP in mid-life (in the 5th decade of life) was associated with an increased 
risk of AD after 25 years in non-treated individuals. In the Kaiser Permanente of Northern 
California Medical Group study, elevated levels of cholesterol at 40-45 years of age were 
associated with a doubled risk of AD and VaD after a 30 year follow-up (Solomon, 
Kivipelto, Wolozin, Zhou, & Whitmer, 2009) and being overweight or obese at 40-45 years 
of age was also associated with a 2 to 3 fold increase in risk of AD in later life (Whitmer, 
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Gunderson, Quesenberry, Zhou & Yaffe, 2007). The Swedish Adoption/Twin Study Aging 
study similarly suggested that higher BMI in the 4th decade of life was associated with 
lower global cognitive ability 25 years later and faster cognitive decline (Dahl et al., 2009). 
Physical activity reduces fat mass and lowers blood pressure and cholesterol levels 
(Hogervorst et al., 2012), and it is thus a cost effective way of reducing cardiovascular and 
dementia risk in midlife. 
 
1.4.3. Association with an overall healthy lifestyle and diet 
Active lifestyles may appear to influence cognitive functioning because they are 
accompanied by other healthy behaviours that exert an independent effect on cognition. 
For example, certain diets help to protect against cardiovascular risk factors (see section 
1.4.2.) and they may also have direct neurological effects. A prospective study of older 
adults found a positive relationship between monounsaturated and polyunsaturated fatty 
acid intake and global cognition over 8.5 years (Solfrizzi et al., 2005). The Mediterranean 
diet is low in fat but does contain high levels of antioxidants, omega-3 fatty acids and 
vitamin B12, which are thought to be neuroprotective. Adherence to the Mediterranean 
diet was associated with a 24% reduced risk of AD after adjustment for age, sex, ethnicity, 
education, ApoE genotype, caloric intake, smoking, comorbidity index and BMI 
(Scarmeas, Stern, Tang, Mayeux & Luchsinger, 2006). Other research suggests that 
caloric restriction may be more important than specific diets in affecting cognitive 
performance; for example, Witte, Fobker, Gellner, Knecht and Flöel (2009) showed a 
significant improvement in memory scores in 50 healthy older adults who adhered to a 
calorie-restricted diet over three months compared to those who continued with their 
normal diet.  
 The associations between physical activity, diet and cognitive functioning may also 
be linked to insulin sensitivity. Insulin resistance is a risk factor for AD even in those who 
do not have diabetes (Rönnemaa et al., 2008; Luchsinger, Tang, Shea & Mayeux, 2004). 
Increasing insulin resistance through feeding a high fat diet can lead to impaired ability on 
task switching in rats (McNeilly, Williamson, Sutherland, Balfour & Stewart, 2011), 
reduced long-term potentiation in the dentate gyrus and impaired Morris Water Maze 
performance (Stranahan et al., 2008). In Witte et al.’s study of human elderly, significant 
relationships were found between increased insulin sensitivity and improvements in 
memory (Witte et al., 2009). Drugs for diabetes have also been found to improve or 
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maintain cognitive ability (Craft et al., 2012). Type 2 diabetes is particularly associated 
with lifestyle factors, including diet and physical activity, and reducing insulin resistance 
through a healthy lifestyle may help to prevent cognitive decline and AD. It could thus be 
suggested that those who choose to engage in physical activity will also choose healthier 
diets and evidence exists for this health ‘knock-on’ effect.  
 
1.4.4. Physical activity may be most important in midlife 
Despite evidence for strong associations in midlife, cardiovascular risk factors have 
been shown to change in the years before dementia becomes clinically apparent, possibly 
due to dysfunctional regulation in the central nervous system caused by pathological 
changes seen in AD. For instance, a meta-review of the literature (Qiu, Winblad & 
Frtaiglioni, 2005) showed that high BP in mid-life is associated with AD, whereas low BP 
in older age is associated with AD. In cross-sectional case control studies in those with 
established dementia, BP is often found to be lower (e.g. Hogervorst, Ribeiro, Molyneux, 
Budge & Smith, 2002). In a longitudinal study, high BP was found to be a risk factor in 
mid-life for later life dementia but was seen to drop in the years preceding the clinical 
onset of dementia (Skoog & Gustafson, 2006). Similarly, being overweight or obese in 
later life (>60 years of age) has been associated with a decreased risk of dementia (West 
& Haan, 2009) despite mid-life obesity being associated with increased risk. This has 
important implications for treatment; two Cochrane reviews found no evidence that 
reducing cholesterol through the use of statins or reducing BP with anti-hypertensive 
medications lowered risk of AD and dementia in individuals above the age of 70 years 
(McGuinness, Craig, Bullock & Passmore, 2009; McGuinness, Todd, Passmore & Bullock, 
2009).  
The neurological benefits of physical activity also suggest the benefit of midlife 
intervention as exercise does not appear to have an effect on Aβ once plaques and 
memory impairments are already present (Richter et al., 2008). These data thus suggest a 
need for early midlife (rather than later life) interventions, as these risk factors tend to 
become unstable in later life. In addition, in midlife after menopause, levels of sex steroids 
(both estrogens and testosterone) drop dramatically in women and men also start to show 
a gradual decline (Hogervorst et al., 2012). Physical activity affects levels of sex 
hormones, which may have a knock-on effect on cognitive functioning. For example, free 
testosterone, which decreases with age (Shkurnikov, Donnikov, Akimov, Sakharov & 
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Tonevitsky, 2008), affects many factors implicated in pathological brain aging and reduced 
levels have been associated with dementia risk (Hogervorst, Bandelow, Combrinck, & 
Smith, 2004). Estrogen also has various potential protective effects on brain function 
(Hogervorst, Henderson, Gibbs & Brinton, 2009). Part of the effect of exercise may thus 
be mediated by its effects on sex steroids but this remains to be further investigated. 
 
1.5. Conclusion 
In all, physical activity presents as a potential lifestyle intervention with evidence 
pointing towards the need for midlife intervention before dementia pathology is present. 
There appear to be multiple mechanisms through which physical activity can affect 
cognitive performance and reduce the risk of dementia through associations with other 
lifestyle behaviours, cardiovascular risk factors and cognitive reserve. In practice, it is 
likely that the beneficial effects of physical activity and cognitive function are due to a 
combination of factors, both direct and indirect. The study of mediating and moderating 
factors is therefore important to determine optimal conditions for the relationship between 
physical activity and cognitive functioning. In the next chapter, we present a literature 
review of exercise studies to identify such factors for investigation in Parts 3 and 4 of this 
thesis. 
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Chapter 2 – Review of previous studies investigating physical activity and 
cognition 
2.1. Introduction 
Physical activity appears to be a potential lifestyle intervention for AD with many 
possible mechanisms for maintaining cognitive performance into older age. There is a 
wealth of studies that have looked into the effects of physical activity on cognitive function 
in the elderly, many of which have found increased scores on cognitive tests or a reduced 
risk of developing dementia for those who participate in physical activity versus those who 
do not. However, there are also many studies that have failed to replicate this, finding 
instead that physical activity has little or no effect on cognitive function. Here we aimed to 
critically review these studies and their findings to establish possible reasons for these 
discrepancies. 
By reviewing the physical activity and cognition literature we have tried to answer 
the following questions. Our first question was whether physical activity has any long-term 
effect on cognitive function in healthy elderly adults, and, second, whether it can protect 
against or delay the onset of dementia. Finally, we wanted to know if exercise can 
improve cognition or offer protection from further decline in those who have already been 
diagnosed with dementia. There have been previous reviews of this literature, such as 
Kramer, Erickson and Colcombe (2006) and Rockwood and Middleton (2007). However, 
here we provide an up-to-date review of a wide range of human behavioural studies with a 
focus on the different types of physical activity and cognitive measures used. Specifically, 
we looked at whether the effect of physical activity is general to all cognitive functions or 
selective for only a few. We also considered the different types and intensities of exercise 
and physical activity measures and which may be most effective in showing improved or 
maintained cognitive function in the elderly. Finally, we looked at a range of potentially 
confounding and moderating variables that may have affected the results of these studies. 
Earlier meta-analyses, such as those by Angevaren, Aufdemkampe, Verhaar, 
Aleman and Vanhees (2008) and Colcombe and Kramer (2003), have found overall 
positive effects of exercise on cognition. However, one meta-analysis (Etnier, Nowell, 
Landers & Sibley, 2006) did not fully support this view, claiming that any small differences 
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in cognition after exercise are in fact due to factors independent of the physical activity. 
This discrepancy may be related to the different studies that were included in the analyses 
and differences in inclusion criteria of studies. For instance, most of these reviews 
focused on aerobic activity only. We therefore included studies that investigated the effect 
of aerobic and/or non-aerobic activity. 
 
2.2. Methods 
To identify studies relevant to this review, we performed searches of PubMed, 
PsycInfo and Cochrane Controlled Trials Register (date range unrestricted) using 
combinations of the keywords “exercise, physical activity, Alzheimer, dementia, cognition, 
cognitive function, memory, executive function”. Full texts of articles that appeared to 
answer the research question were retrieved for further assessment. Inclusion criteria 
were all experimental, cross-sectional or prospective studies that investigated the long-
term effect of any kind of physical activity on cognition (measured in the form of cognitive 
tests or risk of dementia) in middle- to older-aged humans. Randomised controlled trials 
(RCTs) could include exercise programs of any type and duration. We also manually 
searched bibliographies of studies identified in these initial searches for further papers. 
The literature search was completed in February 2009.  
For inclusion in this review, papers had to include both a measure of physical 
activity and a measure of cognitive performance, cognitive impairment or a clinical 
syndrome (dementia, AD, VaD or MCI) in humans only. For the studies investigating 
healthy adults, we selected studies in which the mean age of participants was over 40 
years, and there was no upper age limit. Treatment trials were excluded if they did not 
include a control group, or if the exercise group also undertook social or mental activities, 
as this may have confounded the results reported. For instance, a study by Diesfeldt and 
Diesfeldt-Groenendijk (1977) showing better memory with group gymnastics after a 4 
week RCT was excluded from this review as it was unclear what level of (neurological) 
disability or cognitive status participants had. A study by Fabre, Chamari, Mucci, Masse-
Biron and Prefaut (2002) was also not included as the intervention, sample and results 
matched those in an earlier article (Fabre, Masse-Biron, Chamari, Varray et al., 1999). 
Data was extracted based on pre-defined criteria (see Tables 1-4). The identified studies 
were grouped into categories for critical review. Firstly we looked at cross-sectional and  
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RCT studies that assessed the effect that physical activity has on cognitive function in 
healthy adults using cognitive tests as the outcome measure. The next set of studies 
investigated whether higher levels of physical activity reduced the risk of developing 
dementia. The final studies reviewed examined whether physical activity affected ability 
on cognitive tests in adults with an existing diagnosis of cognitive impairment or dementia. 
It is important to distinguish between the effect of exercise on cognitive function in healthy 
adults and that in adults with dementia, as the same overall effect may be due to different 
processes and therefore have slightly but meaningfully different features, such as the type 
of exercise or the specific cognitive modality on which it has an effect. This would in turn 
lead to different recommendations for interventions. Therefore, we will review separately 
the studies that have included each of these groups. 
 
2.3. Results 
2.3.1. Cognitive Function in Healthy Middle-aged Adults: Observational studies 
A large proportion of the studies found through our search of the literature were 
cross-sectional studies without follow-up (details of these studies are given in Table 1). 
Generally, participants had their recent physical activity levels rated and they then 
completed a selection of cognitive tests. A variety of results were seen across these 
studies, with seven (Christensen et al., 1996; Colcombe et al., 2004; Bixby et al., 2007; 
Deeny et al., 2008; Newson, & Kemps, 2006; van Gelder et al., 2004; Barnes, Yaffe, 
Satariano & Tager, 2003) finding a clear benefit of exercise on all cognitive tests 
completed, and eight finding a benefit on some tests, but not on others (Clarkson-Smith & 
Hartley, 1989; Shay & Roth, 1992; Christensen & Mackinnon, 1993; van Boxtel et al., 
1997; Etnier et al., 999; Lindwall, Rennemark & Berggren, 2008; Newson, & Kemps, 2008; 
Petrella, Miller & Cress, 2004). One study of very healthy elderly participants (van Boxtel, 
Langerak, Houx & Jolles, 1996) found no main effect of exercise, but did report an 
interaction between age and activity on cognitive speed. No studies found a negative 
effect of exercise on cognition. 
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Table 1  
Details of cross-sectional studies investigating the association between exercise and cognitive function in healthy adults. 
Author Year n 
(%F) 
Mean 
age: 
years 
(SD) 
Age 
range: 
years 
Country Groups Exercise / 
fitness 
measure 
Tests Outcome Covariates Notes 
Clarkson-
Smith 
1989 124 
(N) 
69.74 
(N) 
55-88 USA High 
exercise 
(>3100 
kcal/week + 
> 1 1/4 hr 
exercise) vs. 
low exercise 
(<1900 
kcal/week + 
< 10 min 
exercise) 
All activity 
requiring 
physical 
exertion 
(<1kcal/min/kg 
of body 
weight), 
including sport 
and non-
recreational 
activity  
Letter sets, Digit 
span backwards 
and Reading span, 
Simple, 2- and 4- 
Choice RT, 
Analogies, 
Progressive 
matrices, Letter 
series completion 
High exercise 
group performed 
significantly 
better than the 
low exercise 
group on:                                    
Letter sets, 
Reading Span,                                                                                                                                                                          
Simple, 2- and 4-
Choice RT, 
Analogies, 
Matrices, Series 
Completion.                                         
Age, education, 
self-rated health 
status.      
Collapsed 
across sex 
Fitness 
significantly 
increased (HR 
and vital 
capacity) for 
high compared 
to low exercise 
group
Shay 1992 38 
(0%)  
65 (N) 60-73  USA High fit 
(above 
median for 
age group) 
vs. low fit 
(below 
median for 
Predicted 
VO2max 
WMS Visual 
reproduction 
immediate and 
delayed recall, 
Hooper Visual 
Organisation test, 
ReyOsterreith 
Significant 
differences 
between groups 
for:                                       
WMS Visual 
Reproduction 
immediate and 
WAIS-R Verbal 
Intelligence 
Have 
considered 
here only older 
group for 
review. Fitness 
groups relative 
to each other. 
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age group) Complex Figure, 
WAIS-R Digit 
Symbol, SCWT, 
TMT, Verbal 
fluency, Digit span, 
WMS Logical 
Memory immediate 
and delayed, Critical 
Flicker Threshold, 
Finger Tapping 
speed 
delayed recall, 
ReyOsterreith 
Complex Figure 
copy and recall.                                  
17.9% of 
subjects' self-
reported 
activity not 
correlated with 
fitness 
measure. 
Activity 
measured over 
past several 
months 
Christensen 1993 56 
(N) 
76.7 
(N) 
70+ Australia High 
education 
vs. low 
education 
Scale 1 based 
on Schonfield 
(% hours a 
day spent 
active v 
passive). 
Scale 2 based 
on number of 
hours a day 
spent in 
physical, 
social and 
mental activity 
- 7 point score 
Symbol-Digit 
Modalities test,  
Progressive 
Matrices, 
Similarities subtest 
from WAIS-R, 
NART, WMS Visual 
Reproduction, 5 
purpose-designed 
tests 
Physical activity 
from both Scale 
1 and Scale 2 
positively related 
to fluid 
intelligence but 
not memory or 
crystallised 
intelligence 
Age, GHQ-30, 
health, 
education,  
Have 
considered 
here only older 
group used in 
this study. The 
two scales 
associated high 
activity with 
opposite levels 
of education so 
may not be 
reliable 
measures. 
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van Boxtel 1996 80 
(N) 
67.14 
(N) 
55+ Netherlands One group  APAQ Word learning, 
SCWT colour-word 
part III, Concept-
shifting task part C, 
Concept-shifting 
parts O, A and B, 
SCWT colour-word 
part I and 
Continuous tapping, 
Letter digit 
modalities, Verbal 
fluency                                                        
Exercise 
explained little 
variance on all 
cognitive tests 
Age, sex, 
intelligence, 
health  
Recruited 
relatively active 
and healthy 
older adults. 
APAQ not 
validated with 
direct 
measures of 
caloric 
expenditure 
e.g. VO2max. 
Many tests 
were modified 
or based on 
others.  
Christensen 1996 703 
(N) 
(N) 70-89 Australia One group Current levels 
of sport, 
walking, 
heavy 
gardening, 
cleaning 
MMSE, memory for 
a figure, Word 
recall, Address 
recall, Face 
recognition, Word 
recognition, Symbol-
Letter Modalities 
test, NART, WAIS-R 
Vocabulary, 
Information 
Knowledge, WAIS-R 
Similarities, Cube 
Activity 
contributed 
significantly but 
modestly to 
variance 
accounted for in 
fluid and 
crystallised 
intelligence, 
memory and 
MMSE (change 
in R2= .01-.02)                              
Age, sex, 
sensory 
functioning, 
health, 
education, ADL, 
past medical 
conditions, 
activity x 
education, age 
x activity, age x 
education 
Current levels 
of activity 
measured only, 
does not take 
into account 
levels over past 
several 
months. 
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Drawing, Verbal 
Fluency, Simple and 
Choice RT 
van Boxtel 1997 132 
(42%) 
47 (N) 24-76 Netherlands Participation 
v non-
participation 
in additional 
cycling 
session 
Endurance 
cycling (reach 
HR70%) - 
VO2max;                        
Weekly 
participation in 
aerobic sports 
VVLT, Verbal 
Fluency, Continuous 
Tapping, Concept 
Shifting Test, 
Simple and 
Complex RT, Letter-
Digit Subtraction 
test, SCWT colour-
word test 
Positive 
association 
between 
VO2max and 
SCWT colour-
word (added .01 
to R2) and 
Concept Shifting 
task (added .02 
to R2) 
Age, sex, IQ Not controlled 
for general 
health but 
participating 
group rated 
themselves 
higher than 
non-
participating 
group. Subjects 
with IQ scores 
<90 or >140 
were excluded 
Etnier 1999 98 
(N) 
(N) 56-80 USA One group 6 min walk 
test of fitness 
Fluid intelligence 
(Culture Fair 
Intelligence test)                                                                                                                                 
Working memory 
span (word recall)                                                        
Processing speed 
(modified version of 
Digit-Symbol test)                                       
Reaction Inhibition 
(Negative Priming 
task) 
6 min walk test 
added .17 to R2 
for fluid
intelligence and 
.20 for
processing 
speed. Did not 
explain extra for 
working memory 
or reaction 
inhibition 
Age, education, 
depression, 
pulmonary
function 
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Colcombe  2004 41 
(N) 
(N) (N) USA High fit 
(above 
median 
fitness) vs. 
low fit (below 
median 
fitness) 
VO2max Flanker task High fit group 
performed better 
on Flanker task 
than low fit group 
  High fit group 
had a greater 
level of activity 
in prefrontal 
and parietal 
cortex 
Bixby 2007 120 
(68%) 
78.9 
(5.8) 
65-92 USA One group  Frequency 
and intensity 
of physical 
activity 
(YPAS) 
SCWT colour-word 
test 
Physical activity 
intensity  
explains 4% of 
variance in 
SCWT 
interference 
scores 
IQ, education, 
age 
Physical 
activity must 
have been 
stable for 3-
5years to be 
reported. 
Lindwall  2008 1402 
(N) 
75.1 
(10.2) 
60-92 Sweden Non-active 
(never - 1-3 
times/month) 
vs. active 
(several 
times/week - 
every day) 
over last 12 
months 
Light intensity 
e.g. walking, 
golf; high 
intensity e.g. 
jogging, 
skiing, ball 
sports 
MMSE, free recall, 
recognition of 
positions, Digit Span 
backwards, Digit 
Cancellation, 
Comparing Figures, 
Vocabulary 
Active 
participants who 
did light intensity 
activity showed 
higher scores 
compared to 
non-active on 
Vocabulary, 
recognition of 
positions, free 
recall, Digit 
Span, Digit 
Cancellation and 
Age, education, 
depression, 
functional 
status, co 
morbidity 
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MMSE for men 
only. No 
significant effects 
of high intensity 
activity on any 
task 
Deeny 2008 54 
(44%) 
59.9 
(4.6) 
50-70 USA One group Total caloric 
expenditure 
per week 
Sternberg task Physical activity 
significantly 
predicted RT for 
both six- and 
eight-letter 
conditions for 
e4+ only 
Age, education, 
sex, stratified 
for ApoE4+ and 
e4- 
Both 
heterozygous 
and 
homozygous 
ApoE4 carriers 
were included 
Newson  2008 96 
(53%) 
70.79 
(5.23) 
65+ Australia High vs. low 
fitness  
>3 
hours/week of 
vigorous 
activity 
causing 
sweating or 
increase in 
HR or 
breathing vs. 
no activity  
SRT                                                              
Attention (SCWT, 
Map search task), 
Working memory 
(Letter-number 
sequencing, Corsi 
blocks)                                        
Processing speed 
(Digit symbol 
substitution, Boxes 
test)                         
Memory (Names 
test, Doors test)              
Executive Function 
High fit group 
performed better 
on SRT, working 
memory and 
processing 
speed. No 
difference on 
tests of memory, 
attention or 
executive 
function. 
Age, sex, 
education, 
general 
wellbeing, 
crystallised 
intelligence 
(NART-R and 
Spot the Word 
test) 
Only older 
group 
considered for 
this review. 
Activity had to 
be stable for 2 
years to be 
reported. 
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(Six element test, 
Zoo map test) 
Newson 2006 100 
(67%) 
young: 
20 yrs; 
young-
old: 69; 
middle-
old: 77; 
old-old: 
86 yrs 
all 
SD=2 
18-26, 
65-74, 
75-84, 
85-92 
Australia One group VO2max Attention (SCWT, 
Map search)   
Working memory 
(Letter-number 
sequence of WAIS-
III, Corsi blocks)                                         
Processing speed 
(Digit symbol 
substitution, Boxes 
test)                      
Executive Function 
(Zoo map test, Six 
elements test)                                                                
Memory (People 
test, Names test) 
VO2max 
contributes 
additional 26% of 
variance in 
attention, 11% in 
working memory,
23% in 
processing 
speed, 8% in 
executive 
function and 7% 
in memory. 
Age, sex, 
education, 
psychological 
and physical 
wellbeing, 
biomarkers of 
aging 
  
Petrella 2004 35 
(69%) 
77.2 
(6) 
(N) USA Independent 
vs. 
marginally 
dependent 
High vs. low 
leg extensor 
power 
Cognitive Stability 
Index (RT, 
psychomotor speed, 
memory, attention) 
Independent 
group showed 
higher scores on 
RT, psychomotor 
speed and 
memory 
compared to 
marginally 
dependent 
group. No 
Age, education   
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significant 
differences on 
attention. 
Longitudinal studies 
van Gelder 2004 295 
(0%) 
74.91 
(N) 
(N) Finland, 
Italy, 
Netherlands 
Increase, 
stable or 
decrease 
duration of 
activity; 
Increase, 
stable or 
decrease in 
intensity of 
activity over 
follow-up 
Walking, 
bicycling, 
hobbies, 
gardening, 
odd jobs, 
sport 
MMSE Decrease in 
duration and 
intensity of 
activity 
associated with a 
decline in MMSE 
scores. Increase 
in duration and 
intensity of 
activity show no 
change in MMSE 
scores. 
Age, education, 
country, alcohol 
consumption, 
smoking status, 
mental 
activities, 
physical activity 
and duration 
ADL, 
depression, 
BMI, 
antihypertensive 
drugs, HDL, 
cholesterol, BP, 
baseline 
cognitive 
functioning 
Follow up 10 
years 
Barnes 2003 349 
(N) 
69 (N) 59-88 USA Tertiles of 
fitness 
VO2peak MMSE, TMT B, 
SCWT, Digit Symbol 
Substitution Test, 
CVLT, Verbal 
fluency 
Participants with 
lowest baseline 
VO2peak 
showed decline 
in scores on all 
tests, while 
Age, years of 
education, 
intelligence, 
hypertension, 
thyroid disorder, 
self-rated 
Follow up 6 
years 
  
4
0
 
participants with 
highest baseline 
VO2peak 
remained stable.  
health, smoking, 
and baseline 
mMMSE score. 
Stratified by sex 
Abbreviations: (N) - information unavailable; RT - Reaction Time;  HR - Heart Rate; WMS - Wechsler Memory Scale; WAIS-R - Wechsler Adult Intelligence Scale;  TMT - 
Trail Making Test;  NART - National Adult Reading Test; GHQ - General health Questionnaire; APAQ - Actual Physical Activity Questionnaire; MMSE - Mini Mental 
Status Examination; VVLT - Visual Verbal Learning Test; YPAS - Yale Physical Activity Scale; SRT - simple RT; BP - Blood pressure; ADL - Activities of Daily Living; BMI 
- Body mass index; HDL - High-density lipoprotein; CVLT - California Verbal Learning Test 
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2.3.1.1. Test specificity 
There are several possible reasons for the variety in results seen among the 
cross-sectional studies. Firstly, physical activity could have a specific effect on some 
cognitive domains, but not on others. These cross-sectional studies tended to include 
many cognitive measures, as they were looking at cognitive function in general terms. 
This is useful as this can tell us more about possible effects across different cognitive 
domains. However, it also increases the risk of chance findings, especially when only one 
test for each domain is used. The most common domains tested were i) memory, ii) 
cognitive speed, iii) executive function and iv) response inhibition2. Of these, none proved 
to have a consistent association with physical activity. All domains showed positive effects 
after exercise in some studies but not in others. The most reliable function to be improved 
in those who exercised was cognitive speed, with memory and response inhibition 
showing positive associations of exercise in around half of all tests used. When these 
tests were broken down further into individual tasks, the most common tests showing 
positive associations with physical activity were: i) the Trail-Making Test B (TMTb), ii) the 
SCWT test, iii) Simple Reaction Time tests (SRT), iv) Complex Reaction Time tests 
(CRT), v) the Digit Symbol Substitution Test, vi) Verbal Fluency and vii) tests measuring 
word or letter learning such as the Digit Span, measuring short term memory capacity. 
Again, there were no tests that showed a consistent advantage for groups that were more 
physically active. Thus, while we cannot rule out selectivity for specific cognitive domains, 
this cannot explain all of the variance seen in these data. 
 
2.3.1.2. Measures of physical activity 
The variety of results seen in these cross-sectional studies may be influenced by 
the type of activity or the exercise measures used. Some studies analysed only 
participation in activity that caused sweating or increased heart rate (e.g. Newson & 
Kemps, 2008), while others included lower intensity exercise such as walking (e.g. 
Lindwall et al., 2008). Some studies used objective measures of fitness, such as VO2max 
(e.g. Newson & Kemps, 2006). We grouped the studies into those that used objective 
measures of fitness and those that used frequency of activity. Frequency of activity and 
objective fitness measures both showed similar inconsistent results for memory, executive 
                                                 
2
 See also Angevaren et al., 2008 for a similar classification and explanation of tests falling under these 
domains 
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control and inhibition. However, studies measuring activity frequency were more likely to 
report positive associations with better cognitive speed (SRT and CRT) than those that 
used objective measures of fitness. Shay and Roth (1992) found that in 17.9% of 
subjects, the self-reported level of activity did not correspond with their VO2max. Self-report 
of exercise is thus not always related to objective fitness and other factors such as mental 
stimulation, improved mood and social interactions while exercising may be responsible 
for the positive associations found. However, two studies (Deeny et al., 2008; Clarkson-
Smith & Hartley, 1989) considered energy expenditure and both found positive effects of 
exercise on memory and reaction time (RT). Therefore for future work, objective 
measures of energy expenditure and fitness should be used in addition to self-report of 
frequency of physical and other activities (e.g. mental stimulation because of exercise 
etc.) in order to obtain reliable and valid measures of physical activity and fitness. 
 
2.3.1.3. Cross-sectional studies – general issues 
Cognitive domain and exercise measures do not appear to explain all of the 
variance in these cross-sectional studies. However, these studies cannot establish causal 
relationships between variables. Many of these cross-sectional studies run the risk of self-
report bias as they included questionnaires to determine level of activity that rely on 
accurate completion by participants. Self-report by definition is unreliable in those who 
have impaired cognitive function, which can result in artificially increased risks. However, 
we also found two prospective studies which both found that participants with lowest 
cardiovascular fitness over 6 years (Barnes, 2003) or a decline in self-reported physical 
activity over 10 years had a worse drop in scores on the Mini-Mental Status Examination 
(MMSE), a test sensitive to dementia (see Chapter 3). On the other hand, exercise may 
not have an influence on cognition so much as cognition has an effect on the amount of 
exercise a person does. For example, memory limitations may affect the ability to start or 
continue participating in exercise programs. Hence, a review of randomised controlled 
treatment studies (RCT) is required in order to determine the true causal effect of physical 
activity on cognitive function. 
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2.3.2. Cognitive Function in Healthy Middle-Aged Adults: Randomised Controlled Trials  
The other type of studies identified for this review is RCTs (see Table 2 for details 
of studies). RCTs have the benefit over cross-sectional studies in that, by randomising 
participants into two groups, there is increased probability of a causal relationship 
between the two variables. Among the 20 RCT studies that we identified through our 
literature search, six studies (Hawkins, Capaldi & Kramer,1992; Colcombe et al., 2004; 
Lachman, Neupert, Bertrand & Jette, 2006; Cassilhas et al., 2007; Williams & Lord, 1997; 
Bakken et al., 2001) showed a clear benefit of exercise on cognitive function, while a 
further 13 studies (Molloy, Delaquerriere-Richardson & Crilly, 1988; Hassmen, Ceci & 
Backman,1992; Brown, Liu-Ambrose, Tate & Lord, 2008; Perrig-Chiello, Perrig, Ehrsam, 
Staehelin & Krings, 1998; Fabre et al., 1999; Oken et al., 2006; Hill, Storandt & Malley, 
1993; Moul, Goldman & Warren, 1995; Smiley-Oyen, Lowry, Francois, Kohut & 
Ekkekakis, 2008; Zlomanczuk et al., 2006; Emery, Schain, Hauck & MacIntyre, 1998; 
Kramer et al., 2001; Hassmen & Koivula, 1997) showed some benefit of an aspect of 
exercise on some tests used, but not on others. The final seven studies (Blumenthal & 
Madden, 1988; Tsutsumi, Don, Zaichkowsky & Delizonna, 1997; Madden, Blumenthal, 
Allen & Emery, 1989; Blumenthal et al., 1989; Emery & Gatz, 1990; Panton, Graves, 
Pollock, Hagberg & Chen, 1990; Whitehurst, 1991) showed no effect of an exercise 
program on cognitive function. Again, no study found a negative effect of exercise on 
cognition. 
 
2.3.2.1. Test specificity 
Because of the high proportion of studies that showed effects of exercise on some 
tests but not on others, the contrasting results may be due to exercise having a specific 
effect on particular cognitive domains, such as those discussed for the cross-sectional 
studies. For the RCTs identified here, we were able to form groups for i) cognitive speed, 
ii) memory, iii) executive function, iv) inhibition and v) visual attention. Exercise appeared 
to have the most consistent effect on memory and visual attention, although only about 
half of the tests for each domain showed a positive effect of exercise. 
Hall, Smith and Keele (2001) suggested that aerobic activity has selective benefits 
for executive control, and this was supported by a later meta-analysis by Colcombe and 
Kramer (2003). Chodzko-Zajko (1991) examined task difficulty, claiming that automatic 
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processes are less liable to age-related decline and show less benefit from exercise 
compared to those that require conscious thought and controlled processing. However, 
this idea does not seem to be supported by the data described here, as there appeared to 
be no overall consistent advantage on tests of executive control and inhibition for exercise 
groups compared to controls. Angevaren et al. (2008) also found in their meta-analysis 
comparing aerobic exercise vs. no intervention that only simple tests such as auditory 
attention (Digit Span forwards) and motor speed (Finger Tapping3) were significantly 
affected by exercise. While only half of the studies in our review reported a positive effect 
of exercise on Digit Span (forwards and backwards), this was also the only individual test 
to show a repeated positive effect. This was not the case for executive control or inhibition 
tests that require controlled information processing. Similarly, Etnier et al.’s (1997) meta-
analysis of cross sectional studies found a larger effect size for simple than complex 
tasks. 
As mentioned by Chodzko-Zajko (1991), there are very few studies that directly 
examined the relationship between task difficulty and exercise. One study, Hawkins, 
Capaldi and Kramer (1992) used two visual attention tests that each had two levels of 
difficulty: one was a single task, the other a dual task. They found that after the 
intervention period there were no differences between the exercise and no-exercise 
groups on the simpler task, but that time-sharing costs on the dual task were more 
reduced for the exercise than the no-exercise group. Evidence thus suggests that task 
complexity may indeed partly determine whether an effect of exercise is seen or not, 
although it is inconclusive which type of task (simple or complex) actually shows greatest 
benefit. 
 
2.3.2.2. Type of exercise 
The RCT studies reviewed included a wide variety of different exercise programs 
and so the different results reported may be due to specific exercise programs having an 
effect but not others. The exercises involved ranged from aerobic activity, such as jogging 
(e.g. Madden et al., 1989) to non-aerobic exercises, such as strength training (Tsutsumi 
et al., 1997) or yoga (Oken et al., 2006). For the studies that compared an exercise group 
with a no-exercise control group, we split the different exercises into the following groups: 
                                                 
3 One test (the Ross Information Processing assessment A) also showed an overall significant effect of 
memory and abstract reasoning but was only done in one RCT of n=20 (Moul, 1995) 
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i) aerobic (endurance), ii) flexibility and iii) strength. Where the program fell into two or 
more categories of exercise type, the study was placed under the category where that 
type of exercise was performed most. 
Nine out of the 13 studies that compared aerobic exercise against no exercise 
found a positive effect on at least some cognitive tests (Hassmen et al., 1992; Fabre et 
al., 1999; Hill et al., 1993; Moul et al., 1995; Hawkins et al., 1992; Bakken et al., 2001; 
Emery et al., 1998; Hassmen & Koivula, 1997; Whitehurst, 1991). Angevaren et al. (2008) 
reported from their meta-analysis that a 14% increase in VO2max is required for a positive 
effect to be found on cognition. However, four out of six studies that compared strength 
exercise against no exercise also found an effect on cognition on at least some tests 
(Lachman et al., 2006; Molloy et al., 1988; Perrig-Chiello et al., 1998; Zlomanczuk et al., 
2006), suggesting that strength exercise may not only add to the benefit of aerobic 
exercise but may in fact independently affect cognition. 
There is further support for this idea from some other studies that compared 
groups undergoing different types of exercise. Interestingly, while Blumenthal and 
Madden (1988) found no differences between RT performance of aerobic and 
strength/yoga training groups, Colcombe et al. (2004) and Smiley-Oyen et al. (2008) 
found clear advantages of aerobic over flexibility exercises on a Flanker task and Stroop 
Colour Word Task (SCWT) respectively. Cassilhas et al. (2007) also found that resistance 
exercises benefitted participants on some memory tasks (Digit Span, Corsi blocks, 
Similarities and Rey-Osterreith immediate recall) compared to stretching. No study that 
compared flexibility exercises such as Yoga against no exercise found an effect on 
cognitive function. Hence, stretching and flexibility exercises do not seem to render much 
benefit for cognitive function. Colcombe and Kramer’s (2003) meta-analysis suggested 
that participants benefitted most from a combined strength and aerobic exercise program 
compared to aerobic exercise alone. Williams and Lord (1997) indeed found a positive 
effect on cognition of combined aerobic, strength and stretching exercise but had only 
compared this to no exercise (instead of to individual interventions). 
These results combined suggest that the greater the intensity of the exercise, the 
greater benefit it has on cognitive function. This would suggest that the exercise has a 
greater cognitive benefit if it is also has a physiological benefit. Just under half of the 
studies that reported an increase in VO2 measures found a positive effect of aerobic 
exercise, and only one study that found no increase in physiological function reported a 
small positive effect of the aerobic exercise intervention over flexibility training (Smiley-
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Oyen et al., 2008). This suggests that objective measures of fitness may be extremely 
important in determining whether an exercise intervention will have a positive effect on 
cognition. Nearly all of the studies that reported an increase in muscle strength found a 
positive effect of strength exercise on cognition. For instance, Lachman et al. (2006) 
found that the increase in resistance levels over time predicted memory improvement 
over 6 months of exercise. Thus, despite the literature focus on aerobic activity being 
important for cognition, muscle strengthening and resistance training may also have an 
effect. 
Another factor that could influence whether an exercise intervention can benefit 
cognition is the length of the exercise program. It could be predicted that the longer an 
individual maintains regular physical activity, the more their fitness should increase thus 
potentially exerting a greater effect on cognition. The studies highlighted here ranged from 
just two months up to one year. Harada, Okagawa and Kubota (2004) investigated the 
effect of jogging on frontal lobe functioning in young adults and found that most of the 
improvement in cognition already occurred in the first six weeks, but with little 
improvement seen from 6 to 12 weeks. This study needs to be replicated in older 
participants and could indicate that the benefits of exercise are most apparent in the early 
stages of the programme. While there were more consistent effects of exercise on 
cognition for interventions lasting six months or more, there were some benefits already 
reported after a programme of just two months. For example, Bakken et al. (2001), 
Pierrig-Chiello et al. (1998) and Fabre et al. (1999) already showed improvements of 
programmes with duration of only 8 weeks and Hawkins et al. (1992) after 10 weeks, 
respectively. A 6- week follow-up assessment from baseline may help to determine 
optimal effects in future studies. 
Table 2 also indicates that more time spent exercising per week does not 
necessarily equate to more significant cognitive improvements. This supports Angevaren 
et al.’s (2008) claim that it is not the amount of exercise that is done but the intensity at 
which it is done that has a positive effect on cognition. No single study has directly 
examined this statement so it is difficult to draw firm conclusions. On the other hand, 
Lachman et al.’s (2006) findings (see above) do support the statement that the degree of 
objective improvement over time (as well as baseline ability levels) should be taken into 
account in analyses of results. 
Perhaps related to this issue is the problem of relatively low rates of adherence to 
the exercise programmes. For example, in Brown et al. (2008), attendance ranged from 
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just 3 to 51 classes out of 52. This means that some individuals who were in the exercise 
group may actually fit more appropriately into the no-exercise control group. However, 
keeping them in the exercise group for analysis affects the mean change in cognitive 
scores. This is also seen in Oken et al. (2006), where mean attendance at the classes 
was 69% for the aerobic group, and participants claimed to have completed home 
practice on only 54% of all days. This is relatively low and may explain why they found no 
effect of exercise on cognition. Studies of this type must set a required adherence rate for 
an individual to be included in the exercise group as well as include an objective 
assessment of the degree of improvement, with any that were assigned to the exercise 
group but fail to meet the minimum requirements perhaps making up a “some exercise” 
group or by analysing the effect of the intervention as a continuous measure (e.g. degree 
of improved VO2 max or improved strength predicting improved cognitive function). 
 
2.3.2.3. Potential confounding variables 
There are several additional variables that may confound the results of these kinds 
of study if they are not taken into account. For example, Blumenthal and Madden (1988) 
found that baseline fitness predicted RT after 12 weeks of physical exercise, but that 
change in fitness levels over the intervention did not affect the follow-up scores. 
Individuals who chose to take part in one of these exercise studies may have been 
interested in doing so because they already led an active lifestyle and had relatively high 
levels of baseline fitness. Therefore, the variance in improvement may have been too 
small to predict cognitive improvement. This could suggest that baseline fitness may 
significantly affect results of studies that have not taken this into account. Variability in 
high- and low- fitness individuals may affect results in that in high baseline fitness 
participants perhaps little improvement can be found, whereas for low fitness participants 
adherence may be difficult, but also the largest gains can be expected which may, 
however, take some time to become apparent (e.g. to build up adequate fitness levels, 
loss of weight etc.). 
When participants began an exercise intervention program it is also possible that 
they took up other health behaviours, such as a better diet or quitting smoking, perhaps 
because the directing of attention to their own health by participation in the program 
encouraged them to have healthier lifestyles overall. This means that the results of 
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studies that did not monitor other health behaviours may have been confounded by one or 
a combination of major lifestyle changes other than engaging in exercise. 
Another issue that is important is that of age. While some studies investigate the 
effect of exercise in healthy middle-aged adults (e.g. Blumenthal & Madden, 1988), others 
recruited much older participants who were more likely to be experiencing at least some 
degree of age-related cognitive decline or pathology placing them at high risk (e.g. Brown 
et al., 2008). This age difference may mean that results of these studies cannot really be 
compared. On the other hand, several observational studies have suggested that the 
long-term effects of exercise in reducing dementia risk by reducing obesity, improving 
blood cholesterol and reducing blood pressure may be most important when activity is 
engaged with in middle-age (e.g. Kivipelto et al., 2005). The studies in this review showed 
that there were positive effects of exercise occurring in participants with mean ages from 
60 years up to over 90 years. Hassmen, Ceci and Backman (1992) split their sample into 
young (mean age 62.9 years) and old (mean age 69.2 years) age groups, and found that 
there was a positive effect of exercise on the Digit Span test in both age groups. 
However, the fact that another observational study did mention an interaction of age by 
activity (van Boxtel et al., 1996) suggests that all studies should a) control for age but b) 
should also investigate this possible interaction or stratify for age in analyses. The effect 
of sex should also be investigated. Whereas most studies used mixed groups, those that 
included only men (Blumenthal et al., 1988, Cassilhas et al., 2007) found little to no 
effects of exercise. As we see later, some observational studies found stronger effects in 
elderly women than in elderly men. Possible mediating effects of hormones related to this 
should therefore be investigated. 
 
2.3.4. Summary 
The results of treatment studies using healthy elderly adults suggest that some 
aspects of cognition can be improved after moderate and high intensity exercise and 
through increased strength and/or fitness. However, the variety of cognitive tests used in 
these studies make it difficult to determine exactly which cognitive domains may be 
positively affected. While much focus is placed on the benefits of aerobic exercise, 
strength-training exercises may also help to improve cognitive ability. Objective measures 
of strength and fitness should be used, as they may be more reliable in predicting  
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physiological improvement and therefore cognitive improvement than are self-reported 
accounts of recent activity. Researchers should take care to consider different potential 
confounding variables, such as baseline and change in fitness, changing other health 
behaviours, adherence to the program, age and sex, as it is difficult to compare different 
studies without addressing these issues. 
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Table 2 
Details of controlled trials investigating the effect of exercise on cognition in healthy adults. 
Author Year n 
(%F) 
Mean 
age 
(SD) 
Age 
range 
Country Exercise 
groups and 
types 
Frequenc
y of 
Exercise 
Duratio
n 
Tests Outcome Notes 
Hawkins 1992 36 
(72%) 
68 (N) 63-82 USA Exercise (water 
aerobics) vs. No 
exercise 
45min, 
3x/week 
10 
weeks 
Time Sharing test, 
Attentional Flexibility 
test 
Greater 
decrease in 
time sharing 
costs for 
exercise than 
no-exercise 
group in both 
tests 
Older group only 
considered for 
this review. RT 
for simple task 
was similar for 
both groups 
Blumenthal 1988 28 
(0%) 
43.3 
(8.8) 
30-58 USA Aerobic exercise 
(walking/jogging
) vs. Non- 
aerobic exercise 
(strength 
training) 
30-45min, 
3x/week 
12 
weeks 
Memory Search RT No significant 
difference in 
RT between 
groups 
Aerobic group 
increased in 
VO2max by 15% 
while non-
aerobic group 
increased by 3% 
. Time 1 fitness 
accounted for 
19% of the 
variance in Time 
2 RT 
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Tsutsumi 1997 45 
(80%) 
68.8 
(5.7) 
61-86 USA High intensity 
strength training 
vs. Low intensity 
strength training 
vs. No exercise 
3x/week 12 
weeks 
Count backwards in 
7s, Mirror Drawing 
Both groups 
showed 
similar 
improvement 
on both tests 
post-
intervention 
Muscle strength, 
body fat, BP, and 
physical self-
efficacy improved 
for active groups 
but not control 
group 
Madden 1989 85 
(48%) 
67.1 
(N) 
60-83 USA Aerobic exercise 
(cycling/jogging) 
vs. Non-aerobic 
exercise (Yoga) 
vs. Wait list 
control 
Aerobic 
exercise: 
1hr, 
3x/week; 
Non-
aerobic 
exercise: 
1hr, 
2x/week 
16 
weeks 
Letter Search RT, 
Word Comparison 
RT 
No significant 
differences 
between 
groups on any 
task 
Only older group 
considered in this 
review. 
Participants 
showed good 
compliance to 
programme 
(>90%). Aerobic 
capacity 
increased in 
aerobic exercise 
group between 
time 1 and time 
2.  
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Cassilhas  2007 62 
(0%) 
68.1 
(N) 
65-75 Brazil Moderate 
intensity 
resistance 
training vs. High 
intensity 
resistance 
training vs. No 
exercise 
(stretching 
class) 
1hr, 
3x/week 
24 
weeks 
Similarities, Digit 
span, Corsi Blocks, 
Rey Osterrieth 
Complex Figure, 
Toulouse-Pieron 
Concentration 
Attention test 
Both exercise 
groups 
showed higher 
scores on 
Digit span, 
Corsi Blocks 
backwards, 
Similarities, 
and Rey 
Osterrieth 
immediate 
recall 
compared to 
control group. 
High intensity 
exercise group 
performed 
higher on 
Toulouse 
Pieron errors 
than controls.  
Lean mass was 
significantly 
different for high 
intensity group 
and control post-
intervention. 
Exercise 
attendance >75%  
Molloy 1988 45 
(100
% 
82.7 
(N) 
73-90 Canada Exercise 
(balance 
coordination and 
muscle strength 
training) vs. No 
10-35min, 
3x/week 
3 
months 
Colour Slide recall 
and recognition, 
Digit Span, Logical 
Memory, Digit 
Symbol, Word 
Exercise 
group showed 
less decline 
on Word 
Fluency after 
Exercise 
attendence 31-
94%, average 
71%.  
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exercise Fluency,  MMSE intervention 
period. No 
differences on 
any other test. 
Hassmen 1992 30 
(100
% 
66.1 
(N) 
55-75 Sweden Exercise training 
(walking) vs. 
Mental training 
(mental 
arithmetic, 
problem solving 
and logical 
thinkgin) 
20mins, 
3x/week 
3 
months 
Face recognition, 
Digit Span, Simple 
RT, Choice RT 
Increase in 
Digit Span 
after exercise 
training group 
but not mental 
training. No 
differences on 
any other test.  
Exercise group 
was asked to 
walk at least 3 
times per week, 
the control group 
was given 3 
assignments per 
week. No 
differences 
between groups 
in VO2max post-
intervention but 
the exercise 
group had lower 
systolic BP 
compared to 
controls. 
Colcombe  2004 29 
(62%) 
65.6 
(5.66) 
58-77 USA Aerobic exercise 
(walking) vs. 
Toning and 
stretching 
(whole body 
10-15 up 
to 40-
45mins, 
3x/week 
6 
months 
Flanker task Aerobic group 
showed 11% 
reduction in 
conflict on 
task compared 
Aerobic exercise 
group showed an 
increase in 
VO2max 
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stretching/flexibil
ity) 
to 2% in 
controls.  
Oken 2006 135 
(54%) 
72.1 
(N) 
65-85 USA Yoga vs. 
Aerobic exercise 
(walk outdoor 
400m track) vs. 
No exericise 
Yoga: 
90mins, 
1x/week + 
home 
practice. 
Aerobic: 
1hr, 
1x/week + 
home 
exercise 
6 
months 
SCWT Colour-word 
test, 10-word List 
Learning, Letter-
number sequencing 
No differences 
between 
groups on any 
task 
Participants 
attended 69% of 
classes and 
exercised 54% of 
all days for 
exercise 
intervention; 
attendance 78%, 
exercised 64% of 
all days for yoga 
class. Groups did 
not differ on all 
physical 
measures 
Brown  2008 154 
(88%) 
79.6 
(6.3) 
62-95 Australia General 
exercise 
(walking, 
resistance, 
flexibility and 
balance) vs. 
Flexibility and 
relaxation 
(gentle bending 
and rotation of 
1hr, 
2x/week 
6 
months 
Similarities, 
Arithmetic, Picture 
Completion, Digit 
Symbol, Digit Span, 
Visual Paired 
Associates, Verbal 
Paired Associates, 
TMT, SCWT Colour-
word test, Verbal 
Fluency      
General 
exercise group 
showed 
improvements 
in similarities 
and arithmetic 
only. Flexibility 
and no 
exercise 
groups did not 
Range of 
attendance 3-51 
classes out of 52 
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joints) vs. No 
exercise 
improve on 
any tasks 
Perrig-
Chiello  
1998 46 
(39%) 
73.2 
(N) 
65-95 Switzerla
nd 
Exercise 
(strength 
training) vs. No 
exercise 
1x/week 8 
weeks 
Immediate and 
delayed recall and 
recognition, Digit 
Symbol 
Significant 
increase for 
immediate and 
delayed recall 
and 
recognition in 
exercise group 
only. No 
differences 
between 
groups for 
cognitive 
speed 
Exercise 
frequency was 
very limited. 
There was a 
significant 
increase in 
muscular 
strength for 
exercise group. 
Fabre 1999 32 
(84%) 
65.9 
(N) 
60-76 France Aerobic training 
(walking/running
) vs. Mental 
training 
(memory and 
perceptive 
activity) vs. 
Aerobic and 
mental training 
vs. Control 
Aerobic: 2 
x 
1hr/week 
walking. 
Mental 
training: 1 
x 
90min/we
ek mental 
activity 
8 
weeks 
WMS, BEC96 Aerobic and 
mental activity 
group showed 
highest 
increase in 
WMS score, 
followed by 
aerobic only, 
then mental 
only, then 
control. No 
Aerobic groups 
showed an 
increase in 
VO2max. 
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change on 
BEC96 for any 
group 
Blumenthal 1989 101 
(50%) 
67.0 
(4.9) 
60-83 USA Aerobic exercise 
(cycling and 
jogging) vs. 
Yoga vs. 
Waiting list 
control 
Aerobic: 1 
hr, 
3x/week. 
Yoga:  at 
least 1 hr, 
2x/week) 
16 
weeks 
Short Story module 
of the Randtman 
Test, Digit Span, 
Benton Revised 
Visual Retention 
test, Selective 
Reminding, TMT, 
SCWT, Digit 
Symbol, Visual 
Scanning, Fluency 
test (verbal and non-
verbal) 
Aerobic group 
showed no 
difference in 
any cognitive 
scores post 
intervention 
compared to 
control groups 
Yoga not done 
as often as 
aerobic activity: 
aerobic = 48 
sessions, yoga = 
32 sessions. 
Good adherence 
rate (96%). 
There was an 
increase in 
VO2peak for 
aerobic group 
only. 
Hill 1993 87 
(51%) 
64 
(3.1) 
60-73 USA Exercise 
(flexibility, 
walking and 
running) vs. No 
exercise 
50mins, 3-
5x/week 
1 year Logical Memory, 
Digit Symbol, 
Crossing-off task 
Exercise 
group stayed 
stable over 
time on 
Logical 
Memory but 
control group 
declined. No 
differences 
between 
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groups on 
other tasks 
Moul 1995 30 
(63%) 
69.1 
(.79) 
65-72 USA Aerobic exercise 
(walking) vs. 
Strength training 
vs. Control (mild 
stretching) 
30-
40mins, 
5x/week 
16 
weeks 
Immediate memory, 
Recent memory, 
Temporal 
Orientation, Problem 
Solving and Abstract 
Reasoning, 
Organisation, 
Auditory Processing 
Aerobic group 
improved by 
7.8% on 
Organisation 
and Auditory 
Processing. 
Strength and 
Control group 
did not 
improve on 
any task. 
Aerobic group 
only showed 
increase in 
VO2max by 
15.8%. 
Smiley-
Oyen 
2008 57 
(72%) 
70.2 
(N) 
65-79 USA Aerobic exercise 
vs. Flexibility 
(e.g. Yoga) 
50mins, 
3x/week 
10 
months 
Simple RT, Choice 
RT, Incongruent RT, 
SCWT, WCST, 
Go/No-go 
Aerobic group 
showed 
significant 
decrease in 
SCWT errors 
and latency 
while 
Flexibility 
group showed 
small initial 
decrease in 
latency but 
increase in 
There were no 
significant 
differences in 
VO2peak change 
between groups 
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errors. No 
change on RT, 
WCST or 
Go/No-go 
tasks for any 
group. 
Zlomanczuk 2006 41 
(100
% 
64 (N) 57-72 Poland Exercise 
(strength and 
endurance) vs. 
No exercise 
45 mins, 
3x/week 
3 
months 
SCWT, Face/Name 
Association 
Exercise 
group showed 
improvement 
in association 
test 
performance 
over time. No 
changes on 
SCWT or for 
control group 
on any task 
 
Williams 1997 149 
(100
% 
71.7 
(N) 
60+ Australia Exercise 
(aerobic, 
strength and 
stretching) vs. 
No exercise 
60 mins, 
2x/week 
12 
months  
Digit span forwards 
and backwards, 
Picture 
Arrangement, 
Cattell's Matrices 
Exercise 
group 
improved on 
all cognitive 
measures but 
control group 
did not 
Mean adherence 
of 59 (range 26-
82) weeks of 
exercise 
intermittant with 
weeks off. 
Exercise group 
improved in 
physiological 
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measures over 
time. 
Improvement in 
Digit Span 
associated with 
improvements in 
muscle strength 
Emery 1990 39 
(83%) 
72 (6) 61-86 USA Exercise 
(aerobic) vs. 
Social 
interaction (card 
games, art 
projects etc.) vs. 
Wait list control 
1hour, 
3x/week 
12 
weeks 
Digit Span, Digit-
Symbol Substitution, 
writing digits and 
writing words 
No change in 
any group on 
any cognitive 
test 
Attendance in 
exercise group 
ranged from 61-
94%, social 
group from 10-
94%. No 
differences over 
time between 
groups for 
cardiovascular 
factors 
Lachman 2006 210 
(78%) 
75.3 60-94 USA Exercise 
(resistance) vs. 
No exercise 
35mins, 
3x/week 
6 
months 
Digit Span 
backwards 
Change in 
resistance 
level over the 
exercise 
period 
predicted 
improvement 
in Digit Span 
Exercises were 
delivered by 
video tape at 
home. Large 
range in 
participation 
rates. Upper and 
lower body 
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in exercise 
group.  
strength 
improved in the 
exercise group 
only.  
Bakken 2001 10 
(60%) 
82.5 
(N) 
72-91 USA Exercise 
(calisthenics, 
bicycling and 
walking) vs. No 
exercise 
6-39mins, 
3x/week 
8 
weeks 
Finger Tracking test 
(measured as 
accuracy index) 
Exercise 
group showed 
improved 
accuracy 
index whereas 
no-exercise 
group showed 
a decline in 
accuracy 
index over 
time 
Attendance to 
exercise group 
ranged from 71-
100% (mean 
90.2%). No 
improvements 
were seen in 
physiological 
measures for 
either group. 
Panton 1990 49 
(53%) 
72.04 
(N) 
70-79 USA Aerobic 
(walking/jogging
) vs. Strength 
training vs. No 
exercise 
Aerobic: 
30-55mins 
(increased 
over 
weeks), 
3x/week. 
Strength: 
30mins, 
3x/week 
26 
weeks 
RT No differences 
between 
groups on RT 
post-
intervention. 
Significant 
correlation 
between 
changes in 
VO2max and 
change in RT. 
The aerobic 
group did more 
exercise than the 
strength group. 
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Emery 1998 79 
(53%) 
66.6 
(6.5) 
50+ USA Exercise 
(aerobic) + 
education + 
stress 
management vs. 
Education + 
stress 
management vs. 
Control 
Exercise: 
45-90mins 
(increased 
over 
weeks), 
3x/week  
10 
weeks 
Digit Vigilance test, 
Finger Tapping, 
TMT (A and B), 
Digit-Symbol 
Substitution, Verbal 
Fluency. 
Exercise 
group showed 
improved 
Verbal 
Fluency 
compared to 
control 
groups. No 
change on 
other tasks. 
16% gain in 
VO2max in 
exercise group 
only.  
Hassmen 1997 
(a & 
b) 
40 
(50%) 
66 55-75 (N) Exercise 
(walking) vs. no 
exercise (3 
home 
assignments per 
week) 
3x/week 3 
months 
Simple RT, Complex 
RT, Immediate 
recall, Delayed 
recall, Face 
recognition, Digit 
span 
Significant 
differences on 
complex tasks 
whereas only 
minor 
differences on 
simple tasks 
 
Kramer 2001 124 
(73%) 
(N) 60-75 (N) Aerobic 
(walking) vs. 
flexibility 
(stretching and 
toning) 
10-40mins 
(increased 
over 
weeks), 
3x/week 
6 
months 
Visual Search, 
Response 
Compatibility task, 
Task-Switching 
paradigm, Stopping 
paradigm, Spatial 
Attention, Rey 
Auditory Verbal 
learning task, 
Aerobic group 
showed 
significant 
improvements 
over the 
flexibility 
group on 
Task-
switching, 
Aerobic group 
showed 5.1% 
increase in 
VO2max, 
flexibility group 
showed 2.8% 
decrease in 
VO2max. There 
were significant 
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Pursuit Rotor task, 
Spatial working 
memory, Verbal 
working memory, 
Face recognition 
task, Digit-digit and 
Digit-symbol task, 
Digit Span forwards 
and backwards 
Stopping, 
Response-
Compatibility 
and Rey 
Auditory 
Verbal 
Learning task. 
Other tasks 
non-
significant. 
differences 
between groups 
for tasks 
involving 
executive 
function but not 
for tasks 
involving little or 
no executive 
control. There 
were also no 
differences for 
tasks of working 
memory.  
Whitehurst 1991 14 
(100
%) 
65 61-73 (N) Exercise 
(bicycling) vs. 
no exercise 
35-
40mins, 
3x/week 
8 
weeks 
Simple RT, Choice 
RT 
No differences 
between 
groups for 
either task 
Aerobic group 
showed 
significantly 
higher VO2max 
compared to the 
control group 
Abbreviations: (N) - information unavailable; RT - Reaction Time;  BP - Blood pressure;  MMSE - Mini Mental Status Examination;  WMS - Wechsler Memory 
Scale; HR - heart rate;  WCST - Wisconsin Card Sort task; TMT - Trail-Making Test 
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2.3.3. The Effect of Exercise on Risk of Dementia 
The second question we investigated was how physical activity can affect an 
individual’s risk of developing dementia. We identified prospective studies that examined 
healthy older adults at baseline and determined the odds ratios of being either i) 
dementia-positive (cases) or ii) remaining dementia-free (controls) over time depending 
upon their level of physical activity. Dementia classification could include cognitive 
impairment (CI), AD, Vascular Dementia (VaD) or dementia as one group. Our search 
highlighted 13 prospective studies that fitted these criteria. All studies identified were 
prospective observational studies. Details of the studies identified can be seen in Table 
3Table 3. Exercise measures tended to be either frequency of specific exercises, such as 
walking or swimming (e.g. Larson et al., 2006) or the number of calories expended in a 
given timeframe (Podewils et al., 2005; Ravaglia et al., 2008). Out of the 13 studies, five 
found a reduced risk of dementia for those who exercised more often. Significant risk 
reduction ranged from 31% (AD and VaD; Lindsay et al., 2002) to 88% (CI; Sumic, 
Michael, Carlson, Howieson, and Kaye, 2007). A further four studies (Larson et al., 2006; 
Laurin, Verreault, Lindsay, MacPherson & Rockwood, 2001; Podewils et al., 2005; 
Ravaglia et al., 2008) found a reduced risk for certain types of dementia only, while four 
(Wang, Karp, Winblad & Fratiglioni, 2002; Verghese et al., 2003; Carlson et al., 2008; 
Rovio et al., 2007) found no reduced risk of dementia following regular exercise. No study 
found an increased risk of dementia for individuals who exercised more. 
 
2.3.3.1. Differences in dementia type 
While most of the studies identified found that exercise either had a positive effect 
on both AD and VaD, or had no effect on either, four studies found different results for the 
different types of dementia. Larson et al. (2006), Laurin et al. (2001) and Podewils et al. 
(2005) found that exercise reduced the risk of AD (and CI in Laurin et al., 2001) but did 
not affect the risk of VaD. However, Ravaglia et al. (2008) found a reduced risk of VaD 
but not for AD. This was the only study that found a significant risk reduction for VaD. 
While this may suggest that exercise exerts an effect at the neural level that favours AD 
over VaD, it may also be due to methodological limitations. Risk factors for AD and VaD 
show great overlap, such as smoking, obesity, homocysteine, high blood pressure and 
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high cholesterol (Kivipelto, Ngandu, Fratiglioni, Viitanen et al., 2005; Hogervorst, Ribiero, 
Molyneux, Budge & Smith, 2002); therefore, it is unlikely that this result is due to biased 
control of these covariates in favour of AD or VaD across these studies. Rockwood and 
Middleton (2007) also found a lack of effect of exercise for VaD and suggested that it was 
due to too small numbers of individuals being classified as having VaD, which is less 
common than AD. A second explanation is that inter-rater agreement on classification of 
dementia type is often moderate at best, even between experienced medical 
professionals (Hogervorst, Barnetson, Jobst, Nagy et al., 2000). However, these 
suggestions are based on a limited number of studies and should be regarded with 
caution. 
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Table 3 
Details of longitudinal studies investigating the effect of exercise on risk of developing dementia. 
Author Year n 
(%F) 
Mean 
age at 
baseline  
Age 
range 
Country Duration Measure of 
exercise 
Dementia 
classification 
Outcome Covariates Notes 
Wang 2002 776 
(79%) 
81.1 
(4.9) 
>75 Sweden 7 years Swimming, walking 
or gymnastics 
(daily vs. weekly 
vs. monthly vs. 
annually) 
Dementia No reduced risk of 
dementia for more 
active group than 
less active 
groups. 
Age, sex, 
education, cognitive 
functioning, 
comorbidity 
resulting in 
hospitalisation 
(CHD, 
cerebrovascular 
disease, diabetes, 
malignancy, hip 
fracture), 
depressive 
symptoms and 
physical functioning 
at baseline 
Limited types of 
exercise were 
included. 
Regular social 
and mental 
activity were 
positively 
associated with 
reduced risk of 
dementia. 
Outcome was 
the same for 
ApoE4 positive 
and negative 
groups. 
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Larson  2006 1740 
(60%) 
75.7 >65 USA 6.2 years 
(SD 2.0) 
Walking, hiking, 
bicycling, aerobics 
or calisthenics, 
swimming, water 
aerobics, weight 
training or 
stretching, or other 
exercise.  (Active: 
15mins >3 times 
per week vs.  
Inactive: <3 times 
per week) 
AD, VaD, 
other 
Active group had 
32% reduced risk 
of any type of 
dementia and 
31% reduced risk 
of AD compared 
to inactive group  
Age, sex, ApoE4 
status, diabetes, 
hypertension, 
cerebrovascular 
disease, CHD, self-
rated health, 
physical 
performance, 
depression, and 
cognitive 
functioning. 
Exercise gives 
greatest risk 
reduction in 
those with poor 
performance-
based physical 
function at 
baseline 
Rovio 2005 1449 
(62%) 
50.6 
(6.0) 
39-64 Finland 21 years Leisure-time 
physical activity 
that causes 
breathlessness and 
sweating (Active: 
20-30mins at least 
twice per week vs. 
Inactive: activity 
less than twice per 
week) 
Dementia, AD  Active group had 
52% reduced risk 
of dementia and 
62% reduced risk 
of AD compared 
to inactive group. 
Age, sex, 
education, follow-up 
time, locomotor 
disorders, vascular 
risk factors, ApoE 
status, smoking, 
alcohol 
consumption 
Outcome 
especially 
pronounced for 
ApoE4 carriers. 
Outcome 
showed a similar 
pattern for men 
and women 
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Laurin  2001 4615 
(60%) 
(N) >65 Canada 5 years High active: high 
intensity >3x/week 
vs. Moderate 
active: moderate 
intensity >3x/week 
vs. Low active: 
activity <3x/week 
CI, AD, VaD, 
other 
specified 
dementia, 
other non-
specified 
dementia 
High active group 
had 53% reduced 
risk of cognitive 
impairment, 73% 
reduced risk of 
AD and 55% 
reduced risk of 
any type of 
dementia 
compared to low 
active group for 
women only. 
Age, sex, 
education, family 
history of dementia, 
smoking, alcohol 
consumption, use 
of nonsteroidal anti-
inflammatory drugs, 
ADL, IADL, self-
rated health, health 
status 
Individuals doing 
activity <3 times 
per week were 
classed as low 
activity even if it 
was at a high 
intensity. Was 
not clear how 
long each 
session of 
exercise must 
last to qualify for 
inclusion. 
Verghese  2003 469 
(64%) 
79.1 (N) 75-85 USA 5.1 years Tennis, golf, 
swimming, cycling, 
dancing, group 
exercise, team 
games, walking, 
climbing more than 
two flights of stairs, 
housework, 
babysitting (Active: 
daily - several days 
per week vs. 
Inactive: once 
weekly - never) 
Dementia 
(AD, VaD, 
mixed 
dementia, 
other 
dementia) 
No reduced risk of 
dementia for 
active compared 
to inactive group. 
Age, sex, 
education, health 
status (cardiac 
disease, 
hypertension, 
diabetes, stroke, 
depression, 
hypothyroidism), 
baseline Blessed 
scores 
Mental activity is 
related to risk of 
dementia. A 
limited number of 
activities were 
included. 
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Podewils 2005 3375 
(N) 
74.8 
(4.9) 
>65 USA 5.4 years High energy 
expenditure 
(>1657kcal/week) 
vs. Low energy 
expenditure 
(<248kcal/week).  
High participation 
(>3 activities) vs. 
Low participation 
(0-1 activities) in 
previous two weeks 
AD, VaD High energy 
expenditure group 
had 32% reduced 
risk of AD 
compared to low 
energy 
expenditure 
group.                                                          
High participation 
group had 56% 
reduced risk of 
dementia and AD 
compared to Low 
participation 
group. 
Age, sex, ethnicity, 
ApoE status 
(stratified), 
education, ADL, 
IADL, social 
support, baseline 
3MS score, white-
matter grade
Reduced risk of 
dementia was 
seen for ApoE4 
non-carriers only 
Abbott 2004 2257 
(0%) 
77 (N) 71-93 Honolulu-
Asia 
cohort 
6 years Active: walk 
>2miles/day vs. 
Inactive: walk 
<1mile/day vs. 
Sedentary: walk 
<.25mile/day 
AD, VaD, 
overall 
dementia  
Active group had 
43% reduced risk 
of overall 
dementia 
compared to 
Inactive group.                                                           
Active group had 
55% reduced risk 
of AD compared 
to Sedentary 
group. 
Age, ApoE status, 
professional status, 
hypertension, 
diabetes, CHD, 
education, BMI, 
childhood years
spent living in 
Japan, cholesterol 
level 
Reduced risk of 
dementia was 
seen for both 
ApoE4 carriers 
and non-carriers 
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Ho 2001 988 
(47%) 
77.4 (6) >70 Hong 
Kong 
3 years Active: participate 
in physical activity 
vs. Inactive: do not 
participate in 
physical activity 
CI  Active group had 
55% reduced risk 
of CI compared to 
Inactive group in 
women only 
Age, education, 
stratified by sex 
Was not clear 
what was defined 
as exercise and 
no exercise (e.g. 
was walking 
classed as 
exercise) 
Lindsay 2002 4088 
(61%) 
73.3 (N) >65 Canada 5years Active: participate 
in physical activity 
vs. Inactive: do not 
participate in 
physical activity 
AD Active group had 
31% reduced risk 
of AD compared 
to Inactive group 
Age, sex, education Not clear what 
was defined as 
exercise and no 
exercise (e.g. 
was walking 
classed as 
exercise) 
Carlson 2008 294 
(0%) 
44.7 (N) 67-85 USA 28-36 
years 
Active: participate 
in physical activity 
vs. Inactive: do not 
participate in 
physical activity.  
Outdoor activities, 
sports, gardening, 
home 
improvement, 
physical activity 
after age 35  
Dementia Active group had 
no reduced risk of 
dementia 
compared to 
inactive group. 
Age, General 
Intellect Demand 
score, stratified by 
zygosity and ApoE4 
This was a twin 
study (61% 
monozygotic). 
Cognitive activity 
reduced 
dementia risk by 
26% in ApoE4 
carriers only. The 
active group had 
activity frequency 
from sometimes 
to daily. This 
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study looked at 
midlife activity. 
Ravaglia 2008 749 
(54%) 
73.2 
(6.0) 
>65 Italy 3.9 
(SD=.7) 
Tertiles of energy 
expenditure for 
walking, stair 
climbing, moderate 
activity, vigorous 
activity, total 
activity.                                                   
Participation vs. 
non-participation in 
30mins moderate 
intensity activity 
4x/week 
Dementia, 
VaD, AD  
VaD risk lower for 
upper tertiles of 
walking, moderate 
activity and total 
activity compared 
to lowest tertile        
No reduced risk of 
dementia overall 
or AD.                                                       
Participation 
group had no 
reduced risk of 
dementia, VaD or 
AD compared to 
non-participation 
group. 
Education, 
comorbidity (2 or 
more vascular risk 
factors/history), 
ADL, age, sex, 
ApoE4 status 
No effect of 
ApoE4 was seen 
but this may be 
due to low 
numbers of 
ApoE4 carriers 
Rovio 2007 1449 
(62%) 
50 (N) 65-79 Finland 20.9yrs 
(SD=4.9) 
Daily work 
commuting time 
(not at all v 
<59mins, 
>60mins/day); 
Occupational 
activity (sedentary, 
physical)  
AD Work-related 
physical activity 
had no effect on 
risk of AD 
Age, sex, 
education, follow-up 
time, locomotor 
symptoms, 
occupation, midlife 
income, leisure time 
physical activity, 
ApoE4 status, 
Those with active 
jobs were less 
likely to exercise 
outside of work 
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vascular disorders, 
smoking status 
Sumic  2007 66 
(59%) 
88.5 
(2.74) 
>85 USA 4.7yrs 
(SD=2.71) 
Walking, biking, 
dancing, jogging, 
swimming, farm 
work, hunting, 
skiing, tennis, 
hiking, home 
maintenance 
(Active: 
>4hours/week vs. 
Inactive 
<4hours/week) 
CI Active group had 
88% reduced risk 
of CI compared to 
Inactive group for 
women only 
Age, sex, race, 
education, SES, 
place of residence, 
living 
arrangements, 
IADL, ApoE4 
status, baseline 
walking speed, 
depression, 
baseline delayed 
recall scores 
Limited types of 
exercise were 
included.  
Abbreviations: (N) - information unavailable; AD - Alzheimer's Disease; VaD - Vascular dementia; ApoE - Apolipoprotein E;  CHD - Coronary heart disease;  IADL - 
Instrumental Activities of Daily Living; ADL - Activities of Daily Living; BMI - Body Mass Index; SES - Socioeconomic status 
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2.3.3.2. Differences in exercise measures 
Among the studies in this category, there was a huge variety in the 
exercise measures used and this may have had an effect on variation in the risk 
reduction ratio in these studies. The studies that found no effect of exercise on 
dementia risk (but also many of those that did find an effect) used self-report 
measures of activity frequency. However, as discussed in the previous section, 
these measures do not always correlate well with objective fitness measures, as 
they depend upon participants being honest and accurate in their recollection of 
physical activity. By the very nature of the disease, those with dementia or in the 
prodromal phases of dementia may have inaccurate recall of their health-related 
behaviours (e.g. see for hormone use Petitti, Buckwalter, Crooks & Chiu, 2002). 
Alternatively, being part of this kind of study may have encouraged healthy 
participants to take up more physical exercise or other health behaviours such as 
healthy diet, quitting smoking etc. (see also section above). Behaviour has the 
potential to change greatly over several years between baseline and follow-up 
measurements, and without knowing exactly how stable the activity has been over 
time it is difficult to know how accurate the odds ratios really are. This could be 
partly overcome by assessing changing exercise behaviours over time and taking 
into account other health behaviours at regular intervals over the follow-up period, 
although the reliability of self-report measures is never perfect. Therefore, using 
objective measures such as improvement in strength and VO2max and perhaps 
blood measures of oxidative stress and vitamin levels could better validate this 
type of research. 
There were also several methodological limitations among the exercise 
measures used in these studies. For example, many studies such as Wang et al. 
(2002) and Verghese et al. (2003) selected only common sports and activities, 
meaning that some individuals were classed as inactive even though they may 
have taken part in some unusual but intense activities. Carlson et al. (2008) used 
criteria of activity being either ‘never’ or ‘sometimes’, with the “sometimes” 
category including ‘activities engaged in up to every day’. This means that this 
study cannot distinguish between those who did the activity every day and those 
who did it every few weeks, which may have made a large difference. These three 
studies were among the four that found no risk reduction for high exercise groups. 
Therefore some of the null results may be explained through the definitions of 
exercise and control groups. 
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We mentioned in the previous section that aerobic and possibly resistance 
training both appeared to have an effect on cognition, whereas flexibility exercise 
did not. A general observation of the studies in dementia risk was that there was a 
focus on high intensity aerobic activity and little mention of yoga and resistance 
exercise. Thus it was not clear how much of a risk reduction might be seen in 
individuals who regularly participated in strength exercises alone. Again future 
work may consider looking specifically at resistance exercises to see if there is a 
connection between the beneficial effects of this type of exercise seen on cognition 
in healthy older adults and the subsequent risk of dementia and CI. 
 
2.3.3.3. Moderating variables 
Some of the studies that have looked at how exercise affects dementia risk 
have investigated the ways in which genetics can act as a moderator variable 
between exercise and risk of dementia. As mentioned in Chapter 1, carriers of two 
ApoE ε4 alleles are much more likely to develop AD than those with one ApoE ε4 
allele, while those with one ApoE ε4 allele are about 2 times more likely to develop 
dementia than those with no ApoE ε4 alleles (Corder, Saunders, Strittmatter, 
Schmechel et al., 1993). While some studies that had the genetic data on their 
participants found that both ApoE ε4 carriers and non-carriers benefited from 
exercise, Rovio et al. (2005) found that those with at least one ApoE ε4 allele 
showed greatest risk reduction. In contrast, Podewils et al. (2005) found that non-
carriers of the ApoE ε4 allele benefited most from exercise. The ApoE ε2 allele is 
thought to provide protection against cognitive decline (Berlau, Corrada, Head & 
Kawas, 2009), while ApoE ε3 is associated with median cognitive decline (Wilson, 
Bienias, Berry-Kravis, Evans & Bennett, 2002). Therefore, individuals without two 
ApoE ε4 alleles may have carried either the ApoE ε2 or the ApoE ε3 allele, and 
this could potentially have confounded some of the results in these studies. Thus, 
a different classification should be used that takes into account the relative 
protective effects of ApoE ε2 compared to the negative effects of ApoE ε4 rather 
than to focus on ε4 alone, although this type of classification requires a very large 
sample. 
Another potential moderating variable between exercise and risk of 
dementia is sex. Women are twice as likely to be diagnosed with AD as men 
(Launer, 1992). There is some evidence that the reduction in female hormone 
estrogen at menopause is linked to the increased risk of AD (Hogervorst, Williams, 
Budge, Riedel & Jolles, 2000). Some studies have found similar patterns of 
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cognition after exercise for both men and women (e.g. Rovio et al., 2005). 
However, other studies have found more pronounced protective effects of exercise 
in protecting against dementia and cognitive impairment for women when 
compared to men (Laurin et al., 2001; Ho et al., 2001; Sumic et al., 2007). 
Exercise may therefore have a particularly protective effect on women who are 
more vulnerable to the risk of dementia. The potentially mediating effects of sex 
steroids in this association should be further investigated (see Clifford et al., 2009). 
 
2.3.3.4. Summary 
Most studies have found that participation in regular physical exercise 
helps to significantly prevent or delay the onset of AD, although whether the same 
is true for other types of dementia is less clear. The wide range of quoted risk 
ratios (from 0% to 88%) may be due to differences in the considered activities, age 
and duration of follow-up (as the risk for dementia increases with age, see Chapter 
1) and a lack of standardised objective fitness measures or only moderate inter-
rater agreement in diagnoses. Many factors appear to interact with effects of 
exercise, including genetics and sex. Based on the findings from the previous 
section, future work may wish to consider different types of exercise as their 
activity measures in addition to the potentially moderating factors mentioned 
above. 
 
2.3.4. The Effect of Exercise in Patients with Existing Cognitive Impairment 
 Although exercise has generally been researched to be a potential 
preventative activity against the onset of dementia, our final question was whether, 
like in healthy adults, exercise could improve cognitive functioning of those with 
dementia. Some longitudinal studies mentioned previously (van Gelder et al., 
2004; Barnes et al., 2003) found associations between frequent exercise and 
better scores on the MMSE, which is a test sensitive to dementia. Although there 
are very few studies that directly answer this question, making it difficult to draw 
conclusions, we believe it is crucial for discussion within this review as there are 
potential benefits to those already diagnosed with the disease. There has been a 
recent meta-analysis of the literature concerning exercise and cognition in those 
with dementia. Forbes, Forbes, Morgan, Markle-Reid et al. (2008) concentrated on 
RCTs but, through use of very strict inclusion criteria, the authors were only able to 
run the analysis on two studies (Francese, Sorrell & Butler, 1997; Rolland, Pillard, 
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Klapouszczak, Peynish et al., 2007). They found that there was insufficient 
evidence of a positive effect of exercise on cognition. However, with only two 
studies it is perhaps not really possible to draw firm conclusions at this stage. Our 
search of the literature also only identified four RCTs that fit our criteria for review, 
so we too are unable to make statements about the findings. However, we discuss 
the studies briefly in terms of their methodologies and how their results compared 
to those performed with healthy adults. These studies shared similar 
characteristics with the RCTs seen in the healthy adults except that the 
participants were diagnosed with mild cognitive impairment (MCI), AD or dementia. 
Details can be seen in Table 4. 
 
2.3.4.1. Cognitive domain measured 
Several different tests of cognitive function were used in these studies, 
such as the MMSE, Verbal Fluency and TMT. While one of the studies found a 
30% improvement on MMSE scores after an exercise intervention (Kwak, Um, 
Son, & Kim, 2008), the other three studies all found no effect of exercise on the 
MMSE or any memory test. Also, while Scherder et al. (2005) found a positive 
effect of exercise on TMT performance, van Uffelen, Chinapaw, van Mechelen and 
Hopman-Rock (2008) found no such effect on the SCWT and Digit-Symbol 
Substitution Tests. The most consistent test to show positive effects of exercise in 
healthy adults was again the Digit Span test. This test also showed most 
consistent improvement with exercise in healthy elderly (see section 3 and 
Angevaren et al., 2008). On the other hand, Scherder et al. (2005) found that 
results on this test were unchanged after exercise. Thus, there is again no 
consistent pattern of which specific cognitive domains or tests are affected by 
exercise. 
 
2.3.4.2. Type of dementia 
The studies reviewed looked at patients with different classes of cognitive 
impairment. Arcoverde et al. (2008) recruited participants diagnosed with AD, 
Kwak et al. (2008) recruited participants with dementia, and van Uffelen et al. 
(2008) and Scherder et al. (2005) both recruited participants with MCI. 
Observational studies suggested that exercise appeared to have a potentially 
selective effect for reducing the risk of AD over other types of dementia. However, 
Arcoverde et al. (2008) found no effect for exercise in AD and the two studies 
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investigating the effect of exercise on cognition in MCI patients both found 
opposite results, so results were not consistent with this idea. 
 
2.3.4.3. Exercise measures 
We saw that for adults without dementia the different results may be due to 
the type or intensity of the exercise performed. Because of the age of the groups 
and disabilities concerned in these studies with dementia patients, many of the 
exercises were low intensity, such as seated gymnastics or walking. Kwak et al. 
(2008) used weight-training exercises and, if they led to changes in strength, this 
may explain why they found a positive effect on MMSE scores in comparison to 
Arcoverde et al. (2008) who used less intense exercises. Therefore, there may 
have been an influence of exercise type in these four studies. Walking showed 
inconsistent effects but was done at different intensities and compared against 
different control programmes. It is also not known whether participants of these 
studies experienced any improvement on physiological measures, which may be 
crucial in treatment studies as discussed previously. 
The treatment studies for participants with CI or dementia looked at 
measures of cognition after 6 weeks, 6 months or a year of regular exercise. As 
with the RCTs in healthy adults, length of intervention did not appear to have an 
effect on the benefit to cognition. However, Scherder et al. (2005) showed a 
positive effect of exercise on cognition after just 6 weeks, again suggesting that 
the benefits can be seen very quickly after the start of an exercise intervention. 
Low rates of adherence to the exercise program were also an issue in these 
studies. One of the studies that found no difference between exercise and control 
groups had relatively low adherence rates (van Uffelen et al., 2008). Although the 
median adherence was 63%, it ranged from 2-81%. As discussed previously, if a 
participant only attends 2% of classes, they are likely to not have benefitted in the 
same way as those who had attended 81%, and thus these two participants should 
probably not be treated the same for purposes of analysis. 
 
2.3.4.4. Moderating and confounding variables 
Kwak et al. (2008) found that exercise improved MMSE scores in a woman-
only group. This could be a chance result; however, this bias was also seen with 
the interventions in healthy adults and the observational studies so it is worth 
considering in future research. None of the studies reported included ApoE ε4 
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status as a variable so it cannot be determined whether the presence or absence 
of ApoE ε4 alleles facilitated or inhibited the effect of exercise on cognition. This 
might also be the subject of future research, as knowledge of the genetic status of 
patients may help determine who may benefit from an exercise intervention and 
who may not. 
Activities of Daily Living (ADL) is a scale that measures functional ability 
(Berlau, Corrada & Kawas, 2009), and deficits on this scale are common in those 
with dementia (Reisberg, Finkel, Overall, Schmidt-Gollas et al., 2001). An 
observation made by some of the studies here was that exercise groups showed 
improved ADL scores compared to the no exercise groups (e.g. Kwak et al., 2008). 
Arcoverde et al. (2008) found that ADL scores were the best predictor of MMSE 
scores for active AD patients. The physiological benefits of exercise may improve 
an individual’s ability to perform certain actions like walking, encouraging 
autonomy and indirectly leading to enriched mental activity and experiences. 
Mental stimulation has been associated with maintenance of cognitive function into 
old age (e.g. Verghese et al., 2003). Thus, it may in fact be an increase in mental 
stimulation rather than physical exercise that has driven the increase in cognitive 
scores seen in some of these studies. 
 
2.3.4.5. Summary 
The review by Forbes et al. (2008) concluded that there was insufficient 
evidence that there was a clear benefit of exercise on cognitive function in the 
elderly with existing cognitive impairment. Despite some studies showing positive 
effects of exercise, we would have to agree with this conclusion at present. There 
is a distinct lack of studies that have investigated this topic and this makes it very 
difficult to establish a clear conclusion. However, we can benefit from these few 
studies by learning about which factors to control in the future, such as early 6 
weeks assessment, stratification by sex and genotypes and assessment of 
improvement in ADL function. 
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Table 4 
Details of RCT studies investigating the effect of exercise on cognitive function in patients with a diagnosis of dementia. 
Author Year n 
(%F) 
Mean 
age 
(SD) 
Age 
range 
Country Duration Deme
ntia 
type 
Exercise 
groups and 
types 
Frequency 
of 
exercise 
Tests Outcome Covariates Notes 
van 
Uffelen 
2008 152 
(44%) 
75 
(2.8) 
70-80 Netherlands 1 year MCI  Exercise 
(moderate 
intensity 
walking) vs. 
Low intensity 
(relaxation, 
ADL, balance, 
glexibility and 
posture) 
1hr/day, 
2days/ 
week 
AVLT, 
verbal 
fluency, 
SCWT 
colour 
word test, 
DSST 
No significant 
main effects of 
intervention on 
cognition 
education, 
baseline 
activity level, 
vitamin status, 
adherence 
and 
supplementati
on, stratified 
by sex 
Median 
adherence to 
program was 63% 
(2-81%).  
Arcoverde  2008 37 (N) 76.7 
(N) 
>65 Brazil 6 
months 
AD  AD active  
(Respiratory 
exercises, 
static and 
dynamic 
balance 
training, gait 
circuits, ADL, 
coordination 
PLUS 
cognitive 
stimulation) vs. 
1hr/day, 
2days/ 
week 
MMSE AD groups 
showed no 
difference on 
MMSE scores 
over time. 
 AD active group 
were much older 
than AD 
sedentary group 
and controls. 
There were no 
differences in final 
fitness levels 
between AD 
active and AD 
sedentary groups. 
Exercises were 
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AD sedentary 
vs. Control 
active (dance 
and gym) 
different for AD 
and control active 
groups.  
Kwak  2008 30 
(100% 
80.97 
(6.22) 
>60 Korea 12 
months 
Demen
tia 
Exercise 
(stretching and 
strength) vs. 
control 
30-40mins/ 
week 
MMSE 30% MMSE 
and ADL 
improvement 
in intervention 
group only  
 The control group 
was slightly older. 
Long term 
intervention better 
than short term.  
Scherder 2005 43 
(88%) 
86 
(N) 
76-94 Netherlands 6 weeks MCI  Exercise (self-
paced slow 
walking) vs. 
Hand/face 
(hand 
stretching and 
facial 
expressions) 
vs. social 
control (social 
visits) vs. 
control 
30mins/ 
day, 3x/ 
week 
Category 
Naming, 
TMT, Digit 
Span, 
VLMT, 
Face 
recognition
, Picture 
recognition 
Category 
Naming and 
TMT better in 
walking group 
and hand/face 
group than 
control group 
immediately 
after 
treatment. No 
difference for 
memory tasks 
Pre-treatment 
scores 
The advantage 
was not 
maintained over 
time 
Abbreviations: (N) - information unavailable; AD - Alzheimer's Disease; MCI - Mild Cognitive Impairment; ADL - Activities of Daily Living; AVLT - Auditory Verbal Learning Test; 
DSST - Digit Symbol Substitution Test; MMSE - Mini Mental Status Examination; TMT - Trail Making Test; VLMT - Verbal Learning Memory Test 
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2.4. Conclusions 
This review aimed to evaluate the conflicting findings of past studies that have 
investigated the effect of physical exercise on cognition in older adults to determine 
whether physical activity may help to maintain cognitive function in older age. In 
particular, we looked at the individual cognitive domains that were examined in each 
study and the type of exercise measure that was used. 
No firm conclusions could be made concerning which specific cognitive 
domains are affected by exercise, and the results here did not always support those 
found by other reviews such as Colcombe and Kramer (2003). The tests used in these 
studies are so varied that some results may have been seen by chance. However, the 
range of cognitive tests showing positive effects may also indicate that exercise 
benefits general cognitive ability to some degree. More replication is needed using 
standardised cognitive tests to determine how specific the effect of exercise is. In 
terms of risk of dementia, there was some evidence that exercise may have a specific 
effect on AD, although again this was based on very few studies and was complicated 
by methodological differences between studies. However, if this finding can be 
replicated, it would suggest that specific neural mechanisms may be targeted by 
physical activity and that would have further implications for which cognitive domains 
are affected. This idea is purely speculative, but it may be worth attention as it could 
determine what the specific cognitive benefits of exercise are. 
Clearer patterns were seen when we looked at the type of exercise intervention 
used in these studies. The main focus has been on aerobic activity, which did appear 
to have an effect on cognition and risk of AD. However, strength-training exercises also 
seemed to be beneficial to cognition in both healthy adults and those with dementia. 
This is especially true when there is an additional measured increase in objective 
physiological measurements, such as VO2max and muscle strength. This is important, 
as strength training exercises may be easier for some elderly to participate in and may 
thus be a more successful intervention (or at least compliment more aerobic activity) in 
terms of promoting adherence. While participation in aerobic activities appeared to 
help to delay dementia onset, it is less clear whether strength training can do the same 
and research may attempt to highlight these sorts of activities in future studies. 
Future work must control for variables that may moderate the relationship 
between exercise and cognition. Adherence to the exercise program must be 
controlled in RCTs as low adherence by a large proportion of the sample can disguise 
a real effect of exercise. Fluctuations in physical activity habits as well as change in 
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other health behaviours, such as diet and smoking, should be monitored over the 
course of an intervention or follow-up period. Behaviour can change over time so a 
single measurement may not be sufficient to map a person’s exercise habits over a 
given timeframe. Genetics must also be taken into account where possible when 
considering dementia risk and cognition in those with dementia, as there is evidence 
that ApoE status can affect whether an individual would benefit from exercise or not 
(e.g. Podewils et al., 2005; Rovio et al., 2005). As mentioned previously, a new 
categorisation for determining ApoE allele status needs to be considered to take into 
account the protective effect that the ApoE ε2 allele may have. There is also evidence 
that women may benefit more from exercise interventions than men (Sumic et al., 
2007), which has additional implications for targeted healthcare recommendations. A 
review published in Women’s Health (Clifford, Yesufu Udechuku, Edwards, Bandelow 
& Hogervorst, 2009; see Appendix A) discusses effects of physical activity and other 
lifestyle interventions for women in midlife specifically.  
In summary, this review has found inconsistent evidence that physical activity 
can have positive effects on cognition and may delay the onset of AD. The 
inconsistencies appear to be partly due to the different types of exercise measures 
used, but they may also be influenced by a variety of different moderating variables 
such as sex, adherence and genetics. The data presented here suggest that more 
research into this area is warranted, and this review has highlighted some important 
variables that must be investigated in future studies. Later in this thesis we explore the 
effect of some of these variables, for example sex and cognitive status, in a 
community-dwelling sample of elderly adults in Indonesia (Chapter 5). We also 
describe an RCT looking at the effects of resistance training to expand knowledge 
about how this type of activity can influence cognition in midlife (Chapter 7). 
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Part Two - Methods and cognitive test selection 
Chapter 3 – Cognitive test selection and covariates 
A clinical diagnosis of AD is ultimately the most desirable outcome measure 
when studying disease prevention. However, the lengthy follow-ups required to 
conduct adequate prospective studies into AD are not possible within the time 
constraints of a doctoral thesis and cognitive testing is often used as an alternative 
measure to assess short-term changes in cognitive function. The heterogeneous 
nature of AD means that relying on the outcome of a single cognitive test may not yield 
a fair impression of an individual’s cognitive ability as it relates to the disorder. In 
addition, a key finding of the literature review presented in Chapter 2 was that physical 
activity might affect cognitive domains differently. Therefore, a battery of cognitive tests 
was used to measure abilities and changes over time in cognitive domains commonly 
affected in AD, with a focus on memory, executive function (e.g. focused attention, 
inhibition, task switching) and word generation.  
For inclusion in this battery, the tests had to show some degree of sensitivity 
and specificity to the cognitive impairment seen in AD. The sensitivity of a test refers to 
the percentage of cases that are correctly identified, while specificity refers to the 
percentage of non-cases that are correctly identified (Ghaaliq Lalkhen & McCluskey, 
2008). Both values are given as a percentage, with 100% for both indicating optimal 
discriminability between cases and non-cases. A value of around 50% suggests that 
the test is no better than chance at discriminating between cases and controls. In 
addition, the tests had to be relatively short in length and be appropriate for 
administering to participants with a range of abilities (i.e. show no ceiling/floor effects). 
This chapter introduces the cognitive measures used in this thesis and describes their 
relevance in AD research. 
 
3.1. Global Cognition 
The Mini Mental State Examination (MMSE; Folstein, Folstein & McHugh, 
1975) was included in the test battery as a clinical measure of global cognition and as 
a screening tool for serious cognitive decline including, but not restricted to, dementia. 
This allowed appropriate samples to be selected based on their baseline level of 
cognitive functioning. The MMSE takes the form of a “question-answer” test that is 
administered by a researcher. It tests a variety of cognitive domains, such as short-
term memory, orientation, visuospatial construction, object naming and language. The 
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MMSE is scored out of a maximum 30 points, with 30 suggesting no impairment. 
Scores less than 27 are generally considered to indicate cognitive impairment with a 
sensitivity and specificity of 0.89 and 0.91 respectively (O'Bryant et al., 2008), while 
cut-offs specifically for dementia are considered to be one or two points lower (e.g. 
Kuslansky et al., 2004). A comprehensive review of fourteen papers found that 
estimates of test-retest reliability for the MMSE were between 0.80 and 0.95 in those 
with and those without age-related cognitive impairment (Tombaugh & McIntyre, 1992). 
This test takes around 3-4 minutes to administer. There are more recent tests of global 
cognition (e.g. Test Your Memory test, Brown, Pengas, Dawson, Brown & Clatworthy, 
2009; Addenbrooke’s Cognitive Examination-Revised [ACER], Mathuranath, Nestor, 
Berrios, Rakowicz & Hodges, 2000; Montreal Cognitive Assessment [MoCA], 
Nasreddine et al., 2005), some of which are reported to have equal or superior 
sensitivity and specificity to the MMSE in some samples (e.g. Brown et al., 2009; 
Smith, Gildeh & Holmes 2007; Chen et al., 2011). However, the MMSE is commonly 
used in memory clinics to aid the diagnosis of AD (including in the validation study in 
Chapter 4) and it has been validated for cross-cultural applicability (Hogervorst et al., 
2011). Therefore, the MMSE was chosen as a screening test for cognitive impairment 
for the purposes of this thesis.  
 
3.2. Memory 
Severe short-term memory deficits are the main feature of AD with extensive 
neuropathology occurring around memory regions, such as the hippocampus (Du et al, 
2001). The literature review presented in Chapter 2 suggested that many of the 
changes in cognitive performance following physical activity are seen in the memory 
domain. Memory tests that met our inclusion criteria described previously were 
therefore included in the test battery.  
 
3.2.1. Hopkins Verbal Learning Test 
The Hopkins Verbal Learning Test (HVLT; Brandt, 1991) is a verbal measure of 
short-term, explicit memory in which participants are read aloud a list of 12 words that 
they are then asked to recall. This is done three consecutive times in total, giving a 
total immediate recall score of up to 36 points (delayed recall after 30 minutes can also 
be given [Benedict, Schretlen, Groninger & Brandt, 1998] but this is covered by 
copyright). There are six equivalent forms of this test, and each word list contains three 
categories of four words. Scoring high on the HVLT requires the recruitment of memory 
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strategies, such as chunking the words into categories, making the task particularly 
difficult for those with disrupted memory networks (De Jager, Hogervorst, Combrinck & 
Budge, 2003). This test can take around 6-8 minutes to administer but has the 
advantage of not showing ceiling effects, as healthy controls often do not score full 
marks (Hogervorst et al., 2002).  
The HVLT appears able to successfully predict dementia cases from healthy 
controls, with an optimal cut-off point for mild dementia of 18/19 out of 36 points 
(sensitivity 0.96, specificity 0.80; Frank & Byrne, 2000; see also Hogervorst et al., 
2002). Test-retest reliability estimates within acceptable limits (around 0.75) have been 
reported for the HVLT in healthy elderly (Benedict et al., 1998; Wesnes, 2012). Data 
from the OPTIMA project (e.g. Schrijnemaekers, De Jager, Hogervorst & Budge, 2006) 
revealed that those with AD showed a small decline on this test over time while healthy 
controls improved after repeated exposure to the test stimuli, even after a 2-3 year 
interval (Schrijnemaekers et al., 2006). On the other hand, those with MCI tended to 
remain stable over time (Schrijnemaekers et al., 2006), suggesting that the HVLT is 
able to differentiate between levels of cognitive impairment (see also De Jager et al., 
2003). A further advantage of this task for our RCT (Chapter 7) is the availability of 
equivalent forms, which make it resistant to learning effects where repeat testing over 
a short time is needed (Benedict & Zgaljardic, 1998).  
 
3.2.2. Verbal Fluency 
Word generation deficits in those with dementia have been reasonably well 
documented (Sailor, Antoine, Diaz, Kuslansky & Kluger 2004; Taler & Phillips, 2008). 
Word generation recruits neural networks particularly implicated in semantic memory 
(Kitabayashi et al., 2001), and recalling one word often prompts generation of 
semantically or physically similar words. The Verbal Fluency task, or the number of 
words from a given category that can be named in 60 seconds, is a way of measuring 
these abilities. The category ‘animals’ is often used, however ‘fruits and vegetables’, 
‘cities and towns’ and ‘items of clothing’ have been validated as alternatives for 
repeated testing (Cunje, Molloy, Standish & Lewis, 2007). Patients with AD tend to 
produce fewer words, especially atypical ones (Sailor et al., 2004), and word 
generation also declines in healthy adults several years before dementia onset (Taler 
& Phillips, 2008; Nutter-Upham et al., 2008). Gomez and White (2006) demonstrated 
that category fluency had greater ability to differentiate patients with mild Dementia of 
Alzheimer’s Type from healthy controls (CDR = 0.5 vs CDR = 0) than did other tasks 
such as Logical Memory, Digit Symbol or the Boston Naming task and verbal fluency 
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scores correlate highly with MMSE scores (Kitabayashi et al., 2001). Category fluency 
shows higher sensitivity (100% [specificity 92.5%]) to dementia compared to letter 
fluency (89% [specificity 85%]; Monsch et al., 1992; Cerhan et al., 2002), an alternative 
form that involves naming as many words as possible that begin with a given letter. 
Studies have reported good test-retest reliability (around 0.83) for category fluency in 
the elderly with and without Alzheimer’s disease (Solomon et al., 1998; Diesfeldt, 
1985).  
 
3.3. Executive Function 
The term executive functioning encompasses the cognitive skills that control 
the planning, initialisation, sequencing and monitoring of complex goal-directed 
behaviour (Royall et al., 2002). Executive function deficits occur early in AD (Perry & 
Hodges 1999; Baddeley, Baddeley, Buck & Wilcock, 2001; Bracco et al., 2007), and 
impairments may also be indicators of pathology in healthy individuals at increased risk 
of developing AD (Parasuraman, Greenwood & Sunderland, 2002; Rosen, Bergeson, 
Putnam, Harwell & Sunderland, 2002). Although the previous literature review did not 
support it, Hall, Smith and Keele (2001) suggested that physical activity mainly affects 
these complex abilities. Therefore, tests of executive function were included in the test 
battery to try to clarify these discrepancies.  
 
3.3.1. Trail-Making Task 
The Trail-Making Task (TMT; Reitan, 1955) is a test of concept shifting that 
comes in two parts. In TMT part A (TMTa), participants are given a series of randomly 
positioned circled numbers (1-25) that they must connect sequentially (1-2-3-4 and so 
on) by drawing a continuous line between them. TMTa serves as a baseline 
measurement of psychomotor speed and visual scanning. In TMT part B (TMTb), the 
stimuli include both numbers (1-13) and letters (A-L), and participants must connect 
them by alternating between the two systems (1-A-2-B-3-C-4 and so on). Participants 
are asked to complete both parts as quickly as they can and the time taken to 
complete each part is recorded. The added cognitive demand of set switching for the 
TMTb creates an interference effect, where TMTb takes longer to complete compared 
to TMTa and elicits more errors. Patients with dementia and cognitive impairment find 
TMTb particularly difficult (e.g. Amieva et al., 1998; Lafleche & Albert, 1995), and 
reaction times and errors increase with dementia severity (Ashendorf et al., 2008; 
Catherine, Ronald & Gerard, 1985). The TMT has sensitivity (specificity) of 81% (71%) 
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for dementia using a cut-off of ≤40 correct connections on average over two test trials 
(Heun, Papassotiropoulos & Jennssen 1998). Performance on the TMT is also 
associated with MMSE scores in adults without AD (Ashendorf et al., 2008). Test-retest 
reliability estimates have been reported to be moderate for the TMT. For example, 
TMT reliability coefficients of <0.65 were observed in healthy elderly who were part of 
the Alzheimer’s Disease Neuroimaging Initiative (ADNI; Wesnes, 2012). However, 
assessments were conducted over the course of 1 year which would allow for some 
deterioration of cognitive functioning acting as a confound (see also Snow et al., 1998).  
  
3.3.2. Stroop Colour-Word Test 
The Stroop Colour-Word Test (SCWT; Stroop, 1935) is a commonly used test 
of selective attention and automatic response inhibition. The full version of the SCWT 
has four conditions: reading a word written in black ink, naming a block of colour, and 
naming the colour of the font that a word is written in, which may be congruent or 
incongruent with the meaning of the word. For example, in congruent conditions, the 
word ‘blue’ would be written in blue font, while in incongruent conditions the word 
“blue” may be written in red font. As the automated response when seeing a word is to 
read it, this task requires relatively low cognitive effort when naming the font colour in 
congruent conditions. However, when the font colour is incongruent to what the word 
says, the viewer has to inhibit the reflexive response and switch attention to the font 
colour. The result is an interference effect with the incongruent condition taking longer 
to complete and eliciting more errors. 
Performance on the SCWT declines with age (Cohn, Dustman & Bradford, 
1984) but those with AD also show significantly larger interference effects compared to 
healthy controls (Bondi et al., 2002; Amieva et al., 2004). Performance also declines 
with disease severity, with MCI patients performing midway between healthy controls 
and AD patients (Kramer et al., 2006) and possible AD patients performing midway 
between probable AD patients and healthy controls (Berardi, Parasuraman & Haxby, 
2005). Those who score under half marks on the full SCWT test have a 7.3-fold 
increased risk of dementia over 7 years compared to those who score higher (Sarazin 
et al., 2007). Intraindividual variation on the incongruent SCWT trials is also 
significantly larger in those with mild Dementia of the Alzheimer’s type (CDR=0.5) than 
in healthy controls (CDR=0; Duchek et al., 2009). Not all studies have found clear 
differences on the SCWT between AD patients and controls (e.g. Binetti et al., 1996) 
and sensitivity for dementia has been reported to be low (41%; Sarazin et al., 2007). In 
addition, test-retest reliability estimates have been shown to vary widely in elderly 
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adults, ranging from as low as 0.48 to 0.96 depending upon the method of scoring 
(Lemay, Bédard, Rouleau & Tremblay, 2004; Seo et al., 2008). On the other hand, 
intraindividual variation on the incongruent trials is higher in healthy ApoE e4+ carriers 
(Duchek et al., 2009) and correlates positively with biomarkers and neurological signs 
of cognitive impairment at post-mortem (Bondi et al., 2002).  
 
3.4. Conclusion  
This chapter has identified two tests of memory and two commonly used tests 
of executive function that appear suitable for inclusion in our test battery according to 
the criteria set. Although not specifically a measure of dementia diagnosis or 
neuropathology indicative of the disease, these tests are all highly sensitive to AD and 
performance on some correlate with indicators of the disease, such as ApoE status or 
biomarkers. These tests are able to assess a wide range of cognitive abilities and are 
of limited duration. Different versions of these tests are also available, allowing reliable 
repeated assessment. These tests should therefore be suitable for inferring changes in 
cognitive ability. While many other cognitive tests are available, we chose those tests 
that are most commonly used in physical activity and dementia/cognitive impairment 
research to allow cross-study comparison. The versions selected for the later studies 
have been assessed for their usefulness, with the findings presented in Chapter 4. 
  
 95 
 
3.5. References 
Amieva, H., Lafont, S., Auriacombe, S., Rainville, C., Orgogozo, J. M., Dartigues, J. F. & Fabrigoule, 
 C. (1998). Analysis of error types in the trail making test evidences an inhibitory deficit in 
 dementia of the Alzheimer type. Journal of Clinical and Experimental Neuropsychology, 20(2), 
 280-285.  
Amieva, H., Lafont, S., Rouch-Leroyer, I., Rainville, C., Dartigues, J. F. Á., Orgogozo, J. M. & 
 Fabrigoule, C. (2004). Evidencing inhibitory deficits in Alzheimer’s disease through 
 interference effects and shifting disabilities in the SCWT test. Archives of Clinical 
 Neuropsychology, 19(6), 791-803.  
Ashendorf, L., Jefferson, A.L., O'Connor, M.K., Chaisson, C., Green, R.C., Stern, R.A. (2008). Trail 
 Making Test errors in normal aging, mild cognitive impairment, and dementia. Arch Clin 
 Neuropsychol, 23(2), 129-37. doi: 10.1016/j.acn.2007.11.005 
Baddeley, A.D., Baddeley, H.A., Buck, R.S. & Wilcock, G.K. (2001). Attentional control in Alzheimer's 
 disease. Brain, 124, 1492-1508. 
Benedict, R. H. B., Schretlen, D., Groninger, L. & Brandt, J. (1998). Hopkins verbal learning Test–
 Revised: Normative data and analysis of inter-form and test-retest reliability. The Clinical 
 Neuropsychologist, 12(1), 43-55.  
Benedict, R. H. B. & Zgaljardic, D. J. (1998). Practice effects during repeated administrations of 
 memory tests with and without alternate forms. Journal of Clinical and Experimental 
 Neuropsychology, 20(3), 339-352.  
Berardi, A. M., Parasuraman, R. & Haxby, J. V. (2005). Sustained attention in mild Alzheimer’s 
 disease. Developmental Neuropsychology, 28(1), 507-537.  
Binetti, G., Magni, E., Padovani, A., Cappa, S., Bianchetti, A., & Trabucchi, M. (1996). Executive 
 dysfunction in early Alzheimer’s disease. Journal of Neurology, Neurosurgery & Psychiatry, 
 60(1), 91-93.  
Bondi, M. W., Serody, A. B., Chan, A. S., Eberson-Shumate, S. C., Delis, D. C., Hansen, L. A. & 
 Salmon, D.P. (2002). Cognitive and neuropathologic correlates of SCWT color-word test 
 performance in Alzheimer’s disease. Neuropsychology, 16(3), 335.  
Bracco, L., Bessi, V., Piccini, C., Mosconi, L., Pupi, A. & Sorbi, S. (2007). Metabolic correlates of 
 executive dysfunction. Different patterns in mild and very mild Alzheimer's disease. 
 J Neurol, 254(8), 1052-65. doi: 10.1007/s00415-006-0488-1 
Brandt, J. (1991). The Hopkins Verbal Learning test: Development of a new memory test with six 
 equivalent forms. Clin Neuropsychol, 5, 125-142. 
Brown, J., Pengas, G., Dawson, K., Brown, L. A., & Clatworthy, P. (2009). Self administered cognitive
  screening test (TYM) for detection of Alzheimer’s disease: Cross sectional study. BMJ 
 (Clinical Research Ed.), 338, b2030. doi: 10.1136/bmj.b2030 
Catherine, L.G., Ronald, B.M. & Gerard, J.E. (1985). Application of the trail making test in differentiating 
 neuropsychological impairment of elderly persons. Perceptual and Motor Skills, 61(3f), 1283-
 1289. 
Cerhan, J. H., Ivnik, R. J., Smith, G. E., Tangalos, E. C., Petersen, R. C. & Boeve, B. F. (2002). 
 Diagnostic utility of letter fluency, category fluency, and fluency difference scores in 
 Alzheimer’s disease. The Clinical Neuropsychologist, 16(1), 35-42.  
Chen, C., Dong, Y., Merchant, R., Collinson, S., Ting, E., Quah, S.L.,…Venketasubramanian, N. 
 (2011). The Montreal Cognitive Assessment (MOCA) is superior to the Mini-Mental State 
 96 
 
 Examination (MMSE) in detecting patient with moderate Cognitive Impairment, No-
 Dementia (CIND) at high risk of dementia. Alzheimer's & Dementia: The Journal of the 
 Alzheimer's Association, 7(4), S240-S241. doi: 10.1017/S1041610212001068 
Cohn, N. B., Dustman, R. E. & Bradford, D. C. (1984). Age-related decrements in SCWT color test 
 performance. Journal of Clinical Psychology, 40(5), 1244-1250.  
Cunje, A., Molloy, D. W., Standish, T. I. & Lewis, D. L. (2007). Alternate forms of logical memory and 
 verbal fluency tasks for repeated testing in early cognitive changes. International 
 Psychogeriatrics, 19(1), 65-76.  
De Jager, C.A., Hogervorst, E., Combrinck, M. & Budge, M.M. (2003). Sensitivity and specificity of 
 neuropsychological tests for mild cognitive impairment, vascular cognitive impairment and 
 Alzheimer's disease. Psychol Med, 33(6), 1039-50. 
Diesfeldt, H.F. (1985). Test-retest reliability of category-bound word production in psychogeriatrics. 
 Tijdschr Gerontol Geriatr, 16(1), 17-20.  
Du, A.T., Schuff, N., Amend, D., Laakso, M.P., Hsu, Y.Y., Jagust, W.J.,…Weiner, M.W. (2001). 
 Magnetic resonance imaging of the entorhinal cortex and hippocampus in mild cognitive 
 impairment and Alzheimer's disease. J Neurol Neurosurg Psychiatry, 71(4), 441-7. 
Duchek, J. M., Balota, D. A., Tse, C. S., Holtzman, D. M., Fagan, A. M. & Goate, A. M. (2009). The utility 
 of intraindividual variability in selective attention tasks as an early marker for Alzheimer’s 
 disease. Neuropsychology, 23(6), 746. doi: 10.1037/a0016583 
Folstein, M.F., Folstein, S.E. & McHugh, P.R. (1975). "Mini-mental state". A practical method for 
 grading the cognitive state of patients for the clinician. J Psychiatr Res, 12(3), 189-98. 
Frank, R. M., & Byrne, G. J. (2000). The clinical utility of the Hopkins verbal learning test as a 
 screening test for mild dementia. International Journal of Geriatric Psychiatry, 15(4), 317-324.  
Ghaaliq Lalkhen, A. & McCluskey, A. (2008). Clinical tests: sensitivity and specificity. Contin Educ 
 Anaesth Crit Care Pain, 8 (6): 221-223. doi: 10.1093/bjaceaccp/mkn041. 
Gomez, R.G. & White, D.A. (2006). Using verbal fluency to detect very mild dementia of Alzheimer type. 
 Arch Clin Neuropsychol, 21(8), 771-5. doi: 10.1016/j.acn.2006.06.012 
Hall, C. D., Smith, A. L. & Keele, S. W. (2001). The impact of aerobic activity on cognitive function in 
 older adults: a new synthesis based on the concept of executive control. European Journal 
 of Cognitive Psychology, 113(1/2), 279-300. doi: 10.1080/09541440126012 
Heun, R., Papassotiropoulos, A. & Jennssen, F. (1998). The validity of psychometric instruments for 
 detection of dementia in the elderly general population. International Journal of Geriatric 
 Psychiatry, 13(6), 368-380.  
Hogervorst, E., Mursjid, F., Ismail R.I., Prasetyo, S., Nasrun, M., Mochtar,…Rahardjo, T.B.R. 
 Validation of Two Short Dementia Screening Tests in Indonesia. In: Jacobsen, S.R. (2011). 
 Vascular Dementia: Risk Factors, Diagnosis and Treatment. NY: Nova Science Publishers. 
Hogervorst, E., Combrinck, M., Lapuerta, P., Rue, J., Swales, K. & Budge, M. (2002). The Hopkins Verbal 
 Learning Test and screening for dementia. Dement Geriatr Cogn Disord, 13(1), 13-20. 
Kitabayashi, Y., Ueda, H., Tsuchida, H., Iizumi, H., Narumoto, J., Nakamura, K.,…Fukui, K. (2001). 
 Relationship between regional cerebral blood flow and verbal fluency in Alzheimer’s 
 disease. Psychiatry and Clinical Neurosciences, 55(5), 459-463.  
Kramer, J. H., Nelson, A., Johnson, J. K., Yaffe, K., Glenn, S., Rosen, H. J. & Miller, B.L. (2006). 
 Multiple cognitive deficits in amnestic mild cognitive impairment. Dementia and Geriatric  
 Cognitive Disorders, 22(4), 306-311. doi: 10.1159/000095303 
 97 
 
Kuslansky, G., Katz, M., Verghese, J., Hall, C.B., Lapuerta, P., LaRuffa, G. & Lipton, R.B. (2004). 
 Detecting dementia with the Hopkins Verbal Learning Test and the Mini-Mental State 
 Examination. Arch Clin Neuropsychol, 19(1), 89-104. doi: 10.1093/arclin/19.1.89 
Lafleche, G. & Albert, M. S. (1995). Executive function deficits in mild Alzheimer’s disease. 
 Neuropsychology, 9(3), 313. 
Lemay, S., Bédard, M.A., Rouleau, I. & Tremblay, P.L. (2004). Practice effect and test-retest reliability of 
 attentional and executive tests in middle-aged to elderly subjects. Clin Neuropsychol, 18(2), 284-
 302. 
Mathuranath, P., Nestor, P., Berrios, G., Rakowicz, W., & Hodges, J. (2000). A brief cognitive test battery 
 to differentiate Alzheimer’s disease and frontotemporal dementia. Neurology-Minneapolis, 
 55(11), 1613-1620.  
Monsch, A. U., Bondi, M. W., Butters, N., Salmon, D. P., Katzman, R. & Thal, L. J. (1992).  Comparisons 
 of verbal fluency tasks in the detection of dementia of the Alzheimer type. Archives of Neurology, 
 49(12), 1253.  
Nasreddine, Z. S., Phillips, N. A., Bédirian, V., Charbonneau, S., Whitehead, V., Collin, I.,…Chertkow, 
 H. (2005). The Montreal Cognitive Assessment, MoCA: A brief screening tool for mild cognitive 
 impairment. Journal of the American Geriatrics Society, 53(4), 695-699. doi: 10.1111/j.1532-
 5415.2005.53221.x 
Nutter-Upham, K. E., Saykin, A. J., Rabin, L. A., Roth, R. M., Wishart, H. A., Pare, N. & Flashman, L.A. 
 (2008). Verbal fluency performance in amnestic MCI and older adults with cognitive 
 complaints. Archives of Clinical Neuropsychology, 23(3), 229-241. Doi: 
 10.1016/j.acn.2008.01.005 
O'Bryant, S.E., Humphreys, J.D., Smith, G.E., Ivnik, R.J., Graff-Radford, N.R., Petersen, R.C. & Lucas, 
 J.A. (2008). Detecting dementia with the mini-mental state examination in highly educated 
 individuals. Arch Neurol, 65(7), 963-7. doi: 10.1001/archneur.65.7.963 
Parasuraman, R., Greenwood, P.M. & Sunderland, T. (2002). The apolipoprotein E gene, attention, 
 and brain function. Neuropsychology, 16(2), 254-74. doi:  10.1037//0894-4105.16.2.254 
Perry, R.J. & Hodges, J.R. (1999). Attention and executive deficits in Alzheimer's disease. A critical 
 review. Brain. 122(3), 383-404. 
Reitan, R.M. (1955). The relation of the trail making test to organic brain damage. J Consult Psychol, 
 19(5), 393-4. 
Rosen, V.M., Bergeson, J.L., Putnam, K., Harwell, A. & Sunderland, T. (2002). Working memory and 
 Apolipoprotein E: what's the connection? Neuropsychologia, 40(13), 2226-33. 
Royall, D.R., Lauterbach, E.C., Cummings, J.L., Reeve, A., Rummans, T.A., Kaufer, D.I.,…Coffey, C.E. 
 (2002). Executive control function: a review of its promise and challenges for clinical 
 research. A report from the Committee on Research of the American Neuropsychiatric 
 Association. J Neuropsychiatry Clin Neurosci, 14(4), 377-405. 
Sailor, K., Antoine, M., Diaz, M., Kuslansky, G. & Kluger, A. (2004). The effects of Alzheimer’s 
 disease on item output in verbal fluency tasks. Neuropsychology, 18(2), 306.  
Sarazin, M., Berr, C., De Rotrou, J., Fabrigoule, C., Pasquier, F., Legrain, S.,…Dubois, B. (2007). 
 Amnestic syndrome of the medial temporal type identifies prodromal AD: a longitudinal study. 
 Neurology, 69(19), 1859-67. 
Schrijnemaekers, A.M., de Jager, C.A., Hogervorst, E. & Budge, M.M. (2006). Cases with mild 
 cognitive impairment and Alzheimer's disease fail to benefit from repeated exposure to 
 98 
 
 episodic memory  tests as compared with controls. J Clin Exp Neuropsychol, 28(3), 438-55. 
 doi:10.1080/13803390590935462 
Seo, E.H., Lee, D.Y., Choo, I.H., Kim, S.G., Kim, K.W., Youn, J.C., Jhoo, J.H. & Woo, J.I. (2008). 
 Normative study of the Stroop Color and Word Test in an educationally diverse elderly 
 population. Int J Geriatr Psychiatry, 23(10), 1020-7. doi: 10.1002/gps.2027. 
Smith, T., Gildeh, N., & Holmes, C. (2007). The montreal cognitive assessment: Validity and utility in 
 a memory clinic setting. Canadian Journal of Psychiatry, 52(5), 329.  
Snow, W.G., Tierney, M.C., Zorzitto, M.L., Fisher, R.H., & Reid, D.W. (1998). One-year test-retest 
 reliability of selected neuropsychological tests in older adults. Journal of Clinical and 
 Experimental Neuropsychology, 10, 60. 
Solomon, P.R., Hirschoff, A., Kelly, B., Relin, M., Brush, M., DeVeaux, R.D. & Pendlebury, W.W. (1998). A 
 7 Minute Neurocognitive Screening Battery Highly Sensitive to Alzheimer’s Disease. Archives of 
 Neurology, 55(3), 349-355.  
Stroop, J. R. (1935). Studies of interference in serial verbal reactions. Journal of Experimental 
 Psychology, 18, 643-662.. 
Taler, V. & Phillips, N. A. (2008). Language performance in Alzheimer’s disease and mild cognitive 
 impairment: A comparative review. Journal of Clinical and Experimental Neuropsychology, 
 30(5), 501-556. doi: 10.1080/13803390701550128 
Tombaugh, T.N. & McIntyre, N.J. (1992). The mini-mental state examination: a comprehensive review. 
 Journal of the American Geriatrics Society, 40(9), 922-35. 
Wesnes, K. (2012, October). A comparison of traditional neuropsychological tests and automated 
 cognitive tests in assessing cognitive decline in the elderly. Poster session presented at the 
 meeting of the 25
th
 European College of Neuropsychopharmacology (ECNP) Congress; Vienna, 
 Austria. 
 
  
 99 
 
This chapter was presented as a poster at the Alzheimer’s Association Annual 
Conference in Paris, France; July 2011 
Chapter 4 – Validation of cognitive tests 
 
4.1. Introduction 
In Chapter 3 we identified a group of cognitive tests on which those with 
dementia and those at risk for dementia perform poorly compared to healthy age-
matched controls. This chapter describes a study investigating whether the specific 
versions of the cognitive tests available and the scoring methods intended for use in 
the present test battery can discriminate between the two groups and whether 
responses are associated with disease severity in a similar manner to the versions 
discussed in Chapter 3. Research studies often use different versions of cognitive tests 
and analyse them in different ways, which can affect their levels of sensitivity to AD. 
For example, computerised versions of tests can be a highly sensitive measure of 
reaction time compared to a manual stopwatch, while speed/accuracy trade-offs can 
mean that error rates alone do not discriminate well between groups. It is therefore 
important to assess whether our methods are sensitive to cognitive impairment 
relevant to AD to ensure their usefulness in the later studies of this thesis. The aims 
were to investigate a) whether scores on these tests could predict group membership 
with a high level of accuracy; b) whether performance on the cognitive tests correlated 
with a clinical measure of AD; c) whether performance on these cognitive tasks at 
baseline differed between those who declined on a clinical measure of AD over 6 
months and those who did not; and d) whether learning effects over time differed 
between groups.   
 
4.2. Method 
4.2.1. Participants 
A total of 26 community-dwelling men and women aged 50 years and over 
were recruited for this study. The experimental group (n=13) consisted of patients who 
had been diagnosed with mild to moderate AD and who were attending a memory 
clinic in the UK to start treatment with Reminyl (galantamine). Galantamine is not a 
cure for AD but aims to slow the progression of dementia by preventing the breakdown 
of acetylcholine in the synapses between neurons, thus helping to compensate for the 
loss of neurons that respond to acetylcholine. At baseline these participants were not 
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taking medication for AD or any other medication affecting mental function (e.g. 
lithium). AD diagnosis was based on ICD-10 criteria (WHO, 1992) and was established 
by clinical evaluation using a consensus group-based decision-making process in the 
memory clinics before referral to the study. The control group (n=13) had no subjective 
cognitive impairment and were required to have an MMSE score ≥27. Control 
participants were either an age-matched carer (in all cases this was the spouse) of a 
participant in the experimental group (n=10) or an age- and sex-matched volunteer 
recruited through word-of-mouth (n=3). Exclusion criteria for both groups consisted of 
presence of a co-morbid psychiatric disorder, other neurological disease, substance 
abuse and previous use of AChEIs or other medication affecting cognition. None of the 
volunteers for either group had a visual impairment that affected their ability on the 
cognitive tasks and that could not be corrected by prescription glasses (verified using a 
visual assessment described in section 4.2.4). Written informed consent was gained 
from all participants before the study commenced as approved by the Newcastle & 
North Tyneside 2 Research Ethics Committee. Consent was also given on behalf of 
the patients by their respective carer regardless of whether the carer participated 
themselves. 
 
4.2.2. Cognitive assessments 
All participants completed the Mini-Mental State Examination (MMSE) as a 
clinical measure of disease severity and as a screening tool for allocation to the control 
group. Participants also completed the Trail Making Test (TMT), Stroop Colour Word 
Test (SCWT), Verbal Fluency and the Hopkins Verbal Learning Test (HVLT) as 
described in Chapter 3. Specific methods are described below: 
- The TMT was a paper-and-pencil version with black, circled numbers 
presented on white A4 paper. A practice trial was given before each part using 8 items 
to ensure that the participant understood the instructions before starting the main test. 
Participants were asked to complete both parts as quickly and as accurately as 
possible. The TMT was scored in terms of an interference effect for reaction time 
(TMTb – TMTa), measured with a manual stopwatch and given in seconds. If 
participants made a mistake, they were given three seconds to correct themselves; 
otherwise they were referred back to the last correct item and reminded of the strategy 
(number to number or alternating).  
- Verbal Fluency was measured as the total number of animals named in 60 
seconds. Category fluency was chosen over letter fluency due to its higher sensitivity 
to AD in previous studies (Monsch et al., 1992; Cerhan et al., 2002). Any living animal 
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was accepted and duplicates were ignored. Responses were recorded using a 
Dictaphone for accurate scoring after testing.  
- The SCWT was a computerised version with two conditions: naming a word 
written in black ink (baseline condition) and font colour naming (incongruent condition). 
The test included 20 trials in the baseline condition and 40 trials in the incongruent 
condition. Each trial consisted of presentation of the stimulus in the centre of the 
screen, flanked by one target word and one distracter (see Figure 2). The participant 
was asked to respond by pressing either a left or right arrow to indicate the spatial 
location of the target (left or right side of the stimulus) as quickly as possible. Six 
practice trials were given with accuracy feedback (“correct” or “incorrect”) before each 
condition began. Reaction time for each trial was automatically recorded, and baseline 
mean reaction time was subtracted from the incongruent condition mean reaction time 
to gain an interference score. Standard deviation (s.d.) on each condition was also 
calculated for each participant as a measure of intra-individual variation, thought to be 
sensitive to decline in AD. The SCWT test was displayed on a Toshiba 15” laptop 
screen. 
- The HVLT list A was used and it was scored as both a trial 1 score and as a 
total immediate recall score (adding all correct words recalled over 3 trials). Trial 1 was 
used as a proxy for digit span, which was shown to be affected by physical activity in 
the literature review (Chapter 2). Total immediate recall showed similar sensitivity as 
delayed recall for dementia and MCI (Hogervorst et al., 2002) so only the immediate 
recall was used to reduce the length of the testing session. As per the standardised 
instructions for this test, words were read aloud at a rate of 1 per second and 
participants were given 90 seconds per trial to recall as many words from the list as 
they could. 
 
 
      
Figure 2  
Screen shot of the SCWT task (a) baseline condition and (b) incongruent condition  
(b) (a) 
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4.2.3. Questionnaires  
Demographic information on participants including age, gender, education 
obtained (years), lifestyle factors (e.g. smoking, alcohol consumption) and medical 
history was surveyed using a questionnaire (Appendix B) and were confirmed by the 
carer who was present. Participants also completed the Geriatric Depression Scale 
(GDS; Yesavage et al., 1983; Sheikh & Yesavage, 1986) to assess mood, which itself 
may have an impact on cognitive performance (Kliegel et al., 2005; Lee & Sternthal, 
1999). The GDS short-form is a 15-item questionnaire to which participants answer 
‘yes’ or ‘no’ to each statement, making it simpler for those with dementia to complete 
than questionnaires with more response choices (Appendix C). The GDS has been 
found to be valid for those with AD who do not deny having cognitive complaints 
(Feher, Larrabee and Crook, 1992) and, since all our participants acknowledged their 
cognitive difficulties, it was deemed a suitable measure of mood in this group.  
 
4.2.4. Visual assessment 
Visual impairments are common in older people and in those with AD (Kirby, 
Bandelow & Hogervorst, 2010) so a visual assessment was used to rule out permanent 
visual impairments that may have impeded participants’ ability to complete the 
cognitive tasks. Participants were asked to name a mixed sequence of the following 
letters: C, D, H, K, N, O, R, S, V and Z. These letters decreased in size and were 
presented at two distances. At 0.6 metres, the letters decreased gradually in size from 
approximately 9 x 9mm to 2 x 2mm. At 6 metres, the letters decreased from 
approximately 102 x 94mm to 31 x 28mm. These letters were in a dark grey font 
printed on a white background, and at each distance there were 55 letters displayed 
one at a time. The letter order was different for the two distances but was consistent for 
all participants.  
 
4.2.5. Design 
This was a repeated-measures study designed to investigate how sensitive 
scores on the cognitive tests selected for this test battery were to the cognitive deficits 
seen in AD. Participants were visited in their own homes and visits varied between 30 
and 60 minutes for each participant depending mostly upon session number (with the 
first session lasting longer than follow-up due to informed consent) and each 
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participant’s ability. Participants were offered frequent breaks during each session in 
case of fatigue; however, none chose to take a break and the testing procedure was 
well tolerated by all participants. Age, education, alcohol intake (units) and GDS scores 
were used as covariates. Smoking had been considered as a covariate, but only one 
participant reported past smoking so it was not included.  
 
4.2.6. Procedure 
 Patients of a memory clinic who were eligible for participation in this study and 
their carer were given the information by clinic staff during a routine visit. The 
investigator contacted them by telephone around 2 days later having given them time 
to consider. This call gave the opportunities for the carer to ask any questions that they 
had about the study and, if they were happy to take part, to arrange a meeting at their 
home before the patient received their first prescription for galantamine. Where the 
carer did not participate in the study, they remained the contact person for the patient 
and were in the home during the testing session. For those control participants who 
were not the carer of an AD patient, the meeting took place at the participant’s earliest 
convenience. At the start of the visit, informed consent was gained and participants 
completed the demographic questionnaire followed by the GDS. They then completed 
the visual assessment and finally the cognitive tasks. Both cases and controls 
completed the same procedure and were tested separately to avoid exposure to the 
test items. Willing participants were revisited six months later and they completed the 
GDS, visual assessment and cognitive tasks only. 
 
4.2.7. Analysis  
The data from this study were analysed using SPSS Version 18.0 with a 
required p value of ≤.05. To test the hypotheses a number of statistical tests were 
conducted on the data. First, a Multivariate Analysis of Variance (MANOVA) was 
performed to assess differences between AD patients before starting on medication 
and controls on the cognitive tasks at baseline. Analysis of histograms, Q-Q plots and 
the Shapiro-Wilk statistical test revealed no significant violations of normality for the 
HVLT trial 1, HVLT total, TMT or Verbal Fluency tasks, but SCWT scores (interference 
scores and standard deviations [s.d.]) were normalised using a Log Transformation. 
Receiver Operating Characteristic (ROC) analysis was also conducted for each task to 
determine optimum cut-offs and their respective sensitivity and specificity of each test 
for group membership (AD patient vs. control).  
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Partial correlations were performed between MMSE scores (as a clinical 
measure of AD) and the other cognitive tests to assess the strength of the associations 
while controlling for the covariates. As MMSE scores had been used as a grouping 
variable, these correlations were performed on AD patients only. Spearman’s Rank 
correlations were also conducted between baseline test scores and MMSE change 
(delta) scores. MMSE delta scores were compared between those with poor cognitive 
performance and those with high performance at baseline. MMSE delta scores were 
coded as ‘0’ if the delta score <0 (indicating a decline) or a ‘1’ if the delta score was ≥0 
(indicating stability or improvement). Cognitive test scores were stratified into below- 
and above-median score. Fisher’s Exact Test (FET) was used due to MMSE delta 
scores not being normally distributed.  
 Finally, a repeated-measures Analysis of Variance (ANOVA) was performed to 
assess whether there were any differences in scores from baseline to follow-up at six 
months between AD patients and controls. Levene’s test for homogeneity of variance 
was not significant for any test meaning the required p value remained at ≤.05.  
 
4.3. Results 
Baseline demographic information and cognitive test scores at baseline and at 
follow-up are shown in Table 5. No significant differences in age (t(24)=-.019, p=.985), 
sex (Chi2=0.16, p=.694), education level (Chi2=0.00, p=1.000), GDS score (t(24)=-0.61, 
p=.549) or alcohol consumption (t(24)=0.59, p=.559) were seen between AD patients 
and controls at baseline. However, as expected, participants in the control group had 
significantly higher mean MMSE scores than the experimental group (t(13.05)=7.93 
p<.001).  
Of the original group of 26 participants, 16 completed both baseline and follow-
up assessments. Baseline characteristics did not differ between those who completed 
follow-up assessments and those who chose to leave the study before completion 
(Age: t(24)=-1.00, p=.330; Education: Chi2=0.14, p=.712; GDS: t(24)=1.52, p=.141; 
MMSE: t(24)=-0.08, p=.936; Sex: Chi2=0.00, p=1.000; Alcohol: t(24)=0.87, p=.391). 
Scatterplots revealed linear relationships between the covariates and moderate 
correlations (<0.55) were seen between them. There were, however, no significant 
correlations between the covariates and performance on the cognitive tests.  
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Table 5 
Baseline demographics and mean scores on cognitive tasks. 
Variable AD patients Controls 
Baseline  
N 
 
13 
 
13 
Mean age in years (s.d.) 69.0 (9.9) 69.1 (8.4) 
Education (%) 
   Secondary 
   Uni Degree 
 
69 
31 
 
69 
31 
Female (%) 46 62 
Mean alcohol consumption (units per week) 
Mean GDS score 
2.2 (5.4) 
2.4 (1.3) 
3.58 (6.2) 
2.1 (1.3) 
   
Cognitive scores   
   Mean MMSE (s.d.) 22.7 (3.1) 29.6 (0.6)  
   Mean HVLT Trial1 (s.d.) 
   Mean HVLT Total (s.d.) 
1.6 (1.7) 
7.1 (4.5) 
7.2 (1.6)  
26.3 (4.5)  
   Mean TMT interference (s.d.) 
a
 122.3 (80.6) 38.67 (12.7)  
   Mean Verbal Fluency words recalled (s.d.) 
   Mean SCWT interference score (s.d.)
 b
 
   Mean SCWT s.d. 
b
 
11.6 (6.6) 
2355 (2265) 
482 
20.8 (7.1) 
463.6 (265)  
3545 
Follow-up 
N 
Female (%) 
Cognitive scores 
 
8 
63 
 
8 
50 
   Mean MMSE (s.d.) 20.6 (3.1) 29.7 (0.5)  
   Mean HVLT Trial 1 (s.d.) 
   Mean HVLT Total (s.d.) 
1.8 (1.6) 
8.3 (4.0) 
9.1 (2.0)  
28.9 (3.9)  
   Mean TMT interference (s.d.)
a
 116.0 (108.9) 37.1 (22.5) 
   Mean Verbal Fluency words recalled (s.d.) 
   Mean SCWT interference score (s.d.)
 b
 
   Mean SCWT s.d.
b
 
9.7 (5.9) 
2184 (2295) 
1923 
25.7 (4.8)  
342.9 (408) 
698 
Abbreviations: s.d. – Standard Deviation; GDS – Geriatric Depression Scale; MMSE – Mini Mental State 
Examination; HVLT – Hopkins Verbal Learning Task; TMT – Trail Making Test; SCWT – Stroop Colour 
Word Test 
a
given in seconds 
b
given in milliseconds 
 
 
4.3.1. Comparison of cognitive test scores for AD patients and controls  
The MANOVA showed a significant difference between AD patients and 
controls on the cognitive tests (F(4, 11)=19.88, p=.000, Pillai’s Trace=.88, η2=.88). 
Because HVLT total scores and SCWT s.d. scores showed high correlations (r>.80, 
see Table 6) with scores on the other tasks they were excluded from the initial 
MANOVA to avoid collinearity. No univariate or multivariate outliers were identified for 
any of the dependent variables, and observed power for this model was high (>.8).  
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Using a Bonferroni adjusted p value (p≤.01) to account for multiple testing, AD patients 
recalled an average 10 fewer words than the controls on the Verbal Fluency task 
(F(1,14)=15.94, p=.001, η2=.53) and 5 fewer words than the controls on the HVLT trial 
1 (F(1,14)=36.80, p=.000, η2=.72). Compared to controls, AD patients also showed 
larger TMT interference scores (average 59 seconds longer; F(1,14)=10.93, p=.005; 
η2=.44) and SCWT interference scores (average 2 seconds longer per trial; 
F(1,14)=20.04, p=.001, η2=.59). Inclusion of the HVLT total score and SCWT s.d. in the 
model did not affect results from the other tasks but HVLT total scores were 
significantly reduced in AD patients compared to controls (F(1,13)=85.70, p=.000, 
η2=.87). SCWT s.d. was also higher by over 3 seconds in AD patients compared to 
controls (F(1,13)=22.41, p=.000, η2=.63).  
 
 
Table 6 
Correlations between cognitive test scores at baseline 
 HVLT 
trial 1 
HVLT 
total 
SCWT 
interference 
SCWT 
s.d 
Verbal 
Fluency 
HVLT trial 1      
HVLT total .94**     
SCWT interference
a
 -.41* -.55**    
SCWT s.d
a
 -.78 -.78** -.41   
Verbal Fluency .65* .69** .44* -.69**  
TMT interference
a
 -.21 -.21 .41 .00 -.09 
Note: Correlation significant at **p<.01 and *p<.05 level. 
Abbreviations: HVLT – Hopkins Verbal Learning Task; SCWT – Stroop Colour Word Test; TMT – Trail 
Making Test 
a
Lower score indicates better performance 
 
 
Results of the ROC analysis are shown in Table 7. All cognitive tests were able 
to significantly predict group membership (AD patient v control) with a high degree of 
sensitivity and specificity (≥70%). The Area Under the Curve (AUC) for each test 
suggested good to excellent discrimination (>.80) between groups by all tests at their 
respective cut-off values except for the SCWT. Baseline HVLT trial 1 and total scores 
were especially sensitive to AD compared to the other tasks. 
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Table 7 
Details of ROC analysis for each of the cognitive tests 
Test Cut-off 
score 
Sensitivity Specificity AUC (%) P 
HVLT trial 1
a
 
HVLT total
 a
 
Verbal Fluency
 a
 
TMT interference
 b 
SCWT interference
 c 
SCWT s.d.
c
 
4.5 
16.5 
12.5 
76 
1717 
543 
100 
100 
78 
77 
70 
20 
100 
100 
92 
100 
100 
20 
100 
100 
82 
82 
23 
06 
.000 
.000 
.007 
.006 
.035 
.001 
Abbreviations: AUC – Area Under Curve; HVLT – Hopkins Verbal Learning Task; TMT – Trail Making 
Test; SCWT – Stroop Colour Word Test 
a
a score below the cut-off indicates allocation to the experimental group 
b
given in seconds; a score above the cut-off indicates allocation to the experimental group 
c
given in milliseconds; a score above the cut-off indicates allocation to the experimental group 
 
 
4.3.2. Disease severity 
There were small and non-significant correlations between MMSE scores and 
SCWT interference scores (r=-.06, d.f.=10, p=.877) and SCWT standard deviations 
(r=-.39, d.f.=10, p=.300). However, there were moderate to high positive correlations 
between baseline MMSE scores and scores on the HVLT trial 1, HVLT total score and 
Verbal Fluency (Table 8). In addition, there was a negative correlation between MMSE 
scores and TMT interference. These correlations indicate that poorer performance on 
the cognitive tasks was associated with lower MMSE scores and thus increased 
severity of AD. With the exception of HVLT total scores, these correlations were only 
borderline significant and an adjustment for multiple comparisons using the average 
correlation between the variables (p<.027) meant that none of these correlations 
reached significance. 
 
 
Table 8 
Partial correlations
a
 between baseline MMSE scores and cognitive tasks (AD patients only) 
 HVLT trial 
1 
HVLT total Verbal 
Fluency 
TMT 
interference
b
 
SCWT 
interference
b
 
SCWT 
s.d.
b
 
MMSE .56* .72** .42* -.63* -.06 -.39 
Note: correlation significant at *p<.10, **p<.05 
Abbreviations: MMSE – Mini Mental State Examination; HVLT – Hopkins Verbal Learning Task; TMT – 
Trail Making Test; SCWT – Stroop Colour Word Test. 
N=13, d.f.=10. 
a
Adjusted for age 
b
Lower score indicates better performance 
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The repeated-measures ANOVA found a group*time interaction for the HVLT 
trial 1 when adjusting for the covariates (F(1,10)=8.53, p=.015, η2=.46). Controls 
showed greater learning effects from time 1 to time 2 on this task (average 1.5 words 
improvement) compared to AD patients (average no improvement; Figure 3). There 
was also a similar trend for Verbal Fluency scores (F(1,8)=4.56, p=.065), but there 
were no significant interactions for the HVLT total, SCWT or TMT interference scores. 
Instead, similar learning effects from time 1 to time 2 were seen for both groups on 
these tasks. 
 
 
(a)     (b) 
 
Figure 3 
Scatterplot of (a) HVLT trial 1 scores and (b) Verbal Fluency total scores, both at Time 1 and 
Time 2 for AD patients and controls.  
a
Data point for 3 participants 
 
 
A high correlation was seen between TMT scores at baseline and MMSE 
change scores (r=-0.805, p=.000), indicating that worse (higher) TMT interference 
scores were associated with a decline in MMSE scores over the 6 months. The same 
correlation was not seen between SCWT baseline scores (interference or s.d.) and 
MMSE change scores (r=0.396, p=.084) nor was this seen for the memory tests 
(p>.25).  
When participants were stratified based on whether they declined or 
improved/remained stable on the MMSE over time, a significant association was seen 
Experimental group 
   Controls  
   AD patients 
      
Experimental group 
   Controls  
   AD patients 
      
y=x 
y=x a 
 109 
 
between TMT baseline scores and MMSE change scores (p=.010) which was 
especially pronounced in the AD group (Figure 4). A cut-off of 77.5 seconds TMT 
interference score had optimum sensitivity and specificity of 83% and 90% respectively 
(AUC=.933; p=.005) to identify decliners in MMSE performance over time. Again, the 
same was not seen between SCWT baseline scores and MMSE change scores, nor 
was this seen for the HVLT and Verbal Fluency tests. Low baseline TMT interference 
scores thus appeared to predict a lack of response to standard treatment with AChEIs 
(as assessed by the MMSE) in AD patients, whereas memory tests did not.  
 
 
 
Figure 4  
Plot to show MMSE change scores against baseline TMT interference scores. 
Note: Red line marks optimum cut-off of 77.5 seconds 
 
 
4.4. Discussion 
The aims of this study were to examine the relevance of our versions of easy to 
administer and well-tolerated cognitive tests to the cognitive difficulties experienced in 
AD. This study found that performance on these tests showed good discrimination 
between varying levels of cognitive ability relevant to AD. HVLT scores were 
particularly sensitive with optimal cut-offs comparable to those by Frank et al. (2000) 
(18/19 points) and Hogervorst et al. (2002). The Verbal Fluency task and TMT 
interference scores were also highly sensitive for AD, although not as strongly as the 
Experimental group 
     AD patients 
     Controls  
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HVLT. Similar findings were reported previously in other cohorts (De Jager, 
Hogervorst, Combrink & Budge, 2003). Both SCWT interference scores and s.d. were 
on average significantly smaller in controls compared to those with AD. However, the 
SCWT showed low discriminability between groups, which has also been reported 
previously (Binetti et al., 1996; Sarazin et al., 2007) and is possibly due to high 
variance in both groups on both conditions of this task. Performance on the memory 
tasks and TMT correlated with dementia severity in AD patients. These tasks therefore 
appear be consistent with what would be expected of tasks that act as domain-specific 
assessments of abilities affected in AD.  
Poor TMT performance at baseline predicted decline in clinical outcomes of AD 
after 6 months particularly in AD patients. Early executive function deficits have been 
demonstrated as a marker of early AD symptoms (Parasuraman, Greenwood & 
Sunderland, 2002). TMT performance can predict conversion to AD (Chen et al., 2000; 
Rapp & Reischies, 2005) and Ewers et al. (2012) also found that TMT performance 
was one of the best predictors of conversion from MCI to AD over 2 years with 
accuracy of 64.6% (95% CI: 55.5, 73.4%). Low TMT performance may therefore be 
indicative of particularly severe pathology or dementia with accompanying vascular 
changes that are less likely to respond to AChEI treatment (Kramer, Reed, Mungas, 
Weiner & Chui, 2002). Our findings may be due to the small sample size but they are 
consistent with previous understanding of executive function deficits. The SCWT test 
did not show this same pattern, despite previous research finding that deficits on this 
task predicted decline in MMSE scores (Clark et al., 2011).  
The SCWT requires attention inhibition, but not task switching as seen in the 
TMT, which may indicate that the TMT is more complex and difficult for those with AD-
type impairment. However, it was also noticed that AD patients in this study often 
forgot the rule for the incongruent condition of the SCWT and reverted to the congruent 
condition rule, meaning that no interference effect was created as participants in effect 
responded in the same way to both conditions. The computerised version of this task 
does not allow for correcting mistakes, however the TMT allows for the participant to 
go back and correct all errors, meaning that an error leads to a time penalty and is 
reflected in the interference effect. In sum, low executive function in AD patients, as 
assessed by TMT interference (but not SCWT) may predict a lack of response to 6 
months of AChEI treatment and this should be investigated further.  
The HVLT trial 1 (and to some degree the Verbal Fluency task) showed a 
difference between groups over time. The control group tended to improve slightly at 
the second meeting, while AD patients tended to show no learning effects from 
baseline to six months. In contrast, implicit learning effects were seen in both groups 
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on the tasks of executive function, although AD patients showed reduced scores 
compared to controls at both assessments. Learning effects on the HVLT trial 1 (and 
Verbal Fluency) may rely on episodic memory while learning effects on the executive 
function tasks is possibly based more heavily on procedural memory, which can be 
relatively preserved in AD (Deweer et al., 1994; Hirono et al., 1997). The HVLT trial 1 
and Verbal Fluency tasks thus appear to measure a specific memory ability that is 
affected by AD. In our RCT we will control for learning effects in controls on these AD 
sensitive tests by using an order-balanced design with practice trials before baseline 
measurements (Chapter 7). 
A strength of this study is that it assessed AD patients before starting 
treatment, removing any possible effect that treatment could have had on their 
baseline cognitive scores. It also allowed us to determine the relationship between our 
versions of cognitive tests and response to treatment over the six months. A limitation 
of this study is the high drop-out rate, although there were no differences between 
those who stayed in the study and those who left after the first testing session. Bias 
caused by attrition is therefore unlikely to account for these findings. However, small 
sample sizes throughout the study preclude generalised conclusions from being made 
on the appropriateness of using these cognitive tests in acting as a proxy for AD. For 
further understanding of the way that these tests respond to AD in different populations 
and over different stages of AD, a multi-centre study is needed to expand the sample 
size and inter-patient variability on covariate measurements.  
This study aimed to validate the cognitive test battery as being sensitive to 
cognitive impairment such as that seen in dementia. These tests appear to offer 
domain-specific tests of cognitive function that are relevant to the impairment seen in 
AD and as such they are used in the studies presented later in this thesis. The HVLT 
trial 1 and Verbal Fluency tasks may be especially relevant to assessing changes over 
time, although the TMT also appears sensitive to early or severe cognitive deficits. 
These tests therefore measure specific abilities that are affected in AD and that are 
thus appropriate targets for interventions based on the cognitive reserve hypothesis. 
Performance on our version of the SCWT test was not consistent with previous 
research and so it has been excluded from the cognitive test battery for the following 
treatment studies presented in this thesis. However, the HLVT (trial 1 and total), Verbal 
Fluency and TMT tasks were included. 
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Part Three – Observational Study 
Chapter 5 – The relationship between physical activity and cognition in an 
elderly Indonesian cohort 
5.1. Introduction 
The literature review presented in Part One (Chapter 2) identified several 
important factors that may influence the relationship between physical activity and 
cognitive performance. Firstly, three studies showed that physical activity was 
associated with reduced risk of cognitive impairment or dementia over 3-5 years for 
women only in stratified analyses (Laurin, Verreault, Lindsay, MacPherson & 
Rockwood, 2001; Ho, Woo, Sham, Chan & Yu, 2001; Sumic, Michael, Carlson, 
Howieson & Kaye, 2007). However, other studies that included only men did still find 
an association, including a 43% reduced risk of dementia over 6 years (Abbott et al., 
2004; see also Cassilhas et al., 2007). It is unclear whether associations between 
physical activity and cognitive performance in general are stronger in women 
compared to in men or whether the differences are incidental due to study 
methodologies as few studies report a direct comparison of effect sizes. 
Secondly, the relationship between physical activity and cognitive performance 
appears to be lessened when cognitive decline is more advanced, as few 
improvements were seen in elderly with clinically diagnosed cognitive impairment or 
dementia after RCTs of physical activity (see Chapter 2). Thus, the strongest 
associations may be seen in younger rather than older elderly who are more likely to 
show dementia pathology. It is important to note that few studies have directly 
compared these two groups so this finding may be due to a lack of evidence or to 
study design. On the other hand, as physical activity is thought to prevent rather than 
reverse cognitive decline, younger and high functioning adults may show a stronger 
association of physical activity and cognitive performance. 
Thirdly, the literature review suggests that physical health may act as a 
pathway between physical activity and cognitive performance. In the next chapter we 
show that physical activity is significantly associated with activities of daily living and 
health-related Quality of Life (QoL) measures (Chapter 6). The physical autonomy that 
comes from improved fitness and physical ability may lead to increased social and 
mental stimulation that in turn has a protective effect on cognition. This may be instead 
of, or in addition to, a direct physiological effect of physical activity on neural systems. 
Functional disability is associated with impaired cognitive function (Perneczky et al., 
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2006) and Arcoverde et al. (2008) found that Activities in Daily Life (ADL) scores 
correlated with MMSE scores in AD patients. However, few studies have used ADLs or 
QoL as a specific variable of interest. It is also unclear whether these associations 
would be affected by other factors mentioned above such as age and sex. 
To test these hypotheses, data were analysed from an observational study of a 
large community-dwelling sample in Indonesia. The data were collected as part of the 
Study of Elderly’s Memory Impairment and Associated Risk factors (SEMAR) study, 
which was developed through a previous collaboration between Loughborough 
University and University of Indonesia (described in detail in Yesufu, 2009). Baseline 
data were collected in 2006 by collaborators at University of Indonesia, with follow-up 
data collected in 2009. The author was not responsible for study design or 
implementation but rather performed secondary data analysis on this cohort to 
investigate the impact of age, sex and physical health on the relationship between 
physical activity and cognitive functioning.  
 
5.2. Method 
5.2.1. Participants 
A total of 719 men and women over the age of 60 years were recruited from 
three sites in Indonesia: Central and South Jakarta (n=298), Borobudur (near 
Yogyakarta; n=214) and Citengah (near Bandung; n=207). Jakarta is an urban area, 
whereas Borobudur and Citengah are both rural. Local residents and those in 
surrounding villages were given study information by village elders or staff at local 
community centres and care homes. None of those who were invited to participate 
declined. Participants were tested at their local community centre (n=667) or care 
home (n=49) where possible. Participants with limited mobility were tested at home 
(n=3). Of the initial sample, 135 participants from the Borobudur area were revisited 3 
years later for follow-up measurements, a follow up rate of 63%. Reasons for attrition 
to follow-up included death and moving away from the area. Written informed consent 
was gained from all participants before study onset and, if participants brought a carer 
with them, they too signed a consent form. Ethical approval was obtained from 
Loughborough University (UK) and the University of Indonesia (Jakarta) prior to study 
onset, as were governmental and local permits.  
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5.2.2. Outcome measures 
Participants completed the Mini Mental State Examination (MMSE) and the 
Hopkins Verbal Learning Test (HVLT), as described in Chapters 3. The HVLT was 
scored in terms of both trial 1 and a total immediate recall score as in Chapter 4. 
Stimuli from both tests were adapted slightly for local knowledge and illiterate 
respondents. Specifically, the precious gems category in the HVLT and the backwards-
spelling task and seasons question in the MMSE were changed. In these study waves, 
Verbal Fluency and the TMT were not included.  
 
5.2.3. Measures 
Aided by trained research assistants at community health centres, participants 
were asked to complete an extensive questionnaire that included questions on 
demographic characteristics and lifestyle behaviours (Appendix D). Forward- and back-
translations (English and Indonesian) were completed prior to study onset to ensure 
that the questionnaire maintained its intended meanings, and all questions were 
administered verbally by a native speaker. Participants were assessed using the 
Mahoney scale of Activities of Daily Living (ADL; Mahoney & Barthel, 1965; Appendix 
E) and the Lawton scale of Instrumental Activities of Daily Living (IADL; Lawton & 
Brody, 1969; Appendix F) scales. These scales rate an individual’s ability to perform 
basic activities, such as eating and bathing (ADL), and more complex activities, such 
as cooking, banking and preparing medication (IADL). Higher scores on both scales 
indicate more independence and less reliance on help from others. The questionnaire 
also included the Symptom Checklist questionnaire (SF-36; Ware and Sherbourne, 
1992; Appendix G), a measure of health-related QoL. This questionnaire includes 
scales on physical, emotional and mental health that are averaged to give a total score 
out of 100 (a higher score indicates higher rated QoL).  
 
5.2.4. Design  
This was a cross-sectional study examining the relationship between self-
reported frequency of participation in physical activity and cognitive performance 
(global and memory) and the impact of possible mediating (ADL, IADL, QoL) and 
moderating (sex, age) factors. A subgroup of participants completed a second 
cognitive assessment three years after baseline as prospective studies have 
demonstrated previously that participation in physical activity is predictive of cognitive 
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status at follow-up several years later (e.g. Laurin et al., 2001; Sumic, et al., 2007; see 
Chapter 2). 
Physical activity variables included regular participation in sport and gardening 
(each scored yes or no) and walking frequency (rated on a 5-point scale from never to 
very often)4. The dependent variables were HVLT trial 1 score, HVLT total score and 
MMSE total score, all continuous variables.  
Covariates included in the analysis were age (years), education (years) and 
smoking status. Increased age, low education and cigarette smoking are known risk 
factors for AD (Lindsay et al., 2002; Reitz, den Heijer, van Duijn, Hofman & Breteler, 
2007; Cataldo, Prochaska & Glantz, 2010). ADL, IADL and SF-36 scores (continuous) 
were also considered as potentially mediating variables because functional ability and 
health may interfere with participation in physical activity. Alcohol consumption was 
measured with the intention to use as a covariate but was excluded as no participants 
reported drinking alcohol (this was mainly a Muslim sample).  
 
5.2.5. Procedure 
All participants were seen individually between 8am and 11am to limit the 
effects of circadian rhythms and heat. After an information session in which informed 
consent was gained, participants completed the demographic questionnaire and SF-36 
questionnaire with the researcher. They were then asked to do the HVLT and MMSE, 
followed by the ADL and IADL assessments. Three years later, participants were 
invited back to repeat the cognitive tasks.  
 
5.2.6. Analysis 
The data were analysed using SPSS v18.0 with a required p value of .05. 
Demographic characteristics and mean cognitive scores for the baseline and follow-up 
samples were calculated using cross tabs and descriptive analyses for means. 
Bivariate correlations were calculated to determine each covariate’s suitability for 
inclusion in the model, showing that the independent variables were all moderately 
correlated with the outcome measures. In addition, the independent variables were 
moderately correlated with each other but not so high as to suspect multicollinearity 
(r<.7). Hierarchical regression analyses using the ‘Enter’ method were performed to 
determine which physical activity variables uniquely predicted cognitive scores while 
                                                 
4
 Participation in gymnastics and dancing was also included in the questionnaire but final response rates 
to this question were too low to include the variables in the analysis 
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accounting for the selected covariates. Step 1 of all regression models included the 
covariates age, education and smoking status. Sport, walking and gardening were 
added in Step 2 and ADL and IADL scores were added in Step 3. In Step 4, QoL 
scores were added. Because walking was recorded as an ordinal rather than scale 
variable, dummy coding was used to transform it into dichotomous variables using 
backwards difference contrasts. Each contrast compared a level of the variable with 
the previous level (e.g. ‘often’ v ‘sometimes’), creating four new variables for each 
physical activity. Walking was then only considered significant in a regression model if 
all four contrasts had a significant beta value (Stockburger, n.d.).  
To assess the impact of sex on the association between physical activity and 
cognitive functioning, moderated regression models were run for each of the outcome 
measures. Each model included an interaction term between the three physical activity 
variables and sex entered as Step 5. Because of the large difference in sample size for 
men and women, the dichotomous sex variable was weighted proportional to the total 
sample (men -0.65, women 0.35) before calculating the interaction terms. Similar 
models were run with interactions between the three physical activity variables and age 
entered as Step 5. The age variable was centred to avoid collinearity with the 
interaction terms by subtracting each value from the mean before calculating the 
interactions.  
For follow up analyses, a regression model was conducted to examine the 
relationship between physical activity at baseline and cognitive performance after 3 
years. In addition, odds ratios were calculated using crosstabs to determine the risk of 
being in a low functioning group dependent on baseline physical activity. Participants 
who had an MMSE score <24.5 and a HVLT score <14.5 were classed as having low 
cognitive functioning based on earlier data (Hogervorst, Rahardjo & Bandelow, 2011).  
The required sample size for each regression analysis was determined as 
N>50+8m, where m is the number of independent variables (Tabachnick & Fidell, 
2001), giving a minimum group size to give sufficient power for each model as n=146. 
Missing cases were deleted listwise. Analysis of residual statistics and plots revealed 
no violation of normality or outliers for any regression model.  
 
5.3. Results 
5.3.1. Baseline Analysis 
Table 9 shows the baseline demographic information of the whole group, which 
was subsequently stratified by sex and by median age. Women had higher IADL 
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(t(703)=-2.01, p=.045) and HVLT total (t(573.7)=-2.44, p=.015) mean scores compared 
to men. Smoking was seen in few cases in women, with men significantly more likely to 
smoke (see Table 9). Women were also more likely to have fewer years of education 
(chi2=8.81, p=.003). Men and women were, however, of similar age and had similar 
proportions of those at risk of dementia based on combined MMSE and HVLT scores. 
 
 
Table 9 
Demographic characteristics and mean cognitive test scores at baseline  
Note: contrast (men v women OR age <68 years v age >=68 years) significantly different, *p<.05, 
**p<.001. 
Abbreviations: SD – Standard Deviation; IADL – Instrumental Activities of Daily Living; ADL – Activities of 
Daily Living; SF-36 – Short Form 36 Questionnaire; MMSE – Mini Mental State Examination; HVLT – 
Hopkins Verbal Learning Task 
a
Based on HVLT (<14.5) and MMSE (<24.5)
  
 
 
The young and older groups were different on all measures, with older 
participants having lower IADL (t(562.9)=9.04, p<.001), ADL (t(446.4)=4.91, p<.001), 
MMSE (t(663.6)=9.04, p<.001), HVLT total (t(670)=7.95, p<.001) and HVLT trial 1 
(t(671)=7.23, p<.001) scores. Older participants had lower levels of education 
(chi2=19.61, p<.001) and were also more likely to smoke (chi2=4.69, p=.030). Older 
participants had increased dementia risk compared to the younger group (chi2=38.87, 
p<.001). 
Variable Total Sex Median age split 
Men Women <68 years >68 years 
N 719 255 464 337 382 
Mean age (s.d.); years 69.4 (7.9) 70.1 (7.7) 69.0 (7.9) 62.7 (2.6) 74.8** (5.5) 
Mean IADL score (s.d.) 
Mean ADL score (s.d.) 
13.3 (3.9) 
19.7 (1.1) 
12.9 (4.0) 
19.6 (0.9) 
13.5* (3.8) 
19.7 (1.2) 
14.7 (2.1) 
19.9 (0.5) 
12.6** (4.1) 
19.5** (1.4) 
Ever smoked; % 31.8 70.8 4.0** 21.4 26.7* 
Education; %      
    <Elementary     76.6 60.6 88.0 33.5 56.3 
    >Elementary 22.9 38.2 12.0* 60.5 47.3** 
Mean MMSE (s.d.) 24.2 (5.6) 24.3 (5.3) 24.3 (5.7) 25.7 (4.3) 23.1** (5.8) 
Mean HVLT total score 
(s.d.) 
Mean HVLT trial 1 (s.d.) 
19.7 (10.7) 
3.9 (2.4) 
18.5 (9.2) 
3.7 (2.2) 
20.4* (8.2) 
4.0 (2.5) 
16.8 (7.3) 
4.5 (2.4) 
12.8** (7.2) 
3.4** (2.2) 
Dementia risk; (%) 29.9 28.2 30.8 20.5 38.2** 
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Frequencies of participation in the different activities at baseline are shown in 
Table 10. A higher proportion of women played sport than men (chi2=19.45, p<.001) 
while a higher proportion of men participated in gardening than women (chi2=7.52, 
p=.006). No differences were seen in walking between men and women (chi2=3.39, 
p=.495). Older elderly were more likely not to play sport (chi2=23.91, p<.001). No 
differences were seen between age groups on gardening frequency (chi2=0.84, 
p=.360) but a higher proportion of younger elderly walked often compared to elderly 
(chi2=37.54, p<.001). 
 
 
Table 10 
Frequency of participation in different physical activities 
Activity Response Whole group Men Women 
Sport No 
Yes 
404 
311 
172 
82 
232 
229 
Gardening No 
Yes 
613 
100 
204 
48 
409 
52 
Walking Never 
Seldom 
Sometimes 
Often 
Very often 
10 
95 
163 
389 
58 
3 
38 
57 
140 
15 
7 
57 
106 
249 
43 
 
 
5.3.1.1. Whole group 
After controlling for the covariates, physical activity significantly explained 
additional variance in cognitive scores (approx 2.8-4.3%). Sport and walking 
specifically were associated with higher MMSE, HVLT trial 1 and HVLT total recall 
scores (Table 11). Gardening was associated with lower cognitive scores although this 
relationship did not reach significance. IADL scores were also associated with all 
cognitive scores, while ADL scores were associated with MMSE scores only. Although 
IADL and ADL scores attenuated the relationship between walking and cognitive 
performance, the relationship remained significant for sport. Adjustment for ADL and 
IADL scores also led to a stronger and significant negative association between 
gardening and HVLT trial 1 score. Further adjustment including SF-36 scores had little 
effect on the associations.   
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Table 11 
Regression analysis for whole group 
a
all
 
models adjusted for age, education and smoking  
***p=≤.001; **p=≤.05; *p=<.10 
Abbreviations: SE – Standard Error; IADL – Instrumental Activities of Daily Living; ADL – Activities of Daily 
Living; SF-36 – Short Form 36; MMSE – Mini Mental State Examination; HVLT – Hopkins Verbal Learning 
Task 
 
 
5.3.1.2. Effect of sex  
 To assess whether the relationship between physical activity and cognitive 
performance is different for women compared to for men, regression analyses were 
stratified by sex (data not shown). Physical activity explained an additional 2.5-4.3% of 
the variance in cognitive scores in men and an additional 2.6-5.0% of the variance in 
 Variables Model 1
a
 Model 2
a
 Model 3
a
 
  β SE β SE β SE 
MMSE Walk seldom 
Walk sometimes 
Walk often 
Walk very often 
Sport 
Gardening 
ADL 
IADL 
SF-36 
5.48*** 
4.48*** 
3.59*** 
1.71** 
1.86*** 
-0.02 
1.57 
1.24 
0.91 
0.63 
0.43 
0.50 
2.69* 
1.72 
1.25 
0.63 
1.60*** 
-0.41 
0.47** 
0.50*** 
1.45 
1.16 
0.86 
0.59 
0.39 
0.45 
0.16 
0.06 
2.62* 
1.64 
1.18 
0.61 
1.61*** 
-0.40 
0.45** 
0.49*** 
0.01 
1.46 
1.17 
0.87 
0.59 
0.39 
0.46 
0.16 
0.06 
0.01 
 F(9, 653)=35.44 
R
2
 change=.043 
F(11, 651)=47.15 
R
2
 change=.115 
F(12, 650)=43.19 
R
2
 change=.000 
HVLT trial 1 Walk seldom 
Walk sometimes 
Walk often 
Walk very often 
Sport 
Gardening 
ADL 
IADL 
SF-36 
2.14** 
1.80** 
1.38*** 
0.82** 
0.74*** 
-0.13 
0.72 
0.57 
0.42 
0.30 
0.20 
0.23 
1.49** 
1.16** 
0.85** 
0.57* 
0.68*** 
-0.22 
0.13 
0.11*** 
0.72 
0.58 
0.43 
0.30 
0.20 
0.23 
0.09 
0.03 
1.30* 
0.92 
0.67 
0.49* 
0.72*** 
-0.17 
0.06 
0.07** 
0.012** 
0.72 
0.58 
0.43 
0.30 
0.20 
0.22 
0.09 
0.03 
0.01 
 F(9, 626)=32.03 
R
2
 change=.029 
F(11, 624)=29.39 
R
2
 change=.026 
F(12, 623)=28.42 
R
2
 change=.012 
HVLT total Walk seldom 
Walk sometimes 
Walk often 
Walk very often 
Sport 
Gardening 
ADL 
IADL 
SF-36 
6.54** 
5.29** 
4.48*** 
2.43** 
1.98*** 
-0.93 
2.15 
1.71 
1.26 
0.89 
0.60 
0.68 
3.98* 
2.76 
2.40* 
1.45* 
1.74** 
-1.28* 
0.42 
0.45*** 
2.11 
1.70 
1.26 
0.87 
0.59 
0.66 
0.26 
0.09 
3.36 
1.98 
1.79 
1.19 
1.87** 
-1.14* 
0.20 
0.34*** 
0.06** 
2.10 
1.69 
1.26 
0.87 
0.58 
0.65 
0.26 
0.09 
0.02 
 F(9, 626)=43.13 
R
2
 change=.028 
F(11, 624)=42.08 
R
2
 change=.043 
F(12, 623)=40.68 
R
2
 change=.013 
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cognitive scores in women, but the association was only significant in women. 
Adjustment for ADL, IADL and SF-36 scores did not affect these observations except 
that the strength of the association between sport and HVLT trial 1 scores was similar 
between men and women after full adjustment.  
To statistically test whether sex moderated the relationship between physical 
activity and cognitive functioning, moderated regression analyses were performed 
using the following interaction terms: walking*sex, sport*sex and gardening*sex (Table 
12). These models showed that the interaction term of sport*sex was consistently 
significant for all outcomes, suggesting that sex acted as a moderating variable 
between sport and cognitive functioning. The interaction of gardening*sex was also 
significant for HVLT trial 1 but no other interaction terms were significant.  
 
 
Table 12 
Regression analysis using interaction terms for physical activity*sex
a
 
Cognitive test Interaction term t β SE 
MMSE Walk*sex 
Sport*sex 
Gardening*sex 
-1.79 
1.98* 
0.66 
0.27 
1.41 
0.60 
0.15 
0.71 
0.91 
  F(14,648)=37.49* 
R
2
 change=.01* 
HVLT trial 1 Walk*sex 
Sport*sex 
Gardening*sex 
1.44 
2.24* 
-2.10* 
0.32 
2.33 
-2.76 
0.22 
1.04 
1.32 
  F(14,621)=34.87* 
R
2
 change=.01* 
HVLT total Walk*sex 
Sport*sex 
Gardening*sex 
1.43 
2.42* 
-1.94 
0.43 
3.42 
-3.48 
0.30 
1.41 
1.79 
  F(14,620)=38.29* 
R
2
 change=.02* 
Note: significant at *p≤.05 
a
All models adjusted for age, education, smoking, walking, sport, gardening, ADL, IADL and SF-36 
Abbreviations: SE – Standard Error; MMSE – Mini Mental State Examination; HVLT – Hopkins Verbal 
Learning Task 
 
 
5.3.1.3. Effect of age 
To examine whether the relationship between physical activity and cognitive 
performance is reduced with increased age, another group of moderated regression 
models were performed for each outcome using the following interaction terms: 
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walking*age, sport*age and gardening*age (Table 13). The interaction terms between 
age and sport were significant for HVLT trial 1 and total scores, suggesting that age 
played a moderating role on the relationship between sport and memory. No other 
interactions were significant.  
 
 
Table 13 
Regression analysis using interaction terms for physical activity*age 
Cognitive test Interaction term t β SE 
MMSE Walk*age 
Sport*age 
Gardening*age 
0.25 
1.63 
0.01 
0.01 
0.07 
0.00 
0.03 
0.05 
0.06 
  F(15, 644)=34.62* 
R
2
 change=0.00 
HVLT trial 1 Walk*age 
Sport*age 
Gardening*age 
0.18 
-3.18* 
0.52 
0.00 
-0.08 
0.02 
0.01 
0.02 
0.03 
  F(15, 617)=23.78* 
R
2
 change=0.01* 
HVLT total Walk*age 
Sport*age 
Gardening*age 
-0.04 
-2.20* 
0.42 
-0.00 
-0.16 
0.04 
0.04 
0.07 
0.09 
  F(15, 617)=32.40* 
R
2
 change=0.01* 
Note: significant at *p=≤.05 
a
All models adjusted for age, education, smoking, walking, sport, gardening, ADL, IADL and SF-36 
Abbreviations: SE – Standard Error; MMSE – Mini Mental State Examination; HVLT – Hopkins Verbal 
Learning Task 
 
 
5.3.1.4. Odds ratios  
We documented 215 cases of high dementia risk based on combined test cut-
offs of HVLT (<14.5) and MMSE (<24.5). Those who participated in sport had a 78% 
reduced risk of being in an at-risk group for dementia (OR: 0.22, 95% CI 0.15, 0.33) 
while those who walked a lot (walked often or very often) had a 45% reduced risk of 
being in that group (OR: 0.55, 95% CI; 0.39, 0.76). Participating in gardening was also 
associated with reduced risk but this did not reach significance (OR: 0.64, 95% CI: 
0.39, 1.05). 
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5.3.2. Follow-up analysis  
Demographic information about the participants who were retained to follow-up 
after 3 years are shown in Table 14. There were no relationships between any type of 
physical activity at baseline and cognitive function at follow-up, including odds of being 
in an at-risk group for dementia (data not shown). 
 
 
Table 14 
Demographic information for participants at follow-up 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
5.4. Discussion 
The aims of this study were to examine the influence of a range of mediating 
and moderating factors identified by the literature review presented in Chapter 2 on the 
relationship between physical activity and cognitive functioning in a large elderly 
cohort. Participation in sport and walking was associated with better memory and 
general cognitive abilities. The associations between walking and performance on 
each of the three tasks were explained by improved physical health measures (as 
assessed by IADL, ADL and SF-36), suggesting that walking may promote cognitive 
health through maintaining physical autonomy and health. However, the association of 
sport with cognitive performance was relatively independent of physical health and 
suggests other mediating factors are involved. The data showed that the relationship 
between participation in sport and cognitive performance was strongest in women 
compared to in men after adjustment for physical health. Age also appeared to act as a 
Variable  
N 135 
Mean age (SD); years 
Female; % 
70.4 (8.0) 
63.0 
Mean ADL score (s.d.) 
Mean IADL score (s.d.) 
19.8 (0.5) 
12.8 (3.7) 
Ever smoked; % 29.6 
Education; %  
   < Elementary 76.3 
   > Elementary 23.0 
Mean MMSE (s.d.) 23.2 (4.5) 
Mean HVLT total (s.d.)  14.2 (6.9) 
Dementia risk; % 39.3 
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moderator of the relationship between sport and memory, with the relationship 
weakening in the oldest-old. Participation in physical activity was not associated with 
cognitive performance or risk of cognitive impairment after 3 years. 
Surprisingly, participation in gardening was associated with decreased memory 
performance and an increased risk of cognitive impairment relative to non-participation 
in women. This was generally a weak association and post hoc analysis showed that it 
was explained by those who worked in farming (n=258). Farmers were more likely to 
participate in gardening perhaps to grow produce to sell or for private consumption and 
were also more at risk of having lower cognitive scores. Culture and its associations 
with socio-economic or other lifestyle factors may thus heavily influence the 
relationships between particular types of physical activity and memory. On the other 
hand, engaging in sports was similarly (to European and US based cohorts) protective 
against poor memory in this middle-income country. Different types of physical activity 
should thus be considered individually in relation to the country under investigation in 
observational studies. 
Our study found that the association between physical activity and cognitive 
functioning was stronger in women compared to in men, which is consistent with 
previous findings. For example, a study of a Chinese cohort found a 55% reduced risk 
of cognitive impairment over 3 years in women only who took part in physical activity 
(yes v no) compared to those who were inactive (Ho et al., 2001). This sex difference 
has also been seen in Western countries (Laurin et al., 2001; Sumic et al., 2007). 
These consistencies suggest that this impact of sex may not be due to sociocultural 
factors, as these would differ between geographical regions, and thus supports the role 
of hormones as a possible mediating factor in the relationship. We also found that the 
association was strongest for memory in younger elderly, who also had significantly 
higher MMSE scores and lower risk of dementia. This may be because those with 
cognitive impairment misreported their physical activity habits in this study, but these 
findings are also consistent with the premise that the association is weakened when 
dementia pathology is likely to be more advanced. This therefore supports the need for 
midlife interventions before dementia pathology develops, as discussed in Chapter 2 
and in the review presented in Appendix A. 
Unlike in Ho et al. (2001), physical activity was not associated with cognitive 
functioning after 3 years. This may indicate that physical activity has only short-term 
effects that do not last if physical activity is stopped or that other factors (such as 
morbidity) interfere with both physical activity and cognitive decline (unfortunately no 
follow-up physical activity or health data was available to further investigate this). 
However, the mean age at follow-up was 70 years and since no association was seen 
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in the older-age group at baseline, it is uncertain whether the lack of an association is 
actually due to the age of the participants. The small sample retained to follow-up 
meant that the group size was too small to stratify to gain a meaningful comparison 
based on age. In the literature review in Chapter 2, few studies recruited participants 
under the age of 65 years at baseline and those that did investigated dementia risk 
(not cognitive ability/impairment) and showed conflicting findings (Rovio et al., 2005; 
Rovio et al., 2007; Carlson et al., 2008). Further longitudinal research with regular 
cognitive assessments and measurements of physical activity is needed in this area to 
determine whether long-term associations change as risk of having underlying 
dementia pathology increases.   
The strengths of our study include the large sample size, which allowed for 
direct comparisons of the effect size between groups stratified by sex and by age. The 
community sample also allowed the investigation of everyday activities rather than in 
an artificial environment. Our study has several limitations. The measure of physical 
activity was not comprehensive, although the questionnaire did include those activities 
that were most commonly performed. The selective effects seen in the regression 
models may be due to the method of self-report, which can be unreliable as those with 
existing cognitive impairment can find it difficult to accurately report activities that they 
are engaged in. In addition, walking was measured on a scale that depends upon each 
respondent’s own interpretation of the response levels (e.g. seldom vs. sometimes). 
This would most likely bias the findings towards the null. Objective measures of 
physical activity/fitness are needed (e.g. daily caloric expenditure, cardiovascular 
fitness, muscle strength, balance, grip strength) to improve the reliability of the 
independent variable and the sensitivity of statistical outcomes.  
In sum, this study has identified specific groups for whom physical activity may 
be especially beneficial. We provide evidence that engaging in sport is associated with 
better cognitive ability and memory particularly in elderly Indonesian women. This 
finding in a middle-income country is novel but important as the majority of people with 
dementia are estimated to live in developing countries and this is where the largest 
growth in incident cases is expected to be (Wimo, Winblad, Aguero-Torres & von 
Strauss). Indonesia is the world’s fourth most populous country with a rapidly growing 
elderly population (Wibowo et al., 2004) and these results may have important 
implications for lifestyle behaviours in the middle- to older-age groups. Due to time and 
resource constraints, only the MMSE and HVLT tests were used and so we cannot 
generalize our findings to executive function abilities, but this study provides evidence 
that memory is affected by physical activity. However, being a cross-sectional study, 
these results may simply reflect lower exercise adherence in those with existing 
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cognitive or physical problems and also cultural factors that cannot be controlled for. 
Thus, controlled studies that use objective measures of physical activity need to be 
conducted in this region to determine causal direction. Methodological improvements 
may also help to determine if amount or intensity of physical activity is related to future 
cognitive ability as this may have implications for healthcare advice for this region. In 
the following chapter we include a study further investigating the association between 
health and physical activity. In Part Four we then present an RCT investigating 
physical activity effects in middle-aged adults for whom this type of intervention may be 
most appropriate.  
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This chapter involves analysis of data collected as part of the study described 
in Chapter 5 and is currently in press. 
Chapter 6 – A Cross-sectional Study of Physical Activity and Health-
Related Quality of Life in an Elderly Indonesian Cohort 
6.1. Introduction 
Average life expectancy is increasing rapidly around the world (World Health 
Organisation 2011) and with this comes a higher rate of age-related illness and 
disability. Poor health has high social and economic costs, especially where there are 
long recovery times. Health-related Quality of Life (QoL) is a measure of the physical, 
psychological, social and functional well-being of an individual (Fallowfield 2009; 
Hennesey et al 1994). QoL measures are increasingly used as prognostic indicators 
for a variety of conditions and are predictive of future hospitalisation and mortality (Dorr 
et al 2006; Efficace et al 2006; Mapes et al 2003). They can also be used to aid the 
selection of treatment by balancing efficacy with side effects (Fallowfield 2009) that 
may contribute to relapse or require further care. Improving QoL in community samples 
may help to lower the demand on medical services and reduce number of person 
years lost to illness and/or disability in the future. Assessing and improving QoL 
therefore has possible wide reaching clinical implications. 
 Sedentary lifestyles are common in many parts of the world (van der Bij et al 
2002), despite the fact that physical activity is often recommended in later life due to its 
benefits to cardiovascular and cognitive health (e.g. Houde and Melillo 2002; Clifford et 
al 2009). Physical activity has been associated previously with improved QoL in 
middle- to older-aged adults. Acree et al’s (2010) cross-sectional study found that 
participation in regular physical activity was associated with increased QoL in men and 
women aged around 70 years. Intervention studies have found similar results. For 
example, Cakar et al (2010) found that completing stretching, strength and 
cardiovascular exercises three times per week for six weeks led to improvements in 
QoL for those in long-term care. In addition, men completing six months of structured 
aerobic activity showed improved QoL compared to a control group continuing their 
daily routine (Antunes et al 2005). Physical activity in general therefore appears to 
have positive effects on QoL. 
 It is unclear whether all types of physical activity have a positive effect on QoL. 
While Antunes et al (2005) found benefits of aerobic activity, three months of 
resistance training was also associated with increased ratings on a QoL mental health 
subscale (Kimura et al 2010). However, Oken et al (2006) found that a group of elderly 
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adults who performed yoga once per week for six months showed increased QoL 
whereas a walking group did not. This suggests that some types of physical activity 
may be more strongly associated with QoL than others, perhaps due to intensity or 
specific characteristics, such as whether it is a social activity or not. On the other hand, 
a review of the literature found consistent increases in QoL as a result of physical 
activity regardless of the type (Rejeski and Mihalko 2001). In addition, the social 
interaction and mental stimulation a participant receives while taking part in an 
intervention study may contribute more to QoL than does the physical activity. The first 
aim of this study was thus to examine whether different types of physical activity are 
associated with self-rated QoL within one large, community-based, observational 
study. 
 The second aim of this study was to identify other factors that may contribute to 
the relationship between physical activity and QoL. Improved functional ability as 
assessed by Instrumental Activities of Daily Living (IADLs) may at least partially 
mediate the relationship between physical activity and QoL. Functional ability and 
reliance on help from others have been shown previously to be associated with QoL in 
the elderly (Patrick et al 2000; Wlodarczyk et al 2004; Andersen et al 2004). Improved 
muscle strength and flexibility that come from regular physical activity may enable 
individuals to carry out tasks without the need for help from others, thus increasing 
QoL ratings. Although physical activity does not appear to reduce disability, reviews of 
the literature have found that it does lessen “functional limitations” and increases 
independence (Keysor 2003; Paterson and Warburton 2010; Spirduso and Cronin 
2001). This relationship has been little explored in previous literature. Therefore, the 
present study also aimed to investigate whether IADL abilities mediate the relationship 
between physical activity and QoL. 
 
6.2. Method 
6.2.1. Participants 
A total of 719 community-dwelling men and women aged 52-98 years were 
recruited from three sites around Indonesia: Central and South Jakarta (n=298), 
Borobudur (near Yogyakarta; n=214), and Citengah (near Bandung; n=207). Local 
residents and those in surrounding villages were given information about the study by 
village elders or staff at local community centres and care homes. Participants were 
tested at their local community centre (n=667) or care home (n=49) where possible. 
Participants with limited mobility were tested at home (n=3). Written informed consent 
was gained from all participants before study onset and, if participants brought a carer 
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with them, they too signed a consent form. Appropriate measures (assignment of 
participant ID, secure storage of data etc.) were taken to ensure anonymity and 
confidentiality of the data. Ethical approval was obtained from Loughborough 
University (UK) and the University of Indonesia (Jakarta) prior to study onset, as were 
governmental and local permits. 
 
6.2.2. Measures and procedure 
Participants were asked to complete an extensive questionnaire to provide 
information on demographic characteristics and lifestyle behaviours, including 
participation in several different physical activities. This questionnaire was used 
previously in Indonesia (Yesufu 2009) and a native speaker administered all questions 
verbally. Forward- and back-translations (English and Indonesian) were completed 
prior to study onset to ensure that the questionnaire maintained its intended meanings. 
Physical activity variables included regular participation in sport and gardening (both 
scored ‘yes’ or ‘no’) and frequency of participation in walking (rated on a 5-point scale 
from ‘never’ to ‘very often’). Other measures of physical activity, such as gymnastics 
and dancing, were included on the original questionnaire; however, there was not 
enough variability in the answers to these questions to include them in the analysis. 
IADLs were assessed using the Lawton scale (Lawton and Brody 1969). This scale 
rates an individual’s ability to perform activities such as cooking, shopping and 
preparing medication. Higher scores indicate more independence and less reliance on 
help from others. 
 Health-related QoL was assessed using the Medical Outcome Survey Short 
Form-36 questionnaire (SF-36; Ware and Sherbourne 1992). This questionnaire 
consists of 36 questions about the respondent’s health and physical pain as well as 
how their health restricts their daily activities. The physical functioning and role 
physical dimensions were removed to avoid circular reasoning, leaving six dimensions 
in the final rating. Participants’ responses to each dimension were standardised to a 0-
100 point scale and were averaged to create a total score. Large UK population 
studies suggest that the SF-36 has high internal consistency (Brazier et al 1992; 
Jenkinson et al 1993) and high construct validity, with significant differences in SF-36 
scores between those who report recent illness and those who do not (Jenkinson et al 
1993; Lyons et al 1994). 
 This was a cross-sectional study examining the relationship between self-
reported frequency of participation in physical activity and scores on the SF-36 while 
adjusting for age in years (as QoL has been seen to decline with age [Ho et al 2007]). 
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Years of education completed and smoking status were also included as covariates 
that may reflect on QoL. The IADL score was used as a possible mediating variable of 
interest. Weight was not available for these analyses but will be included in follow-up 
analyses of a smaller subset. Alcohol consumption was considered as a covariate but, 
as this was a largely Muslim sample, no participants reported drinking alcohol. 
 
6.2.3. Statistical analysis 
Hierarchical regression was used to examine the relationship between different 
types of physical activity and SF-36 scores while controlling for the selected covariates. 
Covariates (age, education and smoking status) were added as a block in Step 1, with 
the physical activity variables being added as a block in Step 2. IADL scores were 
added at Step 3 to examine whether they explained any relationship between physical 
activity and SF-36 scores. All variables were added using the Enter method. As 
walking frequency was scored on a Likert scale, coding was used to transform the 
variable into four separate dummy variables (each with two levels) by contrasting each 
level of walking with the previous level (e.g. ‘often’ versus ‘sometimes’). These new 
dummy variables were then put into the regression model in the same step 
(Stockburger n.d.). Walking was classed as significantly explaining variance in SF-36 
scores only if the beta values of all four dummy variables were significant. Analysis of 
residuals revealed no violation of normality or presence of outliers and multicollinearity 
was not suspected as no high correlations were seen between predictor variables. 
Analyses were carried out in SPSS v. 18.0 with a required alpha value of <.05. 
 
6.3. Results 
Of the original 719 participants, complete data sets were available for 677. 
Participants had a mean age of 69.2 years (s.d.=7.7 years) and 434 (64.1%) of the 
participants were women. SF-36 total scores ranged from 0 to 99 with a mean of 77.9 
(s.d=15.7). IADL scores ranged from 0 to 16 with a mean of 13.3 (s.d.=3.9). The 
numbers of participants reporting participating in the different physical activities were: 
sport n=311; gardening n=100; walking often or very often n=447. Table 15 shows the 
Pearson correlations between each of the independent variables and SF-36 scores. 
Participation in walking and sport were both significantly correlated with SF-36 scores 
(r=.306 and r=.169 respectively), with those participating in more physical activity 
showing higher SF-36 scores. Similarly, IADL scores showed a significant positive 
correlation with SF-36 scores (r=.354) and walking (r=.238). 
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Table 15 
Pearson correlations between walking and selected covariates 
 Walking Sport Gardening Age Education Smoking IADL 
score 
Walking 1       
Sport .249** 1      
Gardening .140** .070 1     
Age -.202** -.188** -.066 1    
Education .174** .540** .087* -.158** 1   
Smoking -.071 -.196** .081* .049 -.012 1  
IADL score .238** .014 .069 -.284** .001 .012 1 
SF-36 score .306** .169** .038 -.142** .246** -.049 .354** 
Abbreviations: IADL – Instrumental Activities of Daily Living; SF-36 – Medical Outcome Survey Short 
Form-36 
*significant at the p<.05 level 
**significant at the p<.001 level 
 
 
Table 16 shows the standardized beta values and significance levels for each 
variable at each step of the regression model, as well as changes in R2. After 
accounting for age, education and smoking status, physical activity explained 10% of 
the variance in SF-36 scores. Of the three physical activities, only walking uniquely and 
significantly contributed to the model. After adjustment for IADL scores (which 
independently explained a further 9.5% of the variance in SF-36 scores, p=.000), 
walking remained significant in the model (see Figure 5) although the strength of the 
association between walking and SF-36 scores was reduced by approximately one 
third. A large part of the relationship between walking and SF-36 scores was therefore 
independent of IADLs. Standardised beta values revealed that the individual 
contributions of walking and IADL scores to SF-36 scores were comparable. Education 
also explained a significant amount of the variance in SF-36 scores in all steps of the 
regression model, while age was not a significant predictor after adjustment for IADL 
scores.  
A compound score that included frequency of participation in all of the physical 
activities was not significant in another regression model (results not shown). When 
data were stratified by sex, similar results were found for men and women. Stratifying 
the sample by district also revealed no differences in the relationship of walking and 
SF-36 scores between those living in rural and those living in urban areas.  
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Table 16 
Standardised beta values of each variable and R
2
 and F values at each step of the regression 
analysis 
Dependent variable: Medical Outcome Survey Short Form-36 scores 
Abbreviations: IADL – Instrumental Activities of Daily Living 
*significant at the p<.05 level 
**significant at the p<.001 level 
 
 
6.4. Discussion 
The aims of this study were to investigate whether different types of physical 
activity were associated with QoL in an elderly, community-based sample and whether 
increased IADL abilities mediated this relationship. This study found a strong 
association between participation in walking and higher QoL ratings. IADLs were also 
strongly associated with higher QoL ratings and they partially explained the association 
between walking and QoL. However, much of the relationship between walking and 
QoL was independent of IADL abilities. Participation in sport or gardening was not 
associated with QoL, which may indicate that the associations with these activities are 
confounded by other variables such as education. These findings may also be 
influenced by fitness; for example, Stewart et al (2003) showed that improved fitness 
as measured by VO2max and weight was associated with increased QoL. The physical 
activity scales are based upon subjective ratings and are thus vulnerable to self-
serving bias and inaccuracies, and the Lawson scale of IADLs shares these 
weaknesses. Objective measures, such as accelerometer readings and functional 
ability tests, are thus recommended in future work to help lessen these limitations. 
Despite methodological limitations, this study provides evidence of a relationship 
between physical activity and QoL independent of IADLs and future work should aim to 
examine different types of physical activity to confirm which are most effective.   
Variable Step 1 Step 2 Step 3 
Age 
Education 
Smoking 
-.137** 
.227** 
-.026 
-.075* 
.210** 
-.030 
.048 
.189** 
-.021 
Walking seldom 
Walking sometimes 
Walking often 
Walking very often 
Sport 
Gardening 
 .505** 
.922** 
.983** 
.397** 
-.022 
-.005 
.285** 
.591** 
.622** 
.267** 
-.052 
-.022 
IADL   .371** 
R2 
R2 change 
.081 
.081** 
.186 
.105** 
.280 
.095** 
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Figure 5 
Error bar chart of walking frequencies and Quality of Life ratings 
Abbreviations: 95% CI – 95% Confidence Interval; SF-36 – Medical Outcome Survey Short Form-36 
 
 
Education was highly associated with QoL ratings in this study. Glasgow et al 
(1997) also found that those with increased years of education had higher ratings on 
the related SF-20 in a large sample of middle-aged diabetes patients. Education may 
be linked to better access to services or awareness of seeking health advice and 
support, or even taking preventative measures against serious illness or injury. Future 
research in this area should thus consider low education as a risk factor for low QoL 
and its associated outcomes. In addition, possible interactions between education level 
and physical activity should be investigated.  
IADLs are often targeted during occupational therapy, and this study suggests 
that the individual contribution of walking to QoL may be comparable to that of IADLs. 
While walking should not be taken as an alternative to standard care, these findings do 
imply that treatment outcomes may be significantly improved through incorporating 
additional walking as part of treatment programmes due to its relationship with QoL. In 
addition, walking may be recommended to the older age community by occupational 
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health advisors as a convenient and accessible activity to act as a buffer against long 
recovery times in the event of illness or disability. These conclusions and implications 
are cautionary since this was an observational study and it is therefore difficult to 
establish a causal relationship between physical activity and QoL. Indeed, these 
findings are contrary to Oken et al’s (2005) intervention study that found no association 
between walking and QoL. These differences may be due to the present study using a 
community sample with no exclusions made in relation to health, whereas the 
intervention study by Oken et al recruited relatively healthy adults. Other intervention 
studies (as mentioned in the introduction) have also shown improvements to QoL after 
physical activity and thus this relationship is worthy of further attention due to the 
importance of the possible health benefits.  
 The findings of this study may be especially pertinent to developing countries, 
and it is unclear how these findings translate to those living in developed areas with 
better access to public health services. Previous studies have suggested that these 
associations may be specific to certain population groups. For example, Luncheon and 
Zack (2011) found that the associations between physical activity and QoL were limited 
to white women in comparison to Latina, Asian and African American women living in 
California, USA. On the other hand, Rejeski and Mihalko’s (2001) review suggested 
that race made no difference to the relationship although they too claimed that those 
results were based mainly on white middle-class samples. As this study assessed a 
population from a developing country, the results indicate that physical activity may be 
beneficial to other ethnic groups. Physical activity may also affect QoL in both men and 
women, as these associations were similar regardless of sex. Thus, the present study 
proposes that the effects of physical activity may be independent of demographic 
characteristics, although future controlled studies are needed to confirm this.  
 In summary, participation in walking is associated with improved QoL in this 
elderly South East Asian cohort, and this relationship stands independently of IADL 
abilities and education. Further evidence of a causal relationship would indicate that 
walking in addition to standard IADL-targeted treatment may be useful for health 
promotion and treatment outcomes, thus having wide reaching clinical benefits to a 
range of population groups. The role of fitness and other potential mediating variables 
should be further investigated to strengthen healthcare advice.  
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This chapter was presented at the Alzheimer’s Association Annual Conference 
in Paris, France; July 2011 
Part Four – Randomised controlled trial 
Chapter 7 – Randomised Controlled Trial of Resistance Exercise on 
Cognition in Healthy Middle-Aged Adults 
7.1. Introduction 
The literature review presented in Chapter 2 revealed that resistance training is 
a little-explored area but there is some evidence of a positive effect on cognitive 
performance. However, some of these studies looked at male- or female-only samples 
(e.g. Cassilhas et al., 2007; Zlomanczuk et al., 2006), or did not use tests of memory 
recall (e.g. Panton, Graves, Pollock, Hagberg & Chen, 1990; Tsutsumi, Don, 
Zaichkowsky & Delizonna, 1997). Lachman, Neupert, Bertrand & Jette (2006) found 
significant improvements of 6 months of strength training on the Digit Span test, but 
this study did not measure changes in executive function abilities. Perrig-Chiello, 
Perrig, Ehrsam, Staehelin & Krings (1998) compared strength training to no exercise 
over 8 weeks and found an improvement in memory but not in cognitive speed. Being 
a short intervention it is uncertain whether this is due to the exercises targeting 
memory alone or if the exercises were not sustained for long enough to have an effect 
on cognitive speed.  
Resistance training is of interest as it does not focus on an aerobic component 
per se, but rather on physiological effects that come from strength changes. For 
example, Williams and Lord (1997) found that changes in muscle strength predicted 
cognitive change over 12 months. The observational study presented in Part Three 
found relationships between everyday physical activity and memory but also 
highlighted problems with observational and follow-up designs (e.g. causality and loss 
to follow-up as a confound). This section thus describes a Randomised Controlled Trial 
(RCT) that was designed to address some of these problems, especially those related 
to causality and the effect of potentially uncontrolled mediating variables over time. The 
study presented in this chapter aimed to investigate whether resistance training had a 
greater effect on cognitive performance over 12 weeks compared to a control activity, 
while also controlling for psychological factors that often accompany engaging in 
physical activities in everyday life. This study was conducted in middle-aged adults as 
our literature review suggested that interventions should be done in midlife to prevent 
later cognitive impairment.  
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7.2. Method 
7.2.1. Participants 
A total of 20 men and women completed this study (see Figure 6 for details of 
participation and attrition). Participants were all community-dwelling sedentary (<2 
hours of activity per week) adults aged between 40 and 65 years at study onset. None 
had been diagnosed with any form of dementia and all participants had a baseline 
MMSE score of at least 27 points to exclude cases with cognitive impairment that could 
have interfered with daily life (e.g. dementia). Volunteers were asked to complete a 
health screen questionnaire (Appendix H) before they were recruited to the study to 
verify that they were physically able to complete the exercises and were not at high risk 
of suffering contraindications. If the researchers had any concerns from this 
questionnaire, participants would be asked to visit their GP for advice before starting 
on the study. Volunteers who were taking up new exercise regimes or diets of their 
own initiative, either for leisure or for medical reasons (e.g. to lower blood pressure), 
were asked to stabilise their routine for a minimum of two months before starting on the 
study (n=2). Volunteers were excluded from the study if they had a physical disability 
or illness preventing them from physical activity or had an illness that may have been 
exacerbated by the training programme (n=2; see Figure 6). Exclusion criteria also 
included of presence of a co-morbid psychiatric disorder, other neurological disease, 
substance abuse and previous use of medication affecting cognition. Participants were 
recruited through word-of-mouth and by contacting local community groups. 
Advertisements were placed in local newspapers (Leicester Mercury, Loughborough 
Echo), on the Loughborough University news website and in libraries, GP surgeries 
and shops around the local area in poster format. A radio interview was also conducted 
to spread awareness of the study. All participants gave full written informed consent 
approved by Loughborough University Ethical Advisory Committee before study onset. 
 
7.2.2. Training programmes 
This study had a crossover design in which all participants completed both a 
resistance-training programme and a control programme. Participants were randomly 
assigned to one of two groups. Group one completed the resistance-training 
programme and a sedentary control programme. Group two completed the resistance-
training programme and a flexibility control programme, designed to control for the 
mental stimulation of the resistance training intervention (the literature review in Part 
One indicated that stretching and flexibility programmes showed no effect on 
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cognition). Each programme lasted 12 weeks and the two programmes were 
completed with a four-week washout period in between.  
 
 
 
Figure 6 
Flowchart of recruitment and participation 
 
Nb: Group RS – Resistance/Sedentary; RF – Resistance Flexibility; SR – Sedentary/Resistance; FR – 
Flexibility/Sedentary. 
 
 
7.2.2.1. Resistance programme 
The resistance programme involved exercises with latex-free resistance bands. 
There were five bands of increasing resistance level and the programme was designed 
to increase muscle strength between baseline and post-intervention assessments by 
progressing through the resistance levels over the course of the programme. To reach 
an expected increase in muscle strength, the programme was to be performed three 
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times per week throughout the 12 weeks, and participants were encouraged to keep to 
this target wherever possible. Several muscle groups around the body were targeted 
by this intervention, namely the obliques, pectorals, gastrocnemius, quadriceps, biceps 
and deltoids (Figure 7). There were 6 different exercises, each targeting one of the 
different muscle groups (upper body rotation, arm extension, lunge, knee extension, 
arm curl and arm raise, respectively. Participants were given a set of written 
instructions and pictures to remind them how to complete each exercise when they 
were at home (see Appendix I). 
 
 
  
Figure 7  
Location of the muscle groups targeted by the resistance training intervention 
Picture adapted from: http://wserver.flc.losrios.edu/~willson/fitnessHandouts/muscleGroups.html 
 
 
Each session consisted of a 5-minute warm-up, a 30-minute resistance section, 
and a 5-minute cool-down. Participants performed 3 sets of each exercise with 1-
minute rests in between, and each set consisted of 12-15 repetitions. Once participants 
could perform 15 repetitions in all 3 sets comfortably without strain, they could move on 
to the next exercise band in their next exercise session. Each participant began the 
programme at the lightest resistance level for two weeks to get used to the movements 
of the exercises, and they could move on to the next band if they were ready. 
Participants could move on to a new exercise band for one muscle group (but not 
Obliques 
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others) if necessary to help optimise their training. Participants had an exercise diary in 
which they could note which resistance level they completed during their last session 
and how many repetitions they performed. They were therefore able to monitor their 
own progress through the study.  
The bands were standardised to arm length to ensure that the amount of 
extension of each band was the same for all participants (bands were cut such that, 
when held out straight but not stretched, they reached from the individual’s 
outstretched arm to the centre of their chest with extra length for wrapping around the 
hands, similar to the procedure used in Lachman et al., 2006). Resistance bands were 
chosen for this study as they are thought to provide similar strength training standards 
as weights in the early stages of training (e.g. Colado & Triplett, 2008). The 
investigators considered these bands to be safer and easier for participants to store in 
their homes as compared to free weights. They are also easily transportable (for 
example, if participants were going on holiday during the study), helping to promote 
adherence throughout the 12 weeks. 
 
7.2.2.2. Flexibility programme 
The flexibility programme involved Yoga-type stretching exercises. To match 
the resistance programme, the flexibility programme was performed 3 times per week 
for 12 weeks, and each session involved a 5-minute warm-up, a 30-minute flexibility 
exercise, and a 5-minute cool-down. The exercises stretched a range of muscle 
groups. However, they were not designed to increase strength in these muscles and 
the exercises did not change over the 12 weeks. Participants were again given a set of 
pictures and written instructions to remind them how to complete each exercise when 
they were at home (instructions taken from select parts of Currie, 20025). 
Past research has shown little evidence of a benefit of stretching alone on 
cognitive function (e.g. Colcombe et al., 2004) and this was therefore considered an 
appropriate control activity as the social and mental stimulation added by the 
resistance programme (visiting the lab, obtaining instructions etc.) could be matched 
as closely as possible with the flexibility group. The flexibility group met with the 
investigator at the same time points as the resistance group and also completed the 
same assessments. Participants were not told that this was a control programme but 
that the aim of the intervention was to assess the impact of different exercises on 
                                                 
5 With thanks to Guy Hearn, photographer, for permissions to use his work for this purpose. 
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cognitive performance, thus treating the flexibility programme as a pseudo-intervention 
programme to remove participants’ expectations regarding cognitive benefit or decline. 
 
7.2.2.3. Sedentary programme 
 Although no benefits of stretching exercises have been seen previously, a 
sedentary control programme was used to control for any potential positive effects 
seen in the flexibility programme that may have masked benefits seen in the resistance 
group. Participants undertaking this programme were asked to maintain their normal 
lifestyle behaviour from before they enrolled on the study (including exercise, diet and 
social habits) for the 12 weeks. They completed the same cognitive and physical 
assessments as in the training programmes.  
 
7.2.2.4. Exercise diaries 
Participants received diaries (Appendix J) in which they were asked to log when 
they performed an exercise session as well as whether the session was completed. 
This was partly to help to encourage and remind them to perform the exercises, but it 
was also to help assess participants’ adherence to the programme. Participants were 
strongly encouraged to perform the exercises three times per week but were also 
asked to complete the diaries honestly and accurately such that genuine adherence 
could be assessed and controlled for in the analysis. Participants were also asked to 
note the resistance level and the number of repetitions that they achieved during the 
resistance programme. This was to help them to monitor their own progress through 
the resistance bands and for the investigator to use as a measure of progression 
through the programme. 
 
7.2.2.5. Encouraging adherence to the exercise and control programmes 
One of the greatest challenges posed by intervention studies is that adherence 
rates can be quite varied, and Dishman and Buckworth (1997) suggest that attrition in 
exercise studies often exceeds 50%. This means that, in some cases, sample sizes 
are small and individuals placed in the exercise group may in fact have done very little 
exercise, leading to small differences between the exercise and control groups. 
Several strategies were therefore recruited in an attempt to encourage full and 
prolonged participation in the physical activity programmes: 
(i) Education - Education about the benefits of the intervention and helpful 
advice on how to complete it have been found previously to help improve adherence 
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(e.g. Keele-Smith & Leon, 2003; Medina-Mirapeix et al., 2009). On their first visit to the 
university, volunteers were briefed on the challenges posed by dementia and the 
importance of the research to addressing those problems. Participants were promised 
a letter explaining the results of the study to help maintain their interest in the research, 
to help them feel as though they had played a central role in the study right until the 
end, and to encourage them against withdrawing. 
(ii) Support to overcome perceived barriers - The investigator kept in regular 
contact with each participant throughout the study such that they could answer 
questions, give advice, discuss any perceived barriers to exercise and keep up to date 
with progression through the exercise programmes. Participants received exercise tips 
to help reduce perceived barriers to exercise and these were reviewed at the six-week 
follow-up meeting. Where necessary, participants were able to change individual 
exercises if they found them too difficult and thus impacted on their performance.  
(iii) Goal setting - Goal setting and feedback during the programme appear to 
increase adherence (e.g. Duncan & Pozehl, 2002; Pinto, Rabin & Dunsiger, 2009; 
Chao, Foy & Farmer 2000), perhaps because it helps to increase the individual’s 
confidence and/or motivation. The investigator was also able to give positive feedback 
concerning participants’ adherence and muscle strength changes. Although 
participants were not set structured targets in this study, they were given individualised 
targets based on their previous adherence and performance at their 6-week review 
meeting. 
   
7.2.2.6. Safety considerations for the exercise programmes 
The training programmes were developed to be suitable for a sedentary, 
middle- to older-age participant group with adherence to guidelines from the American 
College of Sports Medicine (Whaley, Brubaker & Otto, 2005) on prescribing exercise 
programmes as well as with the guidance of a trained physiologist (Dr R Ferguson). All 
participants underwent a training session before beginning the exercises at home to 
ensure that they understood how to complete the exercises properly and safely, and 
this was reviewed at 6 weeks. The importance of performing a warm-up and cool-down 
during every exercise session was explained to participants during their training 
session, and participants were encouraged to give these sections priority over the 
resistance/flexibility section if they were short of time. Participants were instructed to 
cease exercising immediately if initial muscle ache persisted or if they became injured 
or ill at any time during the 12 weeks. No direct adverse effects were reported but four 
participants ceased exercising for up to one week due to unrelated illness or injury. 
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Participants were also encouraged to contact the investigator if they had any questions 
or concerns about the programme and the investigator remained in contact with all 
participants throughout the intervention. For the first two weeks of the resistance 
programme, participants were given the lightest resistance band only to get 
accustomed to the exercises and to avoid participants starting on too high a resistance 
level, reducing risk of adverse effects.  
 
7.2.3. Cognitive outcome measures 
Participants were assessed on the Hopkings Verbal Learning Test (HVLT; trial 
1 and total), Verbal Fluency and Trail Making Test (TMT) as described in Chapter 4. 
Different versions of the HVLT were used on different occasions to avoid ceiling effects 
in the later sessions of the intervention. Version 2 and 4 were used during 
familiarisation, then the main assessments alternated between versions 1 and 5. The 
MMSE was also used as a screening tool for cognitive impairment at the start and 
finish of each intervention.  
 
7.2.4. Physiological measures  
Lachman et al. (2006) found that an increase in resistance level over the 
course of an exercise intervention predicted memory improvement. Therefore, in this 
study, muscle strength was measured before and after each of the exercise 
programmes to determine whether changes in strength drove any of the changes seen 
in cognitive scores. Lower body muscle strength was measured using a dynamometer 
on one muscle group only (quadriceps) so as to limit the demand on participants’ time. 
However, this muscle group was one of those targeted by the main intervention so that 
changes in muscle strength due to the training programme could be estimated. 
The strength test measured both isokinetic and isometric strength with 
participants in a seated position (see Figure 8a). The isokinetic strength involved kicks 
which pushed a bar (fixed at lower shin level) at varying resistance levels, namely 
60/s, 180/s and 240/s. The isometric strength involved maintaining a constant force 
for 3 seconds against the bar that did not move. The order of the different resistance 
levels was randomised for each participant. This testing took around 20-25 minutes for 
both legs. Grip strength in the right hand was also measured using a handheld 
dynamometer (see Figure 8b), as this has previously been shown to be related to 
cognition and risk of AD (Atkinson et al., 2010; Buchman, Wilson, Boyle, Bienias & 
Bennett, 2007). 
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Resting heart rate and BP were assessed at baseline and at the end of each 
training programme. Saliva samples were taken at the same time points and frozen at -
20 degrees to analyse testosterone and cortisol levels at a later stage. Participants 
were given a salivette in which to dribble saliva immediately after waking in the 
morning of the meetings with the investigator. Height and weight were measured and 
BMI was calculated from these. Waist:hip ratio was also measured at baseline and 12-
week follow-up sessions for each intervention.  
A limitation of the observational study described in Chapter 5 is that the 
possible acute effects of physical activity were not controlled for, meaning that 
cognitive function scores may have been influenced in those who walked some 
distance to the testing centre compared to those who arrived by car. In this RCT, 
participants were asked not to walk to the University but instead to drive or take a taxi. 
They were also asked to avoid other moderate-intense physical activity, as well as to 
avoid consuming caffeine or alcohol, during the morning and/or afternoon prior to each 
session.  
 
 
a)       b) 
  
Figure 8.  
Testing apparatus for a) lower body strength and b) grip strength 
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7.2.5. Lifestyle measures 
A screening questionnaire (Appendix H) was completed at enrolment to assess 
demographic variables of interest (e.g. education and occupation) and general health 
(including details of any treatments and family history of memory problems). This 
health information was used to assess the risk of adverse effects for each participant 
and also to control in the analysis for medical conditions that have may put the 
participant at increased risk of cognitive impairment, such as stroke and diabetes.  
The Hospital Anxiety and Depression Scale (HADS; Zigmond & Snaith,1983; 
Appendix K), a standardised measure of mood and anxiety, and a social support 
questionnaire (Appendix L) were used to assess relationships between these variables 
and changes in cognitive performance after physical activity. 
Although asked to maintain their usual lifestyle outside of the study, previously 
sedentary participants may make multiple lifestyle changes, such as improved diet or 
more social contact, when they commence a physical activity programme in studies 
such as this. It is thus possible that it is these lifestyle changes that lead to cognitive 
changes rather than the participation in physical activity itself. A lifestyle questionnaire 
(Appendix M) designed specifically for this study was therefore given to ask about 
levels of physical activity, social activity, diet, smoking and alcohol and tea/coffee 
consumption over the previous two weeks. These questions were similar to those 
asked in the observational study described in Part Three. The data from these 
questionnaires were used to control for these variables in the analysis and to assess to 
what extent these variables may have acted as moderator variables.  
 
7.2.6. Design 
In this crossover study, the effect of treatment (resistance training v control) on 
cognitive performance was assessed. Random allocation to programme order was 
carried out by flipping a coin twice, firstly to determine whether the participant would 
perform the resistance or control programme first, and secondly to determine which 
control programme the participant would perform. Assignment did not occur until just 
before the participant received training. This meant that all of the information about the 
study was kept identical and the baseline measurement was not affected in any way by 
the investigator’s knowledge about which type of exercise they would go on to perform 
next. Although the strength assessment and cognitive testing was not blinded at follow-
up due to practical constraints, a script was adhered to for giving instructions to all 
participants for all cognitive and physiological tests. 
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The exercise programmes took place in the participants’ homes rather than in 
an institutional setting. The exercises were deemed simple and safe enough for 
participants to do alone, and exercising at home allowed participants more flexibility in 
terms of when to exercise thus encouraging more participants to see the trial through 
to the end. It also allowed ongoing recruitment rather than requiring all participants to 
start at one time, which enabled larger group sizes at the end of the study, and this 
method removed the social component of group exercise. All meetings and 
assessments, however, took place at Loughborough University and participants were 
reimbursed for travel costs. 
Hawkins, Capaldi and Kramer (1992) and Perrig-Chiello et al. (1998) found that 
improvements could be seen on cognitive tests after exercise programmes as short as 
10 and 8 weeks, respectively. Thus, each programme ran for 12 weeks but 
measurements were done at 6 weeks also to assess if there were any early 
improvements. Two practise sessions were done before study onset that included 
muscle strength and cognitive testing to help reduce practice effects on these 
measurements after baseline.  
 
7.2.7. Procedure (Figure 9) 
7.2.7.1. Initial recruitment 
The advertisements for this study asked volunteers to register their interest in 
the study by telephone or email. Some questions were asked for initial screening 
purposes (e.g. age and/or health conditions that may have put them at high risk of 
adverse effects to exercise, current activity levels) and contact details were taken. An 
information sheet was sent to volunteers explaining the study further and, if they were 
still interested, a meeting was arranged for the enrolment session. Participants were 
also advised to consult their GP before meeting for enrolment.  
 
7.2.7.2. Enrolment 
This was the first face-to-face contact that most volunteers had with the 
investigator and so involved a full explanation of the aims of the study, the procedures 
and how the results would be used. This was also an opportunity for volunteers to ask 
any questions they may have had. When the investigator and participant were both 
satisfied that the procedures had been fully explained and understood, informed written 
consent was obtained. The demographic/health screening questionnaire was 
completed.  
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7.2.7.3. Familiarisation sessions 
Participants completed two familiarisation sessions at the University at least 
three days apart. This gave them familiarisation time with the muscle strength and 
cognitive measurements. During the first session, participants were also screened for 
cognitive impairment using the MMSE. Cognitive tasks during these and subsequent 
sessions were completed in a 5x6 foot research cubicle with controlled artificial 
lighting. This session lasted approximately 60 minutes.  
 
7.2.7.4. Baseline session 
Baseline measurements were obtained during this session, and participants 
were asked to bring a saliva sample from that morning.  Upon arrival at the University, 
participants were asked to complete the lifestyle, social support and mood 
questionnaires while they sat quietly for 10-15 minutes, after which their BP and resting 
heart rate were taken. Participants then completed the muscle strength test on the 
dynamometer, followed by grip strength. Weight in kg, height in cm and waist:hip ratio 
were taken next. Then participants completed the cognitive tasks. Finally, participants 
were randomly assigned to an intervention group and were given training in the 
relevant exercise programme and keeping the exercise diaries (except for those 
completing the sedentary programme first). This session took approximately 90-120 
minutes in total.  
 
7.2.7.5. Continuation of programme at home 
Participants began their assigned programme at home immediately after the 
familiarisation session. Participants met with the investigator after 6 weeks during 
which they completed the cognitive tests only. For the training groups, progress was 
reviewed and participants had the chance to discuss any problems they had with the 
programme since the last meeting. These meetings lasted approximately 30 minutes.  
 
6.2.7.6. Cessation of the exercise programme 
After 12 weeks, participants returned to the University (with a saliva sample 
taken in the morning) to complete the questionnaires and have their BP, heart rate and 
muscle strength measured. They also completed the cognitive tasks. They were 
instructed to continue their normal routine from before starting on the study for the next 
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four weeks. After the wash out period of four weeks, participants returned for their 
second baseline session. The procedure continued in the same way as described for 
their second programme. 
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7.2.8. Analysis 
All analyses were conducted using SPSS v18.0. Demographic characteristics 
and mean cognitive scores were calculated using cross tabs and descriptive analyses 
for means. A repeated-measures ANOVA was conducted for each cognitive task to 
test the effect size and significance of time*treatment interactions for each cognitive 
test. To maintain power, only age and education were used as covariates in each 
model (no participants reported smoking). Analyses were also stratified by sex. No 
differences were seen in cognitive scores between sedentary and flexibility control 
groups (data not shown), and these groups were combined and analysed as one 
control group for comparison with resistance training. Visual assessment of histograms 
and normality tests revealed some violations of normality on some of the cognitive 
tests, which was expected in the smaller sample. In particular, TMT interference scores 
and HVLT total scores appeared not to be normally distributed. Transformations of the 
data did not improve estimates of normality and so the raw data was used in 
subsequent analysis. Maunchley’s test of sphericity was applied to all ANOVAs and a 
correction was applied when necessary6. 
 
7.3. Results 
7.3.1. Descriptive Statistics 
Participant characteristics and baseline cognitive test scores are shown in 
Table  17, both total and split by control treatment group. Only data from participants 
who completed both the resistance training and a control programme (n=20) are shown 
here. Diet and physical activity outside of the intervention did not change significantly 
from baseline to follow up (data not shown).  
 
 
 
 
 
 
 
 
                                                 
6 Greenhouse Geisser if estimate <.75 or Huynh-Feldt if estimate ≥.75 
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Table 17 
Participant demographics at baseline 
 
Group 1 (Sedentary 
control group) 
Group 2 (Flexibility 
control group) 
Whole group 
N 10 10 20 
Mean age (sd) 
Female; % 
Education; % 
   College or below 
   Degree or above 
58.3 (7.4) 
80 
 
60 
40 
60.1 (6.0) 
80 
 
60 
40 
59.2 (6.6) 
80 
 
60 
40 
Mean MMSE score (sd) 
Family history of dementia; % 
29.1 (0.7) 
50 
28.6 (1.2) 
40 
28.9 (1.0) 
45 
Baseline Psychosocial factors 
   Mean HADS score (sd) 
   Mean social support score (sd) 
 
9.9 (4.8) 
127.0 (24.7) 
 
7.3 (5.7) 
128.4 (23.5) 
 
8.6 (5.3) 
127.7 (23.5) 
Mean alcohol units at baseline (sd) 
Smoke; % 
5.1 (8.0) 
0 
11.7 (12.1) 
0 
8.4 (10.5) 
0 
Baseline physiological factors 
   Grip Strength; kg (sd) 
   Isometric Strength; kg (sd) 
   Isokinetic Strength; kg (sd) 
 
29.5 (7.6) 
138.4 (65.9) 
66.4 (19.1) 
 
31.0 (7.1) 
135.4 (32.7) 
83.2 (25.8) 
 
30.3 (7.2) 
136.8 (48.1) 
75.3 (23.8) 
Nb. There were no significant differences in baseline demographics between groups. 
 
 
7.3.2. Learning effects 
There were significant learning effects on the HVLT trial 1, HVLT total and 
Verbal Fluency scores over the two familiarisation and the baseline sessions. Although 
not significant, TMT interference effects also lessened during familiarisation. Significant 
differences were seen between familiarisation 1 and familiarisation 2, but learning 
effects were not seen between familiarisation 2 and baseline for all tasks (see Table 
18). No correction for learning effects was therefore applied to the following analyses. 
 
 
Table 18 
T-tests between familiarisation and baseline sessions 
Test Familiarisation 1 – Familiarisation 2 Familiarisation 2 – Baseline 
HVLT trial 1 t(21)=-2.22, p=.038 t(17)=-0.62, p=.544 
HVLT total  t(21)=-2.67, p=.014 t(17)=-0.77, p=.454 
TMT interference t(21)=1.23, p=.092  t(21)=0.23, p=.302 
Verbal Fluency t(21)=-2.42, p=.025 t(17)=-1.43, p=.170 
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7.3.3. Whole sample 
 When analysed as a complete group, there were no significant effects of the 
resistance programme on performance on any of the cognitive tests. The data were thus 
stratified to assess whether any effect of the resistance training was influenced by sex, as 
seen in the observational study in Chapter 5. This left just 4 men in the sample, so the 
following analyses were conducted on women only.  
 
7.3.4. Women only 
No significant differences were seen on any of the cognitive tasks after 6 
weeks. However, significant differences were seen between interventions on some of 
the cognitive tasks after 12 weeks (see Table 19), which are described below. 
 
 
Table 19 
Mean (s.d.) cognitive scores for control and resistance interventions (women only) 
Group Control Resistance Group*time interaction 
Time Baseline 12 weeks  Baseline 12 weeks  F p 
HVLT trial 1 9.0 (2.2) 8.4 (1.5) 8.9 (1.4) 9.6 (2.0) 4.789 .047 
HVLT total 31.1 (3.6) 30.6 (3.4) 31.3 (2.5) 32.6 (2.6) 4.155 .062 
Verbal Fluency 29.8 (8.4) 30.8 (7.5) 32.3 (8.9) 32.1 (8.0) 5.035 .046
a
 
TMT interference 21.5 (27.8) 16.3 (11.8) 14.4 (8.0) 18.4 (16.6) 1.545 .238 
Abbreviations: HVLT – Hopkins Verbal Fluency Task; TMT – Trail Making Test 
a
Results shown for Group*time x Education interaction 
 
 
7.3.4.1. Verbal Fluency 
The number of words recalled on this task ranged from 17 to 50, with a mean of 
31 words recalled at baseline and 31 words recalled at follow-up. There were no 
differences in baseline measurements between the resistance and control 
interventions (t(15)=-1.257, p=.228). Although participants showed some improvement 
after both interventions (see Figure 10), there was a larger increase in Verbal Fluency 
scores after 12 weeks of the resistance intervention compared to the control 
intervention. A 3-way interaction was seen between treatment, time and education 
level (p<.05). Post hoc comparisons did not reach significance but those with more 
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years of education appeared showed the greatest improvement after the resistance 
programme (Figure 11). 
 
 
 
Figure 10 
Verbal Fluency performance over 12 weeks of control and resistance interventions 
Note: Error bars represent standard error 
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a) 
b)    
)  
Figure 11 
Change in Verbal Fluency performance over control and resistance interventions for (a) low 
education and (b) high education 
Note: Error bars represent standard error 
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7.3.4.2. HVLT trial 1 
The number of words recalled on this task ranged from 6-12, with a mean of 8.9 
words recalled at baseline and 9.0 words recalled at follow-up. There were no baseline 
differences between resistance and control interventions on the HVLT trial 1 
(t(15)=0.12, p=.910). There was a significant group by time interaction (see Figure 12) 
in which there was a significant improvement in scores after the resistance 
intervention, but not after the control intervention (t(15)=-2.92, p=.011). 
 
 
 
Figure 12 
HVLT trial 1 performance over 12 weeks of control and resistance interventions 
Note: Error bars represent standard error 
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7.3.4.3. HVLT total score 
The number of words recalled on this task ranged from 24 to 36, with a mean of 
31 words recalled at baseline and 32 words recalled at follow-up. There were no 
baseline differences between resistance and control interventions (t(15)=-0.21, 
p=.838). There was a group by time interaction (see Figure 13) for this task in which 
there was an improvement in scores after the resistance intervention, but not after the 
control intervention (t(15)=-2.551, p=.022). 
 
 
 
Figure 13 
HVLT total performance over 12 weeks of control and resistance interventions 
Note: Error bars represent standard error 
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7.3.4.4. TMT interference 
There were no significant baseline differences between the control groups and 
resistance interventions (t(15)=0.73, p=.478). There was no significant treatment x time 
interaction on this task (Figure 14) and follow-up intervention scores were similar after 
both interventions (t(15)=-0.536, p=.600).  
 
 
 
Figure 14 
TMT interference scores over 12 weeks of control and resistance interventions 
Note: Error bars represent standard error 
 
 
7.3.5. Adherence to the resistance and flexibility programmes 
Average reported adherence to the resistance programme was 84.6% (range 
56-100%), compared to 87.2% (range 58-100%) for the flexibility programme (p>.05). 
The training order made no difference to adherence to the resistance programme 
(t(15)=-.158, p=.876) or the flexibility programme (t(7)=.020, p=.984). There were no 
significant correlations between adherence to the resistance programme and changes 
on any of the cognitive tasks (Table 20). 
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Table 20 
Pearson correlations between adherence to the resistance programme and change scores on 
each of the cognitive tasks 
Test Pearson 
correlation 
p 
HVLT trial 1 .234 .321 
HVLT total .209 .377 
Verbal Fluency -.364 .115 
TMT interference -.089 .711 
MMSE .127 .593 
N.b. N=20 for all correlations 
 
 
7.3.6. Muscle strength  
There were no group*time interactions for lower body strength (isometric or 
isokinetic), indicating that lower body strength did not change as a result of the 
resistance intervention. However, a repeated measures ANOVA found a group*time 
interaction for grip strength (F(1,19)=3.01, p=.099), where grip strength improved after 
the resistance intervention (t(15)=-2.34, p=.030) but remained stable over the control 
intervention (t(15)=0.27, p=.791) (Figure 15). There were moderate correlations 
between grip strength and TMT interference (r=.445), HVLT trial 1 (r=.400), HVLT total 
score (r=.402) and Verbal Fluency (r=.689), However, there were no significant 
correlations between changes in grip strength and changes in cognitive performance. 
No correlations were seen between lower body strength and cognitive performance at 
baseline. 
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Figure 15 
Change in grip strength (kg) after 12 weeks of the control and resistance interventions 
 
 
7.3.7. Other variables  
No significant changes were seen on BMI, weight, waist to hip ratio, BP or 
resting heart rate over any of the interventions. Responses on the HADS scale were 
counted to make three scores: depression, anxiety and total (depression + anxiety). 
There were no significant changes over the course of any of the interventions on any of 
the mood scores. Social support was counted to give a total score. There were no 
significant changes in social support over the course of any of the interventions. There 
were no correlations between any of these variables and changes in cognitive scores 
(data not shown). 
 
 
7.3.8. Men only 
 As there were only four men in the sample, these data could not be analysed 
statistically. However, visual analysis of graphs (Figure 16) produced to show 
performance over 12 weeks of each of the interventions showed few differences 
between the interventions on any of the tasks. The inclusion of men in the sample 
therefore appeared to bias the findings towards the null.  
  
 
 
 
 
Figure 16  
Performance on each cognitive task over 12 weeks of the control and resistance interventions in men only 
1
6
4
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7.3.9. Power calculation for future sample sizes 
 The interpretation of the null effect of intervention type on TMT interference 
scores is central to our research question. The power estimate given by the ANOVA 
was low (<.3) compared to in the models testing for differences in the memory tests 
(>.45). We therefore conducted a post hoc analysis using an online calculator7 to 
determine the sample size required in future studies to rule out any effect of resistance 
training on TMT performance. Using a required Alpha Level of 5% and a required Beta 
Level of 10%, the calculator estimated a sample size of 85 would be required.  
 
7.4. Discussion 
This study aimed to investigate whether 12 weeks of non-aerobic activity with a 
strength training component impacted on different cognitive abilities compared to no 
activity or very light stretching exercise in healthy, middle-aged adults. Flexibility 
exercises had no effect on cognitive scores compared to no exercise. The resistance 
training intervention successfully improved memory performance, but not executive 
function, in women compared to the control intervention. The resistance intervention 
led to increases in grip strength, but the changes in memory were not associated with 
changes in grip strength after the intervention. These changes in memory were also not 
associated with other fitness variables (BP, BMI, resting heart rate), mood or social 
support. These differences were not seen in men for either memory or executive 
function, although there were few men in the sample.  
Due to the lack of an association between strength and memory, it is unclear 
how this resistance intervention led to the improvements in memory. This programme 
was not designed to have an aerobic component, but there was no measure of aerobic 
fitness as part of this study, so it is not possible to exclude totally the possibility that 
these memory changes were driven by an aerobic change. These effects may be 
related to other physiological changes, such as Insulin-like Growth Factor (IGF-1) 
release, and/or changes in metabolism or release of testosterone (discussed in 
Chapter 1). These changes may also be a result of psychological mediators due to the 
expectation of strength improvements following the resistance intervention (Stock, 
Clifford and Hogervorst, 2012). Anecdotally, participants reported not enjoying the 
flexibility intervention due to not noticing any physical benefits. In contrast, the 
resistance training received positive feedback and participants reported feeling 
stronger (despite no measured strength changes). Further research should investigate 
                                                 
7
http://www.dssresearch.com/KnowledgeCenter/toolkitcalculators/samplesizecalculators.aspx 
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these physiological and psychological factors as possible mediators of the relationship 
between resistance training and cognitive functioning. However, the lack of an 
association between strength and memory may be due to low power and larger studies 
are therefore essential to determine the true extent of the association while controlling 
for other potential mediators. 
The effects of resistance training appeared to be specific to memory and word 
generation (linked to semantic memory) with performance on the TMT, a measure of 
task switching, being unaffected. This was predicted from the literature review, with 
studies assessing memory finding more significant effects of physical activity than 
studies looking at executive function. Due to the small sample size combined with the 
high variance in scores on this task, the model had low power compared to the 
analyses of the memory tasks and we therefore cannot be certain that an effect of the 
resistance training would not have been seen had there been greater power in our 
study. However, Kimura et al. (2010) also found no effect of 12 weeks of resistance 
training on task switching compared to a health education class in 119 elderly men and 
women combined aged >65 years. In women only (n=33), Zlomanczuk et al. (2006) 
observed no effect of 3 months of resistance training with endurance on the SCWT 
compared to no exercise. In contrast, after 12 months of resistance training, Liu-
Ambrose et al. (2010) found a significant effect on executive function in 135 women 
aged 65-75 years and Kwak, Um, Son and Kim (2008) showed a 30% improvement in 
general cognition in a parallel group study of 30 women with dementia after 12 months. 
This may indicate that longer interventions are needed for improvements in executive 
function to be seen, though again larger replications with the estimated sample size for 
the TMT (n=85) would be needed to ensure that these discrepancies are not simply 
due to low power. 
In our study, associations between resistance training and memory were seen 
in women but not in men. The inclusion of men in the total sample appeared to remove 
the effect of resistance training and memory in women, although there were only four 
men included. Women may benefit more from resistance training due to the potential 
release of testosterone after resistance training (Kraemer et al., 1998; Marx et al., 
2001), which itself can improve memory ability (Davison et al., 2011) although this 
association remains controversial in older adults (e.g. Kocoska-Maras et al., 2011; 
Hogervorst, Matthews & Brayne, 2010). Most other studies of resistance training that 
have shown an association with cognitive function also included a high proportion of 
women (Molloy, Delaquerriere-Richardson & Crilly, 1988; Zlomanczuk et al., 2006; 
Lachman et al., 2006). Further study with high numbers of men with a direct 
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comparison of effect size is therefore needed to fully determine whether they too 
experience improvements in memory after resistance training.  
This pilot study allowed us to trial the methods used and found relative success 
with the resistance programme. Feedback from a questionnaire given to participants 
after the intervention suggested that the resistance bands were well tolerated by 
participants as a home-based intervention. They allowed individual progress to be 
monitored through the different resistance levels and many participants reported having 
taken the bands on holiday, meaning that they did not have to discontinue the 
programme while they were away from home. This helped to maintain reported 
adherence rates above 80% for the majority of participants. The feedback from this 
study can therefore recommend the use of resistance bands in future research of this 
nature, although modifications to the programme should be made in order to ensure 
higher strength increases at follow-up from baseline to allow the influence of strength 
changes can be fully determined.  
Although general dietary habits by each participant were monitored over the 
course of the study, the effects of individual nutrients consumed immediately prior to 
testing were not controlled for. For example, glucose is important for cognitive function 
and those who missed breakfast or who had not eaten for several hours may have 
performed poorly on the cognitive tasks relative to their ability had they eaten. In 
addition, participants were tested at a time convenient to them; therefore, the effects of 
circadian rhythms could not be controlled. Especially given the small sample size, this 
may have had a confounding effect on our findings and these variables should be 
considered in future work.  
In this pilot study, effects of resistance training were seen on memory compared 
to flexibility exercises and no physical activity in this sample of healthy, middle-aged 
women. This study thus adds to the evidence that resistance training, a relatively 
unexplored type of physical activity, is a potential alternative to aerobic activity as an 
intervention for improving memory in middle age and should be investigated thoroughly 
using larger scale studies. These associations in the absence of strength changes 
point towards previously unidentified mechanisms through which resistance training 
affects memory, and consideration of these factors in the future may lead to a better 
understanding of how to prevent cognitive decline in later life. These findings, though 
not conclusive, are consistent with previous studies and effects of cognitive domain 
and sex were also seen previously (Chapters 2 and 5), adding to the evidence that 
these factors act as moderators of the relationship between physical activity and 
cognitive functioning. This study could be expanded to assess whether resistance 
training can add to the benefits of aerobic training where the two are combined, or 
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whether resistance training can be considered an alternative for those who may find 
aerobic activity particularly difficult due to physical health concerns. In the following 
chapter we discuss the implications of these findings in combination with the results of 
the literature review in Chapter 2 and the observational study in Chapter 5.  
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This chapter is published in part with the Introduction in “Frontiers in Clinical 
Drug Research – Alzheimer Disorders” 
 
Part Five – General Discussion 
Chapter 8 - Discussion 
The aim of this thesis was to investigate the effectiveness of lifestyle changes 
for preventing or delaying the onset of AD. In particular, it aimed to explore the 
relationship between physical activity and cognitive functioning and the additional 
mediating and moderating factors that may be involved. Although our literature review 
in Chapter 2 found evidence of a relationship between physical activity and 
cognition/risk of dementia, these findings were not consistent. Chapters 3 and 4 
identified the most optimal cognitive tests to use for AD and other types of age related 
cognitive impairments. These tests have even been shown to be sensitive to 
interventions in young healthy populations. The review in Chapter 2 had identified 
several variables that may explain conflicting results of previous studies investigating 
physical activity and cognitive function. Some of these variables were investigated 
through an observational study of Indonesian elderly and an RCT of resistance training 
in healthy middle-aged adults in the UK (Chapters 5, 6 and 7). The studies in this thesis 
showed consistent effects of sex, with women benefitting from physical activity more 
than men, and of the type of cognitive ability being measured, with stronger changes in 
memory than in executive function performance.  Both aerobic and non-aerobic activity 
have been shown to benefit cognitive ability and while this may be partially through 
improving general health, other mechanisms also appear to be involved as health did 
not fully mediate effects of physical activity on cognition. There is also growing 
evidence that engaging in long-term physical activity behaviours in midlife are more 
effective than in older age when dementia pathology is increasingly present. These 
findings have theoretical implications for the field of dementia prevention and 
recommendations for future research are discussed in this chapter.  
 
8.1. Moderators of effects of exercise on cognition: tests and functions 
The type of cognitive measurement used in observational studies of healthy 
adults and in RCTs seems to have a strong effect on the findings of those studies. 
Although Hall, Smith and Keele (2001) and Colcombe and Kramer (2003) suggested 
that the benefits of physical activity were restricted to complex executive function 
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processes, this thesis has found that the benefits may be stronger for memory. 
Measures of memory such as digit span, word list learning and word generation were 
shown in Chapters 3 and 4 to be highly sensitive to AD. These studies may therefore 
have identified effects of physical activity in healthy middle- and older-age adults on 
cognitive tests that are relevant to AD, supported by previous studies that have found 
reduced risk of dementia in those who are physically active in midlife (Table 3). 
Although we found that some tests of executive function are sensitive to AD, 
performance on these tasks was less affected by physical activity and poor 
performance may be indicative of particularly severe pathology that is less responsive 
to treatment. However, the finding of a lack of an association between physical activity 
and executive function remains controversial (e.g. Eggermont, Milberg, Lipsitz, 
Scherder & Leveille, 2009; Abou-Dest, Albinet, Boucard & Audiffren, 2012). A 
longitudinal study showed that young-elderly with high fitness maintained executive 
function abilities over 6 years while those with low baseline fitness showed decline 
(Barnes, Yaffe, Satariano & Tager, 2003). Liu-Ambrose et al. (2010) observed reduced 
interference effects on executive function tasks among elderly women completing 12 
months resistance training compared to balance training. Memory may therefore show 
immediate benefits of physical activity, while executive function may require longer-
term interventions to show a robust effect.  
The observed differences in exercise’s effects between memory and executive 
function can possibly be explained by the neurogenesis hypothesis described in 
Chapter 1. Neurogenesis is currently accepted to occur mostly in the hippocampus 
(Zhao, Deng & Gage, 2008), an area that is important for memory function (Diana, 
Yonelinas & Ranganath, 2007). Since physical activity is thought to have an impact on 
neurogenesis, memory processes are therefore more likely to benefit compared to 
functions mediated by other cortical areas. However, the brain is highly interconnected 
and the prefrontal cortex has connections with many other regions including the medial 
temporal lobe which contains the hippocampus (Miller & Cohen, 2001). Prolonged 
physical activity over many years may thus impact on executive function abilities 
through knock-on effects from the hippocampus. Executive function may also benefit 
from improved angiogenesis after physical activity, possibly due to the increased 
availability of IGF-1 (Cotman, Berchtold & Christie, 2007; van Praag, Shubert, Zhao & 
Gage) or other direct vascular effects, such as enhanced perfusion leading to reduced 
risk for hypoxia (Querido & Sheel, 2007; Ogoh, 2008; Rhyu et al., 2010). Neuroimaging 
methods may help to sequence changes in these regions at various points through an 
exercise intervention to determine whether temporal differences are seen in the effect 
of physical activity on different cognitive abilities.  
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8.2. Moderators of effects of exercise on cognition: types of exercise 
Different studies investigated the impact of different types of physical activity, 
which makes it difficult to determine which types of physical activity are most effective 
at improving cognitive functioning. Aerobic activity and resistance training both appear 
to have a strong effect on memory and our RCT showed that even low-intensity 
exercise can lead to improved memory performance (see also Tsutsumi, Don, 
Zaichkowsky & Delizonna, 1997; Cassilhas et al., 2007). These effects are likely to be 
due to the range of physiological effects that aerobic activity has on the body that are 
also implicated in cognitive performance, such as improved lung and vascular function. 
However, our randomised trial found that the effects of resistance training on cognitive 
performance were not associated with changes in strength (Chapter 7). In addition, the 
observational study found that associations between sport and memory were 
independent of physical health (Chapter 5). Further research should thus consider the 
influence of other neurophysiological factors, such as growth or sex hormones as well 
as psychological mediators (Stock, Clifford & Hogervorst, 2012) as possible pathways 
between physical activity and cognitive functioning. It is currently unclear whether the 
effects of aerobic and non-aerobic activity are additive or would interact to produce 
optimal benefits, and interventions using both, one and neither of the two types of 
activity should be trialled to investigate this.  
In contrast, this thesis found little evidence that yoga and flexibility-type 
exercises have any benefit to cognition. It could be argued that participants may not 
enjoy a particular intervention, as was seen in our flexibility intervention, and so may 
not engage as strongly as they do with an intervention they enjoy. However, no effect 
of flexibility on cognition was seen throughout the literature (see Chapter 2) so it is 
unlikely to be due to participant preference. As the observed benefits of yoga often 
include improved mood, it suggests that mood is not a strong mediator of the 
association between physical activity and cognition. However, balance may benefit 
from yoga exercises, which could lead to reduced risk for falls in the elderly (Clemson 
et al., 2012; Li, Harmer, Fisher, & McAuley, 2004).  
 
8.3. Moderators of effects of exercise on cognition: gender 
This thesis suggests that certain groups may benefit more from physical activity 
than others. Most of the effects of physical activity are seen in women and a direct 
comparison of effect sizes showed a significant stronger effect of sport on memory and 
global cognition in women compared to in men (Chapter 5). In addition, the effect of 
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resistance training on memory in women was diminished when men were included in 
the analysis in our RCT (Chapter 7). These differences appear to be universal across 
cultures (Chapter 5) and are perhaps due to the range of physiological mechanisms 
through which physical activity affects cognitive functioning. Sex steroids affect brain 
function through multiple mechanisms and women show a sharp decline in both 
estrogens and testosterone after the menopause around the average age of 50 years 
(Hogervorst, Henderson, Gibbs & Brinton, 2009). For example, changes in testosterone 
following resistance training may benefit women more so than men who already have 
optimal levels of testosterone. In addition, there is evidence that estrogen increases 
BDNF, as does physical activity as described in Part One (Zhao, Deng & Gage, 2008). 
When relatively high levels of estrogen and physical activity co-occur, they may interact 
such that the benefit on cognition is increased compared to when they occur alone 
(Berchtold, Kesslak, Pike, Adlard & Cotman, 2001). Due to the range of physiological 
and psychological mechanisms possible, different types of physical activity may be 
beneficial to men and women separately.  
Studies of men did show some benefit of physical activity (Cassilhas et al., 
2007; Shay & Roth, 1992; Abbott et al., 2004) and so it should not be considered a 
female-only intervention. However, it is clear that sex should be considered as a 
moderating factor rather than a covariate in this relationship. In addition, studies in this 
field should always compare the effect size between men and women to determine the 
true effect of the intervention in both groups.  
 
8.4. Moderators of effects of exercise on cognition: genetics 
The literature review suggested that baseline risk of AD, as indicated by genetic 
status, might mediate the relationship between physical activity and cognitive ability 
(Rovio et al., 2005; Podewils et al., 2005). However, as few studies had looked at this it 
was not clear whether the benefit was greatest in those who were ApoE4 positive or 
negative, or whether this was simply a chance finding from repeated analysis.  
Unfortunately this factor could not be investigated in this thesis. However, our 
randomised trial found a possible effect of education, with those with more years of 
education showing a faster cognitive improvement with physical activity (Chapter 7). As 
discussed previously, low education level is a risk factor for AD and is associated with 
lower cognitive scores, as seen in our observational study (Chapter 5). These 
observations may suggest that groups with additional risk factors for AD and cognitive 
decline may be less responsive to short-term treatment interventions. However, it is at 
present unclear whether they may benefit from longer term interventions. Any risk  
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factors for AD should therefore be considered as moderating factors and interactions 
between risk factors and intervention group should be analysed to determine their 
impact on the intervention’s effectiveness. 
 
8.5. Moderators of effects of exercise on cognition: mental activity 
Ultimately, the discrepancies in previous research may be due to physical 
activity alone not being sufficient to maintain cognitive health. Physical activity is known 
to promote the release of neural stem cells (Schaeffer, Novaes, da Silva, Skaf & 
Mendes-Neto, 2009) but there is little evidence that it promotes the survival of these 
cells. Instead, it may be that mental stimulation and learning is required to integrate 
these cells into existing networks; if they are not recruited into existing networks and 
used, they might not offer benefit to cognitive performance. This would also indicate 
that physical activity with a mental or social component will be more beneficial 
compared to physical activity that occurs alone. Indeed, completing both physical and 
mental activities has been shown to create a bigger improvement in memory 
performance compared to completing only one or neither activity over 8 weeks (Fabre, 
Masse-Biron, Chamari, Varray et al., 1999). Rather than being seen as two different 
interventions, physical and mental stimulation may be considered as complementary; 
the success of a physical activity intervention against cognitive decline may depend 
upon the mental stimulation that participants receive outside of the study, while 
research into the benefits of mental stimulation may be most successful if participants 
are also physically active. Therefore, physical activity may be important but not 
sufficient for prolonged cognitive health. Future research is investigating these aspects 
of activity in more depth at Loughborough University and elsewhere. 
 
8.6. Strengths and limitations of our work including future directions 
This thesis adds to the current knowledge regarding factors that may influence 
the relationship between physical activity and age-associated cognitive impairment and 
dementia. The development of these studies and their hypotheses has been evidence-
based, guided by the findings of our literature review. Taking this into consideration, 
this thesis supports future research into the possibilities of using physical activity as a 
lifestyle intervention for age-related cognitive decline with consideration of the 
aforementioned moderating variables. Physical activity should not be considered a 
possible cure for Alzheimer’s disease or a solution to extinguish the presence of 
dementia. Not only is there currently little evidence that physical activity influences 
memory in those already afflicted with cognitive impairment (Chapter 2), the theory 
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presented in this thesis proposes that the effects of physical activity work on an 
individual level, lessening risk rather than preventing completely. Thus, physical activity 
is likely to have its limitations (especially counteracting the impact of genetics) if used 
independently without consideration of other risk factors. Prevention should focus on 
additional lifestyle change including smoking cessation, dietary alterations etc. 
One hypothesis that may explain the discrepancies between the findings of 
previous studies is that, although we predict that physical activity in midlife before 
pathology begins is most important, it may not be possible to measure the true effect 
size using cognitive tasks in healthy adults. Although previous observations suggest 
that physical activity leads to short-term improvements in cognitive function (Chapter 
7), the ultimate effect of long-term physical activity on reduced risk of dementia may be 
maintenance of function. Giving the brain the resources to adapt to pathology does not 
mean that performance will increase when little pathology exists. Healthy, high 
functioning middle-aged adults may therefore not show much benefit of most physical 
activity until they reach older age.  
Although prospective studies are useful for assessing the risk of developing AD 
over a given timescale based on a set of baseline predictors, these studies take a long 
time to conduct and it is difficult to control for variables such as type of activity, intensity 
and mental stimulation. One way to get around this problem is to use MRI in healthy 
middle-aged adults during an RCT. This type of study would be able to assess 
hippocampal changes that may occur after long-term physical activity, even if these 
changes do not show up on tests of memory. Another option is to study MCI patients 
as part of an RCT. Although MCI patients may already show dementia pathology, their 
brains might still have the capacity to adapt and show improvements on cognitive tasks 
after an intervention. Although not all MCI patients go on to develop AD, a physical 
activity intervention may reduce the conversion rate to AD. A future study at 
Loughborough University investigates our resistance training programme in older 
institutionalised elderly to determine whether effects are larger in those with more 
cognitive and/or functional impairment. Studies including participants with dementia 
have shown large effect sizes if they included women in the sample (Hogervorst et al., 
2012) but methodological limitations (e.g. sample size) mean that replication of these 
findings is required.  
Another limitation of our observational work is the lack of objective physical and 
fitness assessment as well as morbidity. Studies at Loughborough University in 
combination with the Shanghai Mental Health Center and the Center for Aging Studies 
Indonesia have collected data on these variables and analyses are now underway. Our 
physical markers did not totally mediate effects in the observational study or RCT but 
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future studies will hopefully include biochemical assessments to investigate 
physiological mechanisms associated with change (including testosterone, collected as 
part of the RCT). Power of the study or the intervention itself may have been 
insufficient in terms of intensity or duration to reflect physiological mechanisms. We did 
not analyse psychological mediators of the effect other than mood which was not seen 
to affect cognitive change in this group without depression. Future work at 
Loughborough University will investigate mediating effects of empowerment and self-
efficacy.  
 
8.7. Conclusions 
 AD and other types of age related cognitive impairment is a growing problem 
around the world but there is evidence that physical activity is a potential lifestyle 
intervention that can help to lower an individual’s risk of developing symptoms of the 
disease. However, various factors appear to mediate or moderate these findings and it 
is thus important to consider their influence when evaluating the effectiveness of 
physical activity as an intervention against AD and other age-related cognitive 
impairments. If our findings can be replicated in larger controlled studies then they 
would support government-funded exercise programmes for the elderly and suggest 
that a simple home-based, affordable resistance exercise programme should be further 
developed to enable the full benefits and participation in those who find aerobic activity 
especially difficult (e.g. those with asthma, Chronic Obstructive Pulmonary Disease 
etc). 
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Abstract  
This review indicates that possible preventative activities and lifestyle changes to 
maintain cognitive health and prevent dementia in old age may be particularly 
important in middle-age. Cardiovascular disease risk factors are the same as those for 
dementia including its most common form, Alzheimer’s disease. Treating high blood 
pressure, high cholesterol and thyroid hormone deficiency, maintaining a normal weight 
having a healthy diet, and engaging in resistance or aerobic exercise can all possibly 
help sustain cognitive health. 
Long-term treatment with estrogenic compounds (> 1 year) does not seem to be 
indicated and may actually confer risks for dementia in older women over the age of 65 
years. The same may be the case for phytoestrogens. The possibility that folate can 
off-set some of the negative effects of (phyto)estrogens merits more research in this 
area. Whether there is an optimum age to engage with these types of life style 
behaviours is currently unclear and also requires additional research.  
 
1.  Introduction 
1.1 Focus and aims of this review of dementia and mid-life risk factors 
There is substantial variation in the rate at which we cognitively age, ranging from 
successful aging with sometimes even superior performance to that of some younger 
people, to that of the severe and devastating cognitive decline seen in dementia [1, 2]. 
Dementia is a pathological condition characterized by brain pathology (e.g. plaques 
and tangles in Alzheimer's disease (AD), vascular pathology in vascular dementia 
(VaD), Lewy Bodies in LBD etc.) and cognitive impairment impacting on activities of 
daily life [3, 2]. Of the dementias, Alzheimer’s disease (AD) is probably the most 
common form and is characterized by gradual progressive loss of memory functions, 
followed by more widespread cognitive dysfunction impacting on the activities of daily 
living, such as shopping, conducting bank transactions and engaging in social 
interactions [3]. The human and economic costs of dementia are high [4] and, with an 
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increasing aging population worldwide, there is a clear necessity of research into 
preventative measures.  
 
The age group identified to target potential interventions towards prevention of 
cognitive decline and dementia has important implications for governmental policy and 
the content of public health messages. Most of the studies reviewed in this article 
suggest that interventions in middle-age, before major irreversible damage to the brain 
is done, may be most successful to prevent dementia. When dementia becomes 
apparent, in most cases after the age of 65 years, the brain will usually show extensive 
pathology, such as neurofibrillary tangles and plaques in AD [5] and it may be too late 
to reverse this process. 
 
In this article we will review various potential preventative activities to be carried out in 
mid-life and beyond to prevent the development of dementia, such as reducing 
cardiovascular risk, engaging in physical exercise and other life style alterations, 
including the intake of caffeine, soy products and hormones. This is not a 
comprehensive review, but uses examples of studies to illustrate that some 
preventative interventions to maintain cognitive health may be most appropriate in 
middle-age rather than old age. Data on intellectual stimulation, the role of education, 
and other demographic and non-modifiable factors, such as genetics, are therefore not 
included in this review as for these data, to our knowledge, no specific focus on middle-
age interventions and risk is given in the literature. In addition, it would be impossible to 
generate any reasonable review including all these factors within the limitations of one 
article. The focus is therefore on cardiovascular disease, exercise and (phyto)hormone 
related interventions as illustrations of the importance of treating people in middle-age 
rather than beyond that when it may be too late for effective interventions. Where that 
is appropriate, given the scope of the journal, we will focus on particular treatments 
pertaining to women (e.g. in the hormone section).  
 
Several cohort studies have shown that AD prevalence is higher in women than it is in 
men (e.g. [6]). While this might be the case because women reach an older age than 
men and age is a risk factor for dementia [6], the age-specific incidence of AD is also 
higher in women than it is in men [7]. This suggests that perhaps gender-related 
lifestyle variables (e.g. fewer women used to smoke than men, differences in activity 
levels) and/or hormone differences could play a role in the development of AD. 
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1.2. Dementia, mild cognitive impairment and age-related cognitive decline  
It should be noted that the distinction between 'normal'8 age-related cognitive decline 
and dementia is often difficult to establish in observational research, even when that 
includes post-mortem confirmation of dementia pathology. Firstly, some elderly with 
brain pathology and lesions will show no cognitive impairment; and overlap of different 
dementia pathology within individuals is more common than finding pure forms (e.g. of 
VaD or AD) [8, 9, 10]). Specificity of the differential dementia diagnosis is thus low and 
data indicate the absence of a linear association between markers of dementia, such 
as brain pathology, and their symptomatic clinical counterparts. In addition, those with 
mild cognitive impairment (MCI  [11]), who are thought to be at risk for dementia, can 
show reversal to normal function, remain in that stage or show decline at follow-up [12] 
and are thus a heterogeneous group. Furthermore, 'dementia' assessment shows 
variation in that some studies have used the required multidisciplinary assessments [3], 
whereas others only used the non specific MMSE cut-offs or related screening tests to 
establish this. Lastly, risk factors for accelerated cognitive decline and dementia are 
often the same (e.g. an older age, low levels of education, high blood pressure, 
diabetes, smoking etc.). Therefore in this review, the distinction between cognitive 
decline (which may be within normal age-adjusted limits) and dementia is highlighted 
for individual studies, but it should be noted that this is a difficult area which warrants 
extensive review in its own right.  
 
2. Cardiovascular risk in mid-life and later life risk of dementia 
2.1. Associations of obesity, blood pressure and cholesterol with dementia risk 
Several large cohort studies which have followed their participants over a period of time 
have suggested that cardiovascular risk factors are also risk factors for AD and other 
types of dementia. These risk factors may be particularly important in mid-life, which is 
when preventative actions should probably take place. The Cardiovascular Risk 
Factors, Aging, and Dementia (CAIDE) study followed their 1449 participants from 
middle-age, beginning at around the mid 40th decade of their lives [13]. They found that 
being obese (body mass index or BMI over 30), having a high blood pressure and high 
total cholesterol in mid-life increased the risk for AD 18 years later by a factor 1.5 to 2; 
these factors individually thus doubled the risk of AD. When the 3 factors were 
presented together, the risk for AD was increased by a factor 6. This was independent 
of reported fat intake or physical activity, age and education. Similarly, in the Honolulu-
Asia Aging Study [14], increased blood pressure in mid-life, in the 5th decade of life, 
                                                 
8
  Indeed some elderly are better at some cognitive tests than some younger participants and ageing is characterized by a 
huge variation of performance within and between subjects and is further test dependent (i.e. not all cognitive tests show a decline 
with age) 
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was associated with an increased risk of AD after 25 years in non-treated individuals. 
In the Kaiser Permanente of Northern California Medical Group study elevated levels of 
cholesterol at 40-45 years of age were associated with a doubled risk of AD and VaD 
after a 30 year follow-up [15] and being overweight or obese in the early 40s was also 
associated with a 2 to 3 fold increase in risk of AD in later life [16]. The Swedish 
Adoption/Twin Study Aging study similarly suggested that higher BMI in mid-life , in the 
4th decade of life, was associated with lower global cognitive ability 25 years later and 
faster cognitive decline [17].  
 
However, these cardiovascular risk factors have been shown to change in the years 
before dementia becomes clinically apparent, with a subsequent lowering of BMI, 
cholesterol levels and blood pressure. This is possibly related to dysfunctional 
regulation at the central nervous system level, which could be a by-effect of the 
pathological changes in the brain seen in the different types of dementia. For instance, 
a meta-review of the literature [18] showed that high blood pressure in mid-life is 
associated with AD, whereas low blood pressure in older age is associated with AD.  
In cross-sectional case control studies, in those with established dementia, blood 
pressure is often found to be lower [19]. In addition, in a longitudinal study, high blood 
pressure was found to be a risk factor in mid-life for later life dementia [20], but was 
seen to drop in the years preceding the clinical onset of dementia. Similarly, being 
overweight or obese in later life (>60 years of age) has been associated with a 
decreased risk of dementia [21], despite mid-life obesity being associated with 
increased risk as mentioned previously.  
 
This has important implications for treatment. For instance, a recent Cochrane review 
[22] found no evidence that reducing cholesterol through the use of statins lowered risk 
of AD and dementia in individuals above the age of 70 years. It may be the case, 
however, that treatment when initiated at mid-life would have preventative actions. A 
similar pattern was found with anti-hypertensive medications, with a review suggesting 
that such medications did not lower risk of cognitive impairment or dementia in 
participants with a mean age of 72.8 years [23]. These data could reflect the need for 
early mid-life, rather than later life interventions, as in later life changes in regulatory 
mechanisms may have become impaired. 
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2.2. Life style behaviours, such as mid-life smoking and coffee drinking, and 
dementia risk 
There may be additional mid-life style changes that can affect the risk for both 
cardiovascular disease and dementia, such as smoking or drinking coffee. The CAIDE 
study mentioned earlier found that alcohol drinking, smoking, physical inactivity, a low-
moderate intake of polyunsaturated fats, and moderate-high intake of saturated fats at 
mid-life all increased the risk of dementia at an older age (>65 years), particularly 
among those who were genetically at risk for AD and carried the apoE epsilon4 allele 
[24]. Similarly, the Rotterdam Study found that smoking in mid-life (in the 5th decade of 
life) increased the risk for dementia and AD by around 50% at a follow-up 7 years later 
[25]. Smoking cessation in mid-life or before is advised as past smoking in mid-life did 
not confer significant risk.  
The relationship between alcohol use and dementia is complicated as dose dependent 
associations (similar to caffeine, see below) may exist (e.g. [26]) and hence is not 
further discussed in this review. We will, however, briefly review some of the literature 
on caffeine which could again suggest the importance of mid-life interventions for this 
factor. 
 
Coffee intake may be an important confound in the relationship described between 
cardiovascular risk factors and cognitive decline due to the impact that caffeine has on 
blood pressure. Despite many GPs advising their older patients to reduce caffeine 
intake because of its suspected effects on blood pressure, a recent review suggested 
that there may actually be protective effects of drinking more than 4 cups of coffee per 
day against hypertension (particularly in women), although this reduced risk of 
hypertension was also seen in coffee abstainers [27]. These data suggest optimal 
inverted U-curve related associations between caffeine intake and blood pressure 
which may also impact on cognitive function and dementia risk. Coffee drinking in the 
CAIDE cohort in mid-life was indeed shown to have protective effects on the later 
development of dementia. Here, however, the lowest risk for dementia (with a more 
than 50% risk reduction) was found in people who drank 3-5 cups of coffee per day in 
mid-life. The cross-sectional data from the Maastricht Aging Study suggested a similar 
coffee intake optimum related to optimal performance on a reading test, although there 
were linear associations for memory and psychomotor speed, and no interactions with 
age [28]. In this cohort, however, there was evidence of decreased caffeine 
consumption with age [28]. This may indicate that different optimal caffeine levels exist 
for each age group (e.g. elderly needing less caffeine for optimal effects on cognitive 
function). Some experimental studies indeed suggest that optimal levels may be 
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dependent upon age, habitual consumption, and cognitive test type. A treatment study 
comparing different age groups found that the positive effect of 250 mg of caffeine on 
short term memory tests was particularly significant in those of middle-age [29], but not 
in those who were older or younger and who were negatively affected by this dose. 
Middle-aged participants were found to habitually drink more caffeine and withdrawal 
effects may thus have explained some of these results. In another study, only including 
30 very healthy middle-aged and old subjects, 100 mg of caffeine was found to 
positively affect colour naming, but not to have any effects on focused attention or 
(short term) memory tests [30] and there was little difference between those of middle-
age and those who were elderly. These data suggest that the higher dosage effect in 
the middle-aged reported by [29] was not explained by withdrawal effects, as these 
would have normally been alleviated by a 100 mg intake in habitual caffeine 
consumers.  
 
We recently also found positive associations between daily coffee consumption and 
memory recall in a cross-sectional large Indonesian cohort of elderly (n=719), but here 
effects were mainly significant for those older than 68 years of age. How much caffeine 
was ingested by this age group in total and strength of the coffee was not investigated. 
However, these data indicate that effects of coffee are not only explained through its 
potential preventive actions in middle-age, as by the age of 68 years, brain pathology in 
some form or another will probably be present. Caffeine can act directly on 
neurotransmitters activity necessary for concentration and memory functions, which are 
affected with age and which could explain its potentially direct positive effects on 
cognition in the old [28]. In our Indonesian study (unpublished data, for description of 
the cohort and methods, see [31]), for global cognition, as measured with the Mini-
Mental Status Examination (MMSE), effects of daily caffeine consumption were also 
most apparent in women, perhaps reflecting gender differences in mechanisms 
underlying cognitive aging (see also sex hormones section).  
 
How these findings taken together translate to advice for the general public is at 
present not clear. However, it can be concluded from this brief review that lifestyle 
behaviours in mid-life may have important effects on cognitive functions in later life. 
Interventions to reduce dementia risk could thus focus on reduction of cardiovascular 
risk, such as cessation of smoking. Whether caffeine, statins and antihypertensive 
medications should be prescribed in mid-life to prevent later life dementia is currently 
not clear. Those who habitually consume coffee should probably continue to do so, but 
whether positive effects of caffeine consumption will be seen in older caffeine naive 
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subjects (and at which dose) remains to be seen.  However, it is also possible to 
reduce obesity and lower levels of LDL cholesterol, triglycerides and blood pressure 
through exercise. Associations of exercise and cognition are discussed in the next 
section. 
 
3. Does exercise protect against dementia and cognitive decline?   
3.1. Biological plausibility for the relationship between physical activity and 
cognitive health 
Physical activity has long been considered important to maintain health but also 
optimal cognitive function. As vascular risk factors are associated with an increased 
risk of dementia, the reduction of body fat mass (particularly around the abdomen) and 
blood pressure [13] through exercise may explain the indirect effects of exercise on 
improving cognitive function and reducing dementia risk. However, there is an 
increasing body of evidence to suggest that physical activity can also directly benefit 
cognitive health and protect the aging brain and several biological mechanisms 
pertaining to the direct protective effects of exercise have been suggested. Exercise 
may encourage prolonged neurogenesis, particularly in the hippocampus [32], an area 
affected in AD [33] and which is thought to crucial play a role in memory processes 
[34]. Other theories suggest that synthesis of neurotransmitters, such as 
norepinephrine, dopamine and serotonin, may be affected by physical activity thus 
assisting in the maintenance of cognitive function [35]. Exercise increases blood flow, 
improving oxygen and glucose deliverance to the body and the brain [36]. Exercise 
could thus reduce the risk of hypoxia, which can lead to the loss of brain tissue [37] and 
is thought to play an important role in age-related cognitive decline. These potential 
mechanisms are discussed in more detail elsewhere (e.g. [38, 39]) but they do give 
theoretical grounding to the premise that cognition can be directly influenced and 
maintained by engaging in physical activity, in middle-age possibly through its 
reduction of cardiovascular risk and in later life possibly through its effects on cerebral 
perfusion, neurogenesis and neurotransmitter synthesis as described above.  
 
3.2. Is exercise particularly important in middle-age and is there a gender 
difference ? 
The CAIDE study mentioned earlier indeed found that the risk of dementia and AD 21 
years later could be dramatically decreased by engaging in leisure time activity at least 
twice a week in mid-life (around the 5th decade of life),, with a risk reduction for 
dementia reported to be 52% and for AD 62% [40] . The Swedish Twin study also 
mentioned earlier showed a similar risk reduction with regular exercise in midlife for 
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dementia and AD after a 31 year follow-up of around 66% [41]. As stated earlier, [13] 
suggested that activity is especially important in middle-age for maintenance of long-
term cognitive health, which may be mediated by reducing blood cholesterol, weight 
and blood pressure.  
 
While exercise in middle-age may have the largest benefits to cognitive health, 
preservation of cognitive functioning in the elderly may also help to resist the onset of 
serious cognitive impairment. There is some evidence, however, that the benefit seen 
on cognition is more pronounced in older women than in older men. For instance, one 
observational study [42] found that risk of AD in women over 65 years of age was 
reduced by around 50% for those who had exercised intensely and frequently in the 
five years previous to assessment, compared to those who were less active. However, 
there was no such reduction for active over less-active men of the same age. Another 
relatively observational small study [43] found an 88% reduced risk of cognitive 
impairment after an average follow-up of 5 years in very old women (of an average age 
88.5 years) who exercised more than 4 hours per week compared to those who 
exercised less. In this study, less active women had 2 times the incidence rate of CI 
compared to less active men and almost 5 times the rate compared to active women 
These findings were independent of co-morbidities and presence of the apoE epsilon4 
allele. Another longitudinal Chinese study [44] found that women over the age of 70 
years had a 2.5 higher risk of cognitive impairment (CI) than men at a 3 year follow-up. 
However, women -but not men- had a doubled risk of CI when they had been 
sedentary at baseline versus those who had been active. This is not to say that men do 
not benefit from exercise, as significant risk reductions have also been seen in studies 
that have used men only [45]. However, the effect in women appears to perhaps be 
exaggerated compared to that in men and there are no studies to our knowledge that 
have found the reverse. The reason for this difference is unclear, but could reflect the 
social influence of the specific exercises that the two groups choose to participate in 
that has an additional beneficial effect on cognition. For example, women may 
participate more in activities that have a social support component, such as exercise 
classes or walking with friends, while men may participate in more activities alone, 
such as jogging and gym workouts (NB: it is interesting to note that this gender bias is 
not reported in intervention studies, where the type of activity and program is 
controlled). Indeed, regular social activity has been shown to reduce risk of dementia 
by 42% [46], so this factor may mediate the magnitude of the effect of engaging in 
exercise and cognitive improvement seen in women. Alternatively, exercise may affect 
sex steroid metabolism and synthesis which could affect cognitive function. This 
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association is described in more detail in section 4. An example of how an exercise 
intervention can affect and interact with various aspects of cognition and dementia risk 
is given in figure 1. 
 
3.2. Exercise treatment for dementia and cognitive impairment and the role of 
fitness 
Relatively few treatment studies have investigated the effects of exercise in individuals 
who had already been diagnosed with dementia or memory impairments. A recent 
study found modest cognitive improvements on cognitive tests after a 24-week aerobic 
and strength training programme among individuals who had memory impairments (but 
not dementia) [47]. However, other randomised controlled trials have found no benefit 
of physical activity on those afflicted with MCI or AD. For example, a one-year walking 
programme was found to have no benefit on memory or executive function in 
participants with MCI [48]. A six-month programme of activity compared to rest was 
also found to have no benefit on MMSE scores in AD patients [49]. It is therefore 
perhaps less likely that exercise can benefit cognitive ability once decline has begun. 
Thus, if uptake of physical activity is left until older age, when brain pathology is more 
likely to be established, there may be less benefit to cognitive health as compared to 
when it has been taken up during middle-age. However, more research needs to be 
done to establish the age at which exercise interventions are most successful at 
preventing the onset of dementia in the future. 
 
It should be noted, however, that the lack of change may be partly due to individuals 
with existing cognitive impairment not being able to benefit from feed-back and 
encouragement (perhaps because of their cognitive impairments) to participate in 
activity that is intense enough to cause physiological changes that may be necessary 
for a benefit to be seen. Previous studies suggest that the benefit of exercise does not 
necessarily increase with length of an exercise session or frequency per week [50]. 
Rather, an increase in objective fitness measures, such as VO2max or caloric 
expenditure, may be more important for predicting an improvement in cognitive 
functioning in mid-life (<60 years old) [51, 52], although some studies (e.g. [53, 54, 55]) 
reporting a positive effect of either aerobic or strength training exercises also showed a 
concomitant increase in objective fitness measures for the exercise groups in slightly 
older participants (around 65 years old). To improve VO2max or muscle strength, 
participants need to fully engage with the exercises to ensure that they are reaching a 
certain level of intensity. Many studies suffered from attrition and/or low compliance to 
exercise regimes and this may help to explain some of the variation seen in past 
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research when no benefits have been seen [50]. Some participants may thus have not 
engaged in exercise of a high enough intensity to actually improve their physical 
fitness. Importantly, the effects of exercise can also be seen very quickly, with some 
studies showing benefits to cognition after just 2 months [56]. This is long enough for 
an improvement in fitness to be detected, so this again supports the notion that relative 
fitness (as improvement from baseline) affects cognition, rather than the exercise 
activity itself. It may be that this problem of adherence is more so the case for studies 
with elderly rather then relatively younger participants but these data need to be further 
investigated. In addition, not all previous studies have reported objective measures of 
fitness, so there is not as yet a wealth of evidence to substantiate this point.  
 
3.3. Which cognitive domains are particularly affected by exercise interventions 
and are these relevant for dementia? 
Numerous cross-sectional studies and controlled treatment trials have shown that 
individuals who participate in exercise and sports show better performance on tests of 
memory, executive function and language compared to those who are mostly 
sedentary (for review see [50]). Following a recent review of the literature [50], 
however, it appears that the relationship between exercise and cognitive function is 
complex and may be affected by mediating variables such as type of exercise and 
cognitive domain being tested. It is at present not clear whether exercise affects 
specific cognitive domains or whether it has a more general effect on cognition, and/or 
whether there is an age-specific effect. While some past studies have found benefits on 
all tests administered, many have found that only some tests show a positive effect. 
This could be due to methodological issues, but it could also indicate that distinct 
processes in the brain are affected differently. It has been suggested previously that 
exercise benefits ability on complex tasks more than on simple tasks, as more 
automatic processes are less liable to decline with age [57]. Other reviews have also 
suggested that physical activity affects primarily executive control processes over more 
simple processes (e.g. [58, 59, 60])  For example, in a treatment study, complex 
reaction time on a dual task specifically - but not the simple tasks- improved in an older 
group attending a 10 week water aerobics class [58]. However, a recent review [50] 
revealed that the more simple memory tasks (e.g. Digit Span) were more consistently 
affected by exercise across most studies. As these tests are not affected by age or 
dementia processes in the early stages of the disease [61], it is not clear what the 
relevance of exercise for prevention of dementia is, as different functional areas may 
be affected by the intervention but not in dementia per se. This area of research is 
further complicated as some studies have used their own versions of tests or tests that 
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are not used in other research of this type, interfering with a direct comparison of 
results. A set of standardised tests should thus be agreed upon by the research 
community, such that future research can be compared to establish which cognitive 
domains may be most affected by exercise and whether this pertains to processes 
implicated in dementia. 
 
3.4. Which types of exercise are most beneficial to maintain cognitive health ? 
Overall, however, the literature suggests that some types of exercise may be more 
beneficial to cognitive function than others. Treatment studies including elderly 
participants that have investigated the effects of aerobic activity, such as running and 
cycling, seem to show the most consistent benefits on cognition [62, 58]. While there is 
no evidence to suggest that stretching exercises, such as Yoga, improve cognitive 
functioning [63], some studies have found that resistance exercise, which increases 
muscle strength, may also help to improve cognitive ability. For example, one study 
[64] found that an increase in resistance level over a 6 month training program 
predicted improved scores on the more complex Digit Span backwards test. In addition, 
[56] found that 8 weeks of resistance exercises lead to significant increases in 
immediate and delayed recall and recognition, as compared to no exercise. These 
findings may have relevance to dementia, in which these functions were to be 
particularly affected.  
 
As mentioned, improvements in fitness may be particularly important for benefits in 
cognition; therefore, any type of exercise that increase aerobic fitness or muscle 
strength may be effective. Some benefits of exercise were seen in the elderly, but once 
cognitive impairment has set in, it seems that this intervention is no longer effective. It 
may be that a lack of improvement in fitness in this group is related to this, and/or 
alternatively the advanced brain pathology, which can no longer be reversed. From 
observational data it thus seems that exercise interventions focused on reducing 
cardiovascular risk should be initiated in middle-age. One of the mediating mechanisms 
responsible for improvements could be concomitant changes in sex steroid levels 
affecting both cardiovascular risk and dementia, particularly in middle-age. However, 
sex steroids such as estrogens have also been found to negatively affect the brain cells 
once dementia-related pathology has set in [65]. This literature is described in more 
detail in the following section. 
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4. Sex hormones and cognitive function 
4.1. Biological plausibility of exercise and sex hormones affecting the brain 
Some but not all studies suggest that testosterone levels increase after exercise (e.g. 
[66]). After the menopause, women have much lower levels of sex steroids (such as 
testosterone and estrogens) than men and this has been mentioned as a possible 
reason for the observed increased risk for dementia (see introduction and paragraph 
4). There is abundant evidence from animal and cell culture studies to suggest that sex 
steroid hormones such as estrogens and testosterone can protect brain. Estrogen’s 
biological plausibility to protect the aging brain was once called ‘its strongest suit’ [67]. 
It is possible that some of the effect of exercise is thus mediated by the promotional 
activity from increased levels of sex steroid hormones, such as testosterone and 
estradiol, which can be converted from testosterone in the brain. In addition, studies 
[68] have suggested that the synergistic interaction between estrogens and physical 
exercise may further increase hippocampal Brain-Derived Neurotrophic Factors 
(BDNF) levels. BDNF is important for memory and neuronal survival. Possibly in line 
with this, one observational study [69] reported that women who took hormone therapy 
for less than 10 years had better cognitive function when they also had high fitness 
levels, than compared to those women with low fitness levels.  
 
4.2. Menopause and cognitive function 
Up to the turn of the century, estrogen research would be mentioned in review articles 
as one of the more promising lines of research leading to potentially successful AD 
treatment options and prevention. This was based on the basic sciences data, the 
observational studies showing a 30-45% lower risk of dementia in women who used 
estrogen therapy and several relatively small treatment trials (e.g. [70, 71]). 
 
Women would take estrogen replacement therapy to alleviate menopausal symptoms, 
such as hot flushes and night sweats, typically occurring in the 5th decade of their lives. 
Because of estrogens biological plausibility to protect the aging brain, one would 
expect that estrogen deprivation after the menopause (which occurs because of 
depletion of ova, which produce estrogens) would dramatically accelerate cognitive 
decline. However, studies investigating the natural menopausal transition actually show 
few cognitive changes [72, 73, 74, 75].  
 
4.3. Surgical menopause and cognitive function 
On the other hand, small prospective studies of women who underwent surgical 
menopause by removal of the ovaries (which leads to an abrupt drop in estrogen 
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levels) showed a rapid drop in cognitive functions sensitive to dementia [76, 77]. One 
large prospective study found that women who had undergone surgical menopause in 
mid-life had an almost doubled risk for dementia, particularly if they had not been 
treated with replacement estrogens up to the age of menopause (at approximately 50 
years of age). This study also showed that the younger the age at surgical menopause 
without hormone replacement treatment, the higher the risk for dementia [78]. In 
addition, meta-analyses of hormone treatment studies found the most significant 
positive effects of estrogens (and testosterone) on cognition in middle-aged recently 
surgically induced menopausal women and/or those who were highly symptomatic [70, 
71]. Effects were most apparent on those tests that are sensitive to dementia and age-
related cognitive decline, such as some memory functions, executive functions and 
attention tests  
 
4.4. Surgical menopause, symptoms, BMI and cognitive function 
A caveat here may be that women who undergo surgical menopause usually report a 
higher frequency (and distress) associated with menopausal symptoms, such as 
forgetfulness, hot flushes and night sweats. It is not clear whether the positive effect 
that estradiol (the most potent estrogen) seemed to have on cognitive functions was 
mediated by alleviation of menopausal symptoms in the earlier studies mentioned 
which showed a positive effect of treatment on cognition. By reducing flushes and 
sweats, estrogens could improve sleep, concentration and mood, each of which could 
have a subsequent positive indirect effect on memory and other cognitive functions 
[79]. Several studies controlling for symptom relief [80, 81] found that symptoms did not 
statistically mediate the association between treatment and improvement in cognition. 
However, as all of the studies which did report a positive effect of estradiol on cognition 
in recently menopausal women had included women who were highly symptomatic, 
whether symptom relief can be entirely eliminated as a mediating factor remains a 
question to be answered. One study with asymptomatic women [82] found no effects 
on cognition, but had also used tests which were earlier not found to be affected by 
estrogens and which are also not sensitive to dementia. Estrogens seem to exert sex 
sensitive specific tests (e.g. on verbal memory and verbal fluency), targeting those 
functions and brain areas, such as the hippocampus [83] and prefrontal brain areas 
[84] which are also affected in dementia and age-related cognitive decline. 
 
The role of BMI and fat mass in the mediation of symptoms and cognitive function is 
also not entirely elucidated. BMI is important as estradiol conversions occur in fatty 
tissue, so a high fat mass should thus theoretically protect against cognitive decline. 
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This was indeed found in one longitudinal study, where overweight women show less 
cognitive decline on specific tests (Fluency, verbal memory) after menopausal 
transition than normal weight women [74]. On the other hand, women with high body 
fat usually complain more of menopausal symptoms, possibly because they are more 
insulated and flushes and sweats thus have a higher impact [85]. Depending on the 
degree of obesity in the cohort, this could perhaps explain why many studies found no 
effects of menopausal transition on most cognitive tests, because a) studies controlling 
for BMI would eliminate the variance related to this factor as described above and 
would thus not be expected to find any associations between menopausal transition; 
and b) beneficial effects of estrogen conversion in fat tissue would probably be 
cancelled out by independent effects of a higher frequency of menopausal symptoms in 
women with a higher fat mass impacting on cognitive function. Importantly, earlier 
reviews show no consistent association between high estrogen levels and cognitive 
function or decline [86]. In fact, high estrogen levels in older women over the age of 65 
years were associated with an increased risk of AD [87]. In addition, the study that 
found less cognitive decline in women with a higher BMI had perhaps not controlled for 
all potential (subclinical) morbidity associated with weight loss and a low BMI, such as 
cancers or other wasting syndrome morbidity, which could impact on cognitive decline. 
Lastly, as discussed, in the longer term, a high BMI in mid-life independently predicts 
both cardiovascular disease and dementia (see section 2), so any small surplus 
positive effect of endogenous estrogens in women with high fat mass in mid-life would 
probably be cancelled out by these negative longer-term effects. Related to this, 
estrogens have been hypothesized to exert their protective effects via their positive 
effects on the cardiovascular system [88] or via protective actions on insulin resistance 
and the development of diabetes mellitus which may detrimentally affect cognitive 
function. However, again the current hypothesis is that for estrogen treatment to have 
beneficial effects on, for instance, cardiovascular disease, this should be initiated in 
middle-age [89, 90].  
 
4.5. Long term treatment with estrogens and cognitive function 
It has now also become clear that longer term estrogen treatment (e.g. > 1 year) has 
no beneficial effects on cognition and that it should not be prescribed for long-term 
maintenance of cognitive function and prevention of dementia. In fact, the initial 
benefits seen after 2-3 months on cognition may start to reverse after one year of 
treatment [70]. For instance, in one observational study (where incidentally undergoing 
surgical menopause was not associated with worse cognitive function in older women 
[91]), those women with a mean age of 74 years who had undergone surgical 
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menopause many years before, but were still using hormone treatment at the time of 
testing, actually had worse cognitive function than those who did not take hormones. 
This was also found in another study which had tested women who had undergone 
surgical menopause 10 years before and who, when still taking hormones at the time of 
testing, had worse cognition then those who did not take estradiol [92]. The study 
which showed that hormone treatment could protect surgically menopausal women 
against dementia [78] had only investigated effects of treatment up to the natural age of 
menopause and not beyond. In another observational study [73], when hormone 
treatment was given before the menopause, when some aspects of memory were 
affected, it was shown to improve cognition. However, when hormone treatment was 
initiated after menopause, cognitive decline accelerated. Similarly in the before 
mentioned study [69] investigating fitness and hormone treatment, when hormone 
treatment was given for longer than 10 years, brain scans showed more gray matter 
decline and a concomitant faster decline in cognitive function than in women who did 
not receive such long term treatment. However, in women who were physically fit, this 
decline was less pronounced, again suggesting an interaction between exercise and 
hormone treatment. 
 
4.6. Age and estrogen treatment 
Negative effects of estrogens may thus be more likely to occur in women who are far 
beyond the natural age of menopause (e.g. after age 65 years) and who may already 
show pathological changes in the brain. Several large well controlled trials indicated 
that estrogens treatment do not improve dementia symptoms in women with AD for 
more than 2-3 months [93, 94, 95] and may even worsen their dementia severity [96]. 
The Women’s Health Initiative Memory Study (WHIMS) also showed a doubled risk for 
AD in older women (> 65 years of age) who had been allocated to conjugated equine 
estrogens treatment, particularly when this was combined with medroxy progesterone 
acetate [97, 98]. 
 
The current hypothesis among many scientists in this particular field is that, similar to 
its indications for cardiovascular disease interventions [89], hormone treatment – when 
given for menopausal symptoms- should be initiated close to the age of menopause, 
but probably also stopped before the sixth decade. This regime would also reduce the 
increased breast cancer risk, which has been shown to occur with hormone treatment, 
particularly after longer duration treatment (e.g. 5 years) in women over the age of 60 
years [99]. 
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Testosterone has been found to have similar effects as estrogens in recently 
menopausal women (e.g. [76]) and can be converted to estrogens in the brain. 
However, similar to estrogens, testosterone does not seem to lower risks for 
cardiovascular disease and breast cancer in women over 65 years of age [87] and 
more trials would need to be done to further elucidate its potential role as an alternative 
for estrogens.  
 
4.7. Other hormones 
Older women after the menopause also have a higher risk of thyroid disease than men 
[100]. Hypofunction of the thyroid is a known risk factor for dementia [101]. We [100] 
found that half of healthy elderly who had thyroid disease (as established by using their 
serum thyroid hormones and comparing these against established laboratory cut-offs 
for thyroid disease) to be unaware of their condition. Even in these preselected 
relatively healthy elderly cohort, hypofunction of the thyroid was shown to significantly 
affect their cognitive function. However, in those without thyroid disease, having high-
normal thyroid hormone and/or lower thyroid stimulating hormone (TSH, as seen in 
subclinical hyperthyroidism) was also found to be associated with a higher risk of AD 
[102] and a more rapid cognitive decline in healthy elderly [100]. This may indicate that 
thyroid hormone treatment, when given for hypofunction of the thyroid, needs to be 
carefully monitored. In addition, thyroid hormone and estrogen both increase sex-
binding globulin, thereby decreasing free and bioavailable sex steroid hormones [103] 
Interactions of sex steroids further exist with Growth Hormone (GH) and Insulin-like 
Growth Factor (IGF-1) which both decline with age [103] and which can also positively 
affect the brain [104]. However, GH treatment, which like thyroid hormone treatment is 
sometimes prescribed by anti-aging practitioners for those without related morbidity, is 
not without risk (e.g. affecting insulin resistance [104]) and should be carefully 
considered. 
 
5. Micronutrients and dementia risk: a focus on phytoestrogens and folate 
5.1. Is soy the solution? 
Because of the negative publicity surrounding the WHIMS, many women stopped 
taking estrogens for menopausal complaints and some switched to what they 
perceived as more natural alternatives for menopausal symptoms and to maintain 
health, such as phytoestrogens. Phytoestrogens are plant hormones with estrogenic 
activity; they can act like estrogens, binding to the estrogen receptor with about half the 
activity of estradiol [105]. Recent years have seen soy, which contains high levels of 
phytoestrogens, to be promoted as a superfood in protecting against cardiovascular 
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disease, cancer, dementia etc. Indeed, in countries such as Japan, where consumption 
of soy products is high, AD risk is lower [106]. While several treatment studies have 
found positive short term effects on cognition in middle-aged women, this was not the 
case for older women [95], although a recent treatment study did show a positive effect 
of phytoestrogen treatment in both older men and women (> age 62 years) who had 
been treated up to 6 months. However, placebo was also shown to have an advantage 
on some of the executive function tests [95, 107]. In addition, several observational 
studies reported, also similar to estrogen treatment (see above), an increased risk for 
dementia and dementia markers with high habitual tofu intake. In an Indonesian 
sample of elderly men and women we found [31], consistent with findings of the 
Honolulu Asia Aging Study (HAAS) [108] and the Kame project [109], that high tofu 
consumption in older participants (> 68 years of age) was associated with worse 
cognitive function and a higher risk of possible dementia. Tempe, a fermented soy 
bean product, in these analyses was found to off-set the negative association of tofu, 
but it had no significant associations with cognition by itself. Genistein (the most potent 
phytoestrogen in soy) had an optimal level relationship with memory performance, 
particularly in women younger than 68 years of age and in older men. In line with the 
data on tofu, in older participants there was a trend negative association for genistein 
with global cognitive function, as measured with the MMSE. In analyses stratified for 
sex, associations were strongest in women, but there were fewer men in this cohort 
and power issues could have potentially explained these results [110]. The HAAS 
similarly found that elderly (>71 years of age) men and their wives who had reported 
consuming tofu more than twice a week in mid-life had a higher risk of dementia, more 
brain atrophy and lower cognitive function than those who consumed less tofu. The 
Kame project also found negative associations of high tofu consumption (more than 3 
times a week) with cognitive decline over a 2 year period in Japanese American elderly 
over age 65 years. In stratified analyses this remained significant only for women who 
were hormone replacement users, but not for those who were not hormone users, 
elderly men or those who consumed moderate (twice a week) to low amounts of tofu. 
These data again suggest that there may be optimal levels of phytoestrogens, perhaps 
interacting with age, sex and estrogen levels. On the other hand, the Study of Women’s 
Health Across the Nation (SWAN) data did not find optimal calculated (from Food 
Frequency Questionnaires, so not measured) levels of genistein and daidizein in their 
middle-aged women  [111]. The SWAN analyses included 195 Japanese and 185 
Chinese women between 42 to 52 years of age and found no association between 
calculated phytoestrogen intake and cognitive function (memory, processing speed and 
executive function). The authors surmised that the effects might only be present in 
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women who are in low-estrogen (post-menopausal) state, although that contradicts 
with the other observational studies mentioned above. The authors used tertiles to 
investigate optimal genistein and daidizein levels, rather than report weekly soy intake 
as was done in the other studies so results are difficult to compare. The cognitive tests 
used in this study were also not affected by soy treatments in our studies and perhaps 
more difficult memory tests (word list free recall) would have shown significant 
differences. Other cohorts including elderly women with Western diets with general low 
soy intakes [112] have generally not found any associations with cognition, possibly 
again indicating optimal levels, which are perhaps also age-dependent.  
 
A novel findings in our Indonesian study was the different associations found for 
different types of soy processed foods. Tofu is processed soy curd, whereas tempe is 
made of the whole soy bean which undergoes fermentation. Tempe has higher 
genistein levels than tofu [113] which would not explain why tempe might off-set 
negative effects of tofu, unless the curvilinear term would follow a U curve, instead of 
the inverted U curve, which gave a better fit for the data. However fermentation using 
molds increases folate levels in tempe [114]. Our earlier work in Oxford indicated that 
a) women with dementia had higher levels of endogenous estrogens than controls 
when sensitive assays were used and b) that women who had high endogenous 
estrogens, but who also had high levels of serum folate, did not perform below the 25 
points performance cut-off score of the MMSE [115].  Future studies need to 
investigate the interaction between serum (phyto)estrogens and folate levels in 
determining dementia risk. 
5.2. Folate and other dietary components                                                                                               
Folate has protective effects on brain function and been associated with lower levels of 
homocysteine, an important modifiable risk factor for cardiovascular disease, dementia 
and AD [116]. A randomised controlled study of participants aged 50-70 years without 
dementia but with raised plasma total homocysteine who were treated with 800 mug 
daily oral folic acid (the supplement form of folate) for 3 years showed improved 
cognitive function on those tests sensitive to aging and dementia compared to those 
taking placebo [117]. However, folic acid has again not been shown to be effective in 
those who already had developed dementia or who had significant cognitive 
impairment [118] possibly again indicating the importance of early interventions, before 
major damage to the brain has occurred.   
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Lastly, other supplements such as anti-oxidant vitamins (E, C, A) may protect against 
cognitive decline, but their use is controversial [119] and the current discussion seems 
to have shifted towards the use of whole foods (e.g. adherence to a Mediterranean diet 
is associated with lower MMSE decline [120] and lower AD risk [121] rather than 
prescribing supplements. Reviews also suggest that lower cognitive decline is 
associated with low intake of foods such as vegetables, fruits and cereals (e.g. [122]). 
Whether these types of diet should be initiated in mid-life or before that for maximum 
benefit remains to be further investigated. 
 
6. Conclusion 
This review has discussed several possible options for maintaining cognitive health in 
women. The interventions discussed should probably take place in mid-life (or even 
before) for maximum benefits, before extensive brain pathology has occurred. This 
pathology, only when it has spread substantially much later in life, can lead to the 
appearance of clinical dementia symptoms, which at present are untreatable. Risk 
factors for cardiovascular disease, such as obesity, high total cholesterol and high 
blood pressure increase dementia risk and the risk for accelerated cognitive decline. 
This risk should thus probably be reduced in mid-life, as these factors have been seen 
to change in the years before dementia onset, probably related to the pathological 
changes in the brain, leading to loss of body mass and a lowering of blood pressure.  
 
Aerobic and resistance exercise will help reduce these risk factors. Whether these 
benefit cognition once dementia has become apparent, however, is unclear. So far 
studies suggest that low level exercise, such as yoga or stretching, is perhaps of less 
value in preventing dementia and improving cognitive function. Improvement in 
physical function (e.g. strength, VO2max) is needed for cognitive benefits, but 
adherence to regimes was often found to be low in treatment studies. It may be that 
some of the benefits of exercise are through its effect on sex steroid metabolism and 
synthesis. Sex hormone treatment may interact with fitness levels, but on the basis of 
the current data is not indicated to maintain longer term cognitive health in women. 
There is in all likelihood an increased risk of cognitive impairment with longer duration 
hormone treatment, particularly in women over the age of 65 years. In addition, some 
studies have shown a reversal of its positive effects already after one year of treatment 
in both middle-aged and old women, so at present this avenue seems of limited value. 
Alternative products, such as soy containing phytoestrogens, should also be regarded 
with caution in the elderly, although an intake of less than twice a week should not 
pose any risks based on current data from treatment and observational studies. 
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Whether estrogenic compounds positively interact with folate remains to be further 
investigated. More research is now focused on whole foods, rather than supplements 
to maintain health.  
 
Future perspectives 
This review has indicated that relatively cheap possible preventative activities to 
maintain cognitive health may exist and these seem to have a particular value for 
women. Visiting the GP to treat high blood pressure and assessment of cholesterol and 
thyroid hormone levels, and maintaining healthy diets, cessation of smoking and 
exercise can possibly help sustain successful cognitive aging and maybe delay 
dementia onset, particularly when this is done at middle-age. 
Well controlled large studies are currently taking place to investigate optimal exercise 
regimes to maintain cognitive health, taking into account limitations (e.g. frailty, risk of 
fractures etc) associated with aging. Long term treatment with estrogenic compounds 
does not seem to be indicated at this stage and may actually confer risks, unless 
alternative regimes (e.g. intermittent treatments) offer safe and effective alternatives. 
Limited data suggest that phytoestrogens are not such an alternative. However, the 
possibility that folate can off-set some of the negative effects of (phyto)estrogens merits 
more research in this area.  
Research has moved from supplements to whole foods containing folate and anti-
oxidants within a varied diet including plenty of vegetables, fruits and polyunsaturated 
fats to maintain both physical and cognitive health. Whether optimal intakes of caffeine 
and alcohol exist to help prevent dementia is unclear, how these interact with 
cardiovascular risk and whether there is an optimum age to engage with these types of 
life style behaviours is currently unclear and also requires additional research.  Future 
research should focus on combinations of life style interventions, such as diet, exercise 
etc and the off-setting of particular behaviours, the optimum levels of interventions and 
the optimal age of initiation of interventions. 
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Appendix B 
Validation Study Participant Questionnaire 
 
Questionnaire 
         
Participant Number……………………………. 
Date …………………………………………… 
 
F2.1 Respondent Characteristics and Demographics 
 
F2.1a What was your age at your last birthday? 
Age ………. years old  
Not sure  98 
No answer  99 
 
F2.1b1 Are you: 
Man  1 
Woman  2 
No answer  99 
 
F2.1b2 What is your marital status: 
Married  1 
Unmarried living 
together 
 2 
Widow  3 
Divorced/separated  4 
Single  5 
No answer  99 
 
F2.1c What is the highest education level that you have obtained? 
No formal education  1 
Elementary or primary school (unfinished)  2 
Elementary or primary school (finished)  3 
Secondary school (unfinished)  4 
Secondary school (finished)  5 
College (finished)  6 
Academy/University at least one year finished 
or more 
Other (please specify)………… 
 7 
No answer  99 
 
F What is your profession? 
Higher – manager, admin or professional  6 
Intermediate – manager, admin or professional  5 
Supervisory or clerical, junior manager, admin or 
professional 
 4 
Skilled manual  3 
Semi or unskilled manual  2 
State pensioner, not working  1 
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F2.1e What is your ethnic origin? 
 F2.1e1 
My father was/is 
F2.1e2 
My mother was/is 
White British  1  1 
South Asian (Indian/British 
Indian/Pakistani, 
Bangladeshi 
 2  2 
Caribbean/British 
Caribbean 
 3  3 
White other (European, 
USA etc) 
 4  4 
East Asian 
(Chinese/Japanese) 
 5  5 
Other, please specify  97  97 
No answer  99  99 
 
 
F What is your religion? …………………………………………………… 
 
F2.1h With whom do you live at this moment? 
Alone  1 
Wife/husband/partner  2 
Wife/husband/partner and 
child 
 3 
Child (without wife/husband)  4 
Relatives  5 
Institution  6 
Other……………….  97 
No answer  99 
 
F2.1i The house you live in: 
Do you own it?  1 
Do you rent it?  2 
Do you live in other people’s house 
(family etc)? 
 3 
Do you live in a social institution/care 
home? 
 4 
Other………….  97 
No answer  99 
 
F Do you have any children? 
No  0 
Yes  1 
No answer  99 
If yes, how many? ………………..  
 
 
Health Survey 
 
F7.1 In general, how would you say your health is? 
Excellent  5 
Very good  4 
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Good  3 
Fair  2 
Poor  1 
F What is your: 
Height …………ft…………..inches 
Weight …………st…………..ibs 
 
(a) Do you smoke? (circle)     Yes      No  
(b) If yes, how many a day? 
Cigarettes                      40 or more            20-39             10-19            1-9 
Cigars or pipes               5 or more inhaled              Less than 5 or non-inhaled  
(c) Do you exercise regularly? (circle)       Yes          No 
(d) How many days per week do you spend at least 20 minutes in moderate to 
strenuous exercise? 
                0     1     2     3    4     5     6     7     days per week 
(e) Can you walk 4 miles briskly without fatigue? (circle)            Yes           No 
(f) Units of alcohol consumed per week…………………… 
      (1= glass beer, 1= glass wine, 1= unit of spirit) 
(g) Number of cups tea/coffee consumed per week ………………… 
 
F2.2 Health 
At present, do you have any health problems for which you are: Yes (1) No (0) 
a Using prescribed medication?   
b Attending your doctor?   
c On a hospital waiting list?   
In the past two years, have you had any illness which required 
you to: 
  
d Consult your doctor/GP?   
e Attend a hospital outpatient department?   
f Be admitted to hospital?   
 
 
If ‘no’ to above questions, please skip next section (F2.3) and continue with F2.4 
Family history 
 
F2.3 Medical examination and history based on Cambridge Mental Disorders of the 
Elderly Examination (Roth, 1984) 
Have you been told by a doctor that you have (had): Yes (1) No (0) 
1 High blood pressure   
2 A heart attack or other heart problem   
3,4 Stroke or TIA   
5a Diabetes   
5b If diabetes, do you take medication (insulin)?   
6a Dementia or other neurological problem   
6b If yes, what…………   
7 Problems with alcohol or drugs   
8 Asthma or other lung disease   
9 Thrombosis or other blood disorder   
10 Digestive/gastrointestinal disorder   
11 Epilepsy   
12 Intolerance to goods containing soya   
13 Cancer or benign growths   
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14 Vision or hearing problems   
  Yes (1) No (0) 
15 Kidney or liver problems   
16 Allergies………………………   
17a Do you use hormone therapy?   
17b If yes, which of the following:   
 Estrogens   
 Thyroid   
 Testosterone   
 Soy/phytoestrogens   
 Viagra   
 Are you using medication prescribed by a doctor:   
18a To be calm, to be able to sleep   
18b To not be depressed   
 
F2.4 Family history 
Has any member of your family had any of the above diseases, please state which 
disease and age at onset: 
Whom: 
(a) Father……………………………………………………………………. 
(b) Mother…………………………………………………………………… 
(c) Sibling……………………………………………………………………. 
 
F.2.5 Do you eat? 
 
Times per day 
(0-4) 
Days per week 
(1-7) 
Days per month 
(1-31) 
(a) White rice    
(b) Brown rice    
(c) Fruit    
(d) Orange/red 
veg 
   
(e) Green veg    
(f) Fish    
(g) Tofu  
(tofu products) 
   
(h) Tempe    
      (g) Tahoe    
(i) Soy milk  
(soy products) 
   
(j) Tumeric    
(k) Miso soup    
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Appendix C 
Geriatric Depression Scale 
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Appendix D 
Observational Study Participant Questionnaire 
 
Questionnaire 
 
SEMAR 
2006 
I. Local Orientation 
1. District / City : 
Jakarta 1 
Sumedang 2 
Yogyakarta 3 
How long have you lived here…yrs  Where did you live before rural/urban   
2. Subdistrict : 
 
3. Village  
RT : _______   RW : _______ 
How long have you lived here………………… Where did you live 
before………. 
4. Location 
Institution 1 
Community 2 
Other place, please specify ………………………. 3 
5. Interviewer 
 
6. Interviewer No.: 
  
7. Respondent Name 
 
8. Respondent No. : 
   
II. Interviewer Visit and Recapitulation  
9. Interview date : date _ _ / month _ _ / 2006   
10. Interview time: 
Start     hour _____ minute ____ 
Finish   hour _____ minute____ 
11. Carer present: 
Spouse 1 
Child 2 
Relative 3 
Caregiver 4 
Other, please specify ………………………. 5 
12. Visit result : 
Rejection     1  Reason for rejection: 
Completion 2 No reason 1 
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Incomplete 3 Weak condition 2 
Delayed 4 Serious illness  3 
Respondent not present 5 Other 4 
Other, please specify 6 Please specify……………. 5 
………………………………  …………………………..  
13. Completion and consistency of answers to this questionnaire is inspected by: 
Name Status Examination Date Signature 
 Interviewer I   
 Interviewer II   
 Supervisor    
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 F1 
 
Informed Consent 
 
Consent from Study Respondent of the influence of phytoestrogen levels on 
memory in men and women in Indonesia 
 
The purpose and details of this study have been explained to me.  I understand 
that this study is designed to further scientific knowledge and that all procedures 
have been approved by the Faculty of Medicine University of Indonesia Ethical 
Advisory Committee. 
 
I have read and understood the information sheet and this consent form. 
 
I have had an opportunity to ask questions about my participation. 
 
I understand that I am under no obligation to take part in the study. 
 
I understand that I have the right to withdraw from this study at any stage for 
any reason, and that I will not be required to explain my reasons for 
withdrawing. 
 
I agree that a saliva sample will be taken and used to assess the level of plant 
hormones in my body. 
 
I understand that all the information I provide will be treated in strict confidence. 
 
I am happy to provide a saliva sample for testing of plant hormones. 
 
I agree to participate in this study. 
 
 
Your Name   : ………………………………………………… 
 
Your Signature    : ………………………………………………… 
 
Caregiver Name  : ………………………………………………… 
 
Caregiver Signature  : …………………………………………............ 
 
Name of Investigator : ………………………………………………… 
 
Signature of Investigator : ………………………………………………… 
 
Date    : ____ / _____________ / 2006 
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 F2 
F2.1 Respondent Characteristics 
 
F2.1a How old are you (age from your last birthday) ?   
Age (if any doubt about the answer/doesn’t remember/doestn’t know, check 
respondent’s ID card) 
…. Yrs old 
Doesn’t know/ doesn’t remember 98 
No answer 99 
F2.1b Sex: 
Male 1 
Female 2 
F2.1c What was the highest education level you graduated from? 
No formal education 1 
Elementary school (unfinished) 2 
Elementary school/Hollands Inlandische School/equivalent 3 
Primary school/ Middelbaar Uitgebreid Lagere Onderwijs/domestic girls 
school/equivalent 
4 
High school/ Hoge Burgerlijke School/equivalent 5 
Academy/ University 6 
Other, please specify……….. 97 
No answer 99 
F2.1d What’s your profession before retire? 
Not working 1 
Civil servant (teacher/lecturer/government employee) 2 
Entrepreneur (businessman/trader) 3 
Employee in private company  4 
Army/police 5 
Doctor/Lawyer 6 
Farmer 7 
Fisherman 8 
Labour/ no permanent job 9 
Other, please specify ............... 97 
F2.1e What is your parents race? 
 F2.1e1 Father F2.1e2 Mother 
Javanese 1 1 
Sundanese 2 2 
Malayan 3 3 
Batak 4 4 
Minang 5 5 
Other, please specify 97 ……………………… 97 ……………………… 
 
F2.1f Your religion/faith: 
Islam 1 
Protestant 2 
Catholic 3 
Hinduism 4 
Buddha 5 
Confucianism 6 
Other, …………..…….. 97 
No answer 99 
F2.1g Living area: 
Urban 1 
Rural 2 
F2.1h With whom do you live at this moment? 
Alone 1 
Wife/husband 2 
Wife/husband and child 3 
Child (without wife/husband) 4 
Relatives 5 
Institution 6 
Others............................. 97 
F2.1i House ownership : 
Own house 1 
Renting 2 
Live in other’s house 3 
Social institution 4 
Others.................................. 97 
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F2.1j Children : 
How many children do you have (including the one(s) who passed 
away) 
......... 
persons 
How many children are still alive ......... 
persons 
How many children live nearby (easy to visit) ......... 
persons 
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 F2 
 
HEALTH STATUS 
 
Important for respondent is they are healthy and never experienced serious illness in the past. 
This is to confirm (i) their own health, and (ii) to avoid possibility of health problems as 
confounding factor in study result. Complete this questionnaire fully and clearly to assert the 
ability to become a participant. Explain clearly and comprehensively whether you have health 
problems, no serious problems, or in good maintenance (controlled). 
 
F2.2 Health Complaint  
  Participant Caregiver 
At present, do you have any health problem for which you are: Yes 
(1) 
No 
( 2) 
Yes 
(1) 
No 
( 2) 
a On medication, prescribed or otherwise (traditional medicine: ask 
to see boxes etc., write down names of drugs and number) 
1 2 1 2 
b Attending your doctor, health provider or traditional healer (and 
for what) 
1 2 1 2 
In the past two years, have you had any illness which require you 
to: 
    
c Consult your doctor health provider or traditional healer 
1 
2 1 2 
d Attend a hospital outpatient department or health centre 1 2 1 2 
E Be admitted to hospital 1 2 1 2 
 
F2.3 Tobacco, Alcohol Consumption and Other Risk Factor for Dementia 
F2.3a Have you EVER smoke? 
Yes 1 
No (continue to F2.3e) 2 
F2.3b Are you a REGULAR smoker ? 
Yes 1 
No (continue to F2.3e) 2 
F2.3c How much do you smoke? (choose amount of cigarettes and one time frame which respondent 
remember easily) 
 Yes Amount 
Amount per day 1 ...... cigarettes 
Amount per week 1 ...... cigarettes 
Amount per month 1 ...... cigarettes 
F2.3d Cigarettes type: 
Kretek 1 
White 2 
 
F2.3e Have you EVER drink alcoholic beverages? 
Yes 1 
No (continue to F2.3h) 2 
 
F2.3f Do you ROUTINELY/ALL THE TIME/OFTEN drink alcoholic beverages? 
Yes 1 
No (continue to F2.3h) 2 
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F2.3g How much alcohol consumptions you have each week? 
1 glass of beer 1 
1 glass of wine 2 
1 unit of spirits 3 
Other, please specify .................................. 97 
F2.3h Do you drink tea? 
GREEN TEA  
Yes 1 
No (continue to F2.3j) 2 
 
BLACK TEA 
 
Yes  
No (continue to F2.3j)  
 
F2.3i How much tea you drink? (conform the answer to glass amount/time frame which respondent 
remember easily) 
 Yes Amount 
Amount per day 1 ...... glass 
Amount per week 1 ...... glass 
Amount per month 1 ...... glass 
F2.3j Do you drink coffee? 
Yes 1 
No (continue to F2.4) 2 
F2.3k How much coffee you drink? (conform respondent’s answer to glass amount/time frame which 
respondent remember easily) 
 Yes Amount 
Amount per day 1 ...... glass 
Amount per week 1 ...... glass 
Amount per month 1 ...... glass 
F2.4 Are you on hormone therapy in the past 6 months? (e.g. use of hormone (for men), viagra, 
plants) circle 
Yes 1 
No 2 
F2.5 Compare to others: 
 More The same Less 
a. Do you feel happy? 1 2 3 
b. Do you feel secure? 1 2 3 
c. Do you in stress or anxious? 1 2 3 
 
F2.6 Food Consumption 
How much do you consume the following 
food item 
Do you eat it daily? If yes, ask how 
many times a day and continue to 
the next food item 
Days in a 
week 
Days in a 
month 
  Yes, how many times a 
day 
No 
  
a Rice 1 ......... 2   
b Fruit/juice 1 ......... 2   
c Orange/red colored vegetables 1 ......... 2   
d Green vegetables 1 ......... 2   
e Fish 1 ......... 2   
f Tempe  1 ......... 2   
g Tahu/Tofu 1 ......... 2   
h Soy milk, other soy product 1 ......... 2   
i Tumeric as jamu (herbal medicine) 1 ......... 2   
j Tumeric as spices 1 ......... 2   
k Tumeric as raw vegetables 1 ......... 2   
l White meat (chicken) 1  2   
m Red meat (beef/lamb/veal) 1  2   
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F2.7 Physical, Mental and Social Activities 
F2.7a Your position during activities 
Position 
Never 
(1) 
Seldom 
(2) 
Sometimes 
(3) 
Often 
(4) 
Very 
often 
(5) 
a Sit 1 2 3 4 5 
b Stand 1 2 3 4 5 
c Walk 1 2 3 4 5 
d Lift heavy things 1 2 3 4 5 
E Feel tired afterwards 1 2 3 4 5 
F Sweat afterwards 1 2 3 4 5 
 
 
                                                        F2  
 
 
F2.7b Compared to people of you own age, how do you rate your physical activity: 
Lighter 1 
As heavy  2 
Heavier 3 
 
F2.7c Do you play sport regularly: 
Yes  1 
No continue to F2.8 2 
F2.7d What kind of sport: 
Kind of sport played Frequency (how often) 
Time frame 
Day Week Month 
1. ...... times 1 2 3 
2. ...... times 1 2 3 
3. ...... times 1 2 3 
4. ...... times 1 2 3 
5. ...... times 1 2 3 
 
F2.8 Mental/Social Activities 
F2.8a Do you engaged in the following activities : 
Activities: 
Never 
(1) 
Seldom 
(2) 
Sometime
s 
(3) 
Often 
(4) 
Very 
often 
(5) 
a Read 1 2 3 4 5 
b Write letters 1 2 3 4 5 
c Watch TV 1 2 3 4 5 
d Talk to friends, neighbours or family 1 2 3 4 5 
e Go to gatherings (social) 1 2 3 4 5 
f Pray together 1 2 3 4 5 
g Have dinners with friends/family 1 2 3 4 5 
h 
Go to theatre /film (ketoprak, ludruk, reog, 
topeng, lenong) 
1 2 3 4 5 
i 
Go to musical gathering 
(jaipongan,gending) 
1 2 3 4 5 
j Involved in community social activities 1 2 3 4 5 
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F2.13 INFORMATION FROM CAREGIVER 
THE FOLLOWING QUESTIONS ABOUT THE ELDERLY IN LAST COUPLE OF YEARS IS DIRECTED 
ONLY TO CAREGIVER  
 
F2.13a Does the elderly you care for (the one concerned with this questionnaire) have memory 
problems : 
Yes 1 
If yes which? explain  
  
No, please continue to F2.13 2 
F2.13b If yes, does it happen consistently 
Yes 1 
No 2 
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Appendix E 
Activities of Daily Living Questionnaire 
No Function Points Criteria 
F5.1 Defecation control 0 Irregular/incontinence 
1 Incontinence sometimes (once a week) 
2 Continence 
    
F5.2 Urinate control 0 Incontinence or using catheter and uncontrolled 
1 Incontinence sometimes (max. 1x24 hour) 
2 Independent 
    
F5.3 Ability to clean themselves (wash 
the face, to comb, brush the teeth) 
0 Need help 
1 Independent 
    
F5.4 Toilet use. To go to and from toilet 
(take off and wear trousers, wipe, 
flush) 
0 Dependent 
1 Need help in some activites but independent in others. 
2 Independent 
    
F5.5 Eat 0 Unable 
1 Need someone to cut the food 
2 Independent 
    
F5.6 Change position from lie down to 
sit up 
0 Unable 
1 Need help to sit (2 persons) 
2 Help from 1 person 
3 Independent 
    
F5.7 Mobility/walking 0 Unable 
1 Use wheel chair 
2 Walk with help from 1 person/walker 
3 Independent 
    
F5.8 Get dressed (put clothes on) 0 Dependent 
1 Partly dependent (e.g. buttoning shirt) 
2 Independent 
    
F5.9 Climb up and down stairs 0 Unable 
1 Need help from others 
2 Independent (climb up and down) 
    
F5.10 Take a bath 0 Dependent 
1 Independent 
    
 Total score  Criteria 
 
ADL Score: 20 : Independent 
12-19 : Lightly dependent  
9 – 11 : Moderately dependent  
5 – 8 : Heavily dependent  
  0 – 4  : Totally dependent  
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Appendix F 
Instrumental Activities of Daily Living Questionnaire 
 
           Activities                                                                                  Criteria 
F6.1 Extending 
message/using 
the telephone 
0 I am unable to use the phone  
1 I am capable of answering phone but unable to 
operate it 
 
2 I am able to operate the phone  
 
F6.2 Shopping 0 I am unable to do any shopping  
1 I am capable of purchasing up to 3 items, 
otherwise I need help 
 
2 I do my shopping independently  
 
F6.3 Preparing meal 0 I am unable to cook  
1 I am able to cook if the ingredients are ready or 
to warm cooked food 
 
2 I cook independently  
 
F6.4 Housekeeping 0 I am unable to do the housekeeping  
1 I am able to do light tasks (sweeping, make the 
bed) only, but otherwise I need help 
 
2 I do the housekeeping independently (capable 
to do all household tasks including mopping and 
washing clothes) 
 
 
F6.5 Washing clothes 0 I am unable to wash my clothes  
1 I am able to wash light clothes or ironing, but 
otherwise need help 
 
2 I do my washing independently (using washing 
machine included) 
 
 
F6.6 Utilisation of 
transportation 
means 
0 I am unable to travel with any transportation 
means 
 
1 I travel on public transport/taxi or private car if I 
am helped/accompanied by another 
 
2 I travel independently  
 
F6.7 Responsibility of 
own medication/ 
preparing own 
medication 
0 I need help from others to prepare and 
consume my medication 
 
1 I am able to take it if medication is previously 
prepared 
 
2 I take my medication independently (I am able 
to prepared my own medication according to 
prescribed dose and time) 
 
 
F6.8 Ability to handle 
finances 
0 I am incapable at handling my own finances  
1 I am able to arrange my daily purchases but 
need help with banking/major purchasing 
 
2 I am able to manage financial problems 
(household budget, pay the rent, receipts, bank 
matters) or to monitor my income 
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Appendix G 
SF-36 Questionnaire (Health-related Quality of Life) 
 
1. In general, would you say your health is: 
            Excellent  
 Very Good 
 Good 
 Fair 
 Poor 
 
1 
2 
3 
4 
5 
2. Compared to one year ago, how would your rate your health in general now? 
Much better now than one year ago 
Somewhat better now than one year ago 
About the same 
Somewhat worse now than one year ago 
Much worse now than one year ago 
     
1 
2 
3 
4 
5 
 
  
The following items are about activities you might do during a typical day. Does your health 
now limit you in these activities? If so, how much? 
(Circle One Number on Each Line) 
 Yes, 
Limited a 
Lot  
Yes, Limited 
a Little  
No, Not 
limited at All  
3. Vigorous activities, such as running, lifting heavy 
objects, participating in strenuous sports 
[1]  [2]  [3]  
4. Moderate activities, such as moving a table, 
pushing a vacuum cleaner, bowling, or playing golf 
[1]  [2]  [3]  
5. Lifting or carrying groceries [1]  [2]  [3]  
6. Climbing several flights of stairs [1]  [2]  [3]  
7. Climbing one flight of stairs [1] [2] [3] 
8. Bending, kneeling, or stooping [1] [2] [3] 
9. Walking more than a mile [1]  [2]  [3]  
10. Walking several blocks  [1]  [2]  [3]  
11. Walking one block [1] [2] [3]  
12. Bathing or dressing yourself [1] [2] [3] 
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During the past 4 weeks, have you had any of the following problems with your work or other 
regular daily activities as a result of your physical health? 
(Circle One Number on Each Line) 
 Yes  No  
13. Cut down the amount of time you spent on work or other activities 1  2  
14. Accomplished less than you would like 1  2  
15. Were limited in the kind of work or other activities  1  2  
16. Had difficulty performing the work or other activities (for example, it took extra 
effort)  
1  2  
 
During the past 4 weeks, have you had any of the following problems with your work or other 
regular daily activities as a result of any emotional problems (such as feeling depressed or 
anxious)? 
(Circle One Number on Each Line) 
 Yes No 
17. Cut down the amount of time you spent on work or other activities 1  2  
18. Accomplished less than you would like 1  2  
19. Didn't do work or other activities as carefully as usual 1  2  
 
20. During the past 4 weeks, to what extent has your physical health or emotional problems 
interfered with your normal social activities with family, friends, neighbors, or groups? 
(Circle One Number) 
Not at all 1 
Slightly 2 
Moderately 3 
Quite a bit 4 
Extremely 5 
 
21. How much bodily pain have you had during the past 4 weeks? 
(Circle One Number) 
None 1 
Very mild 2 
Mild 3 
Moderate 4 
Severe 5 
Very severe 6 
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22. During the past 4 weeks, how much did pain interfere with your normal work (including 
both work outside the home and housework)? 
(Circle One Number) 
Not at all 1 
A little bit 2 
Moderately 3 
Quite a bit 4 
Extremely 5 
 
These questions are about how you feel and how things have been with you during the past 4 
weeks. For each question, please give the one answer that comes closest to the way you have 
been feeling. 
How much of the time during the past 4 weeks . . . 
(Circle One Number on Each Line) 
 All of 
the 
Time 
Most of 
the 
Time 
A Good Bit 
of the 
Time 
Some of 
the Time 
A Little 
of the 
Time 
None of 
the Time 
23. Did you feel full of pep? 1  2  3  4  5  6  
24. Have you been a very 
nervous person? 
1  2  3  4  5  6  
25. Have you felt so down in 
the dumps that nothing could 
cheer you up? 
1  2  3  4  5  6  
26. Have you felt calm and 
peaceful? 
1  2  3  4  5  6  
27. Did you have a lot of 
energy? 
1  2  3  4  5  6  
28. Have you felt downhearted 
and blue? 
1  2  3  4  5  6  
29. Did you feel worn out? 1  2  3  4  5  6  
30. Have you been a happy 
person? 
1  2  3  4  5  6  
31. Did you feel tired?  1  2  3  4  5  6  
 
32. During the past 4 weeks, how much of the time has your physical health or emotional 
problems interfered with your social activities (like visiting with friends, relatives, etc.)? 
(Circle One Number) 
All of the time 1 
Most of the time 2 
Some of the time 3 
A little of the time 4 
None of the time 5 
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How TRUE or FALSE is each of the following statements for you. 
(Circle One Number on Each Line) 
 Definitely 
True 
Mostly 
True  
Don't 
Know  
Mostly 
False  
Definitely 
False  
33. I seem to get sick a little easier 
than other people  
1  2  3  4  5  
34. I am as healthy as anybody I 
know  
1  2  3  4  5  
35. I expect my health to get 
worse  
1  2  3  4  5  
36. My health is excellent  1  2  3  4  5  
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Appendix H 
Randomised Controlled Trial Participant Questionnaire 
Participant ID: ……………     
 
1. Date of Birth: ……./……./19…… 
 
2. Gender (please circle):  male / female 
 
3. What is your occupation? (please tick): 
Higher manager, admin or professional … 
Intermediate manager, admin or professional … 
Supervisory or clerical, junior manager, admin or professional … 
Skilled manual … 
Semi or unskilled manual … 
Retired … 
 
4. What is the highest level of education you have completed? (please tick): 
Primary … 
Secondary … 
College, diploma or equivalent … 
University Degree (undergraduate) … 
University Degree (postgraduate) … 
 
5. What is your marital status? (please tick): 
Single… 
Married… 
Separated… 
Widowed… 
 
6. Do you have children? (please circle): yes / no 
If yes, how many? …….. 
 
7. Do you or have you in the past suffered from any of the listed medical conditions? (please 
tick) 
- Diabetes mellitus … 
- Endocrine problems (prostate/testicular) or hypofunction of the thyroid … 
- Coronary heart disease/arrhythmia/ myocardial infarct/stroke … 
- Asthma or other lung disease … 
- Thrombosis or other blood (clotting) disorder … 
- Digestive, gastrointestinal problems … 
- Dementia (e.g. Alzheimer's disease) … 
- Cancer or benign growths (polyps etc.) … 
- Vision / ear / hearing problems … 
- Kidney or liver problems … 
- Allergies (please state) ………………………………………………………………………. 
- Other (please circle): lung or kidney disease, neurological (e.g. epilepsy, or mental 
health disorders e.g. depression for which you are receiving medical treatment) or 
(please state) 
……………………………………………………………………………………………………
…………………………………………………………………………………………………… 
Are you still receiving medical treatment for these conditions now? (please circle) yes / no 
 
8. Do you have any memory complaints? (please circle): yes / no 
 
9. Has anyone in your direct family (e.g. parent, sibling) suffered from dementia or memory 
problems? (please circle): yes / no 
 
10. Do you have a physically demanding job? (please circle): yes / no 
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Appendix I 
Resistance training exercises 
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Appendix J 
Exercise diaries 
 
Resistance intervention: 
 
Participant ID………….. 
Week Date AM or PM Resistance level used / # reps Completed? (tick) 
1     
    
    
2     
    
    
3     
    
    
4     
    
    
5     
    
    
6     
    
    
7     
    
    
8     
    
    
9     
    
    
10     
    
    
11     
    
    
12     
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Flexibility intervention: 
 
Participant ID………….. 
Week Date Time (AM/PM) Completed?  
1    
   
   
2    
   
   
3    
   
   
4    
   
   
5    
   
   
6    
   
   
7    
   
   
8    
   
   
9    
   
   
10    
   
   
11    
   
   
12    
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Appendix K 
Hospital Anxiety and Depression Scale 
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Appendix L 
Social Support Questionnaire 
 
Please rate on a scale of 1-7 how well your social networks provide the type of 
support or help that is listed in the left hand column as follows. 
 
   1 2 3 4 5 6 7 
                 Never       Sometimes        Always 
 
 
To what extent can you:           Friends / Family/ Colleagues 
Trust, talk frankly and share feelings with?   …..    …..        ….. 
Lean on and turn to in times of difficulty?   …..    …..        ….. 
Get interest, reassurance and a good feeling about you? …..    …..        ….. 
Get physical comfort?      …..    …..        ….. 
Resolve unpleasant disagreements if they occurred? …..    …..        ….. 
Get financial and practical help?    …..    …..        ….. 
Get suggestions, advice and feedback?   …..    …..        ….. 
Visit them or spend time with them socially?   …..    …..        ….. 
Get help in an emergency?     …..    …..        ….. 
Share interests and hobbies and have fun with?  …..    …..        ….. 
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Appendix M 
Lifestyle Questionnaire 
 
 
 
 
